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Tbx6 is a member of the T-box family of transcription factors that is expressed within the 
primitive streak and presomitic mesoderm of the developing mouse embryo and is critical for the 
patterning and specification of the paraxial mesoderm. This work has investigated how Tbx6 
interacts with other T-box transcription factors both in its endogenous expression domain and 
when it is ectopically expressed.  To this end, we have used a combined genetic, transcriptional, 
and biochemical approach to investigate potential competition between Tbx6 and T, a T-box 
transcription factor co-expressed with Tbx6 in the primitive streak and tailbud.  Additionally, we 
have developed a 3-component transgenic system to ectopically express Tbx6 outside of its 
endogenous domain, driving expression in the formed somites and limb buds.  Three-component 
embryos displayed vertebral, rib, and limb anomalies resembling those in Tbx15 and Tbx18 null 
embryos. We showed that ectopic Tbx6 in these embryos could compete with Tbx15 and Tbx18 
at the level of DNA binding.  This suggested that the dynamic interplay of co-expressed T-box 
transcription factors might contribute to observed congenital birth defects resulting from 
heterozygous loss of a particular family member.  While this work focused on one specific 
family of transcription factors, it implies that transcription factor family members that are related 
via a conserved DNA binding domain may also compete for downstream targets in vivo and that 
this then contributes to the overall developmental dynamics of the organism. 
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1.0  INTRODUCTION 
Generation of a multi-cellular organism from the fertilized egg is a remarkable process involving 
cell proliferation, cell differentiation, morphogenesis, and pattern formation. These carefully 
orchestrated processes ultimately result in formation of a functional organism and require many 
genes that are essential for survival of the embryo.  Tissue-specific transcription factors regulate 
distinct gene expression profiles in the developing embryo resulting in the generation of different 
cell types that exhibit distinct behaviors and functions. The T-box family of transcription factors 
are critical components of cell type specification, differentiation, and proliferation during 
embryonic development and when mutated result in specific syndromes in humans (Naiche et al., 
2005b).  Our lab is primarily interested in two T-box transcription factors, T and Tbx6, and their 
roles in mesoderm development in the mouse embryo.  Understanding how these critical 
transcription factors regulate mesoderm development can elucidate potential roles in congenital 
human birth defects.   
1.1 DEVELOPMENT OF THE MOUSE EMBRYO 
After fertilization, the single cell mouse embryo undergoes several rounds of cell division to 
form a ball of cells known as the blastocyst.  The blastocyst consists of two different cell types; 
the outside layer, the trophectoderm, which will give rise to the extra-embryonic tissues that 
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support development of the embryo and contribute to the formation of the placenta, and the 
pluripotent inner cell mass (ICM), which will form the embryo proper. Implantation into the 
mother’s uterus occurs at approximately embryonic day (e)4.5, after which the embryo will then 
elongate and form a hollow, cup-shape. As the embryo elongates, the ICM will contribute to the 
epiblast, from which the definitive ectoderm, mesoderm and endoderm are derived, as well as the 
extraembryonic mesoderm of the yolk sac, allantois, and amnion (Tam et al., 2006). The 
ectoderm will give rise to neural tissue and epidermis; mesoderm will form the kidneys, gonads, 
heart, skeletal muscle, and the skeleton; and endoderm will form the liver, pancreas, lungs, and 
gut (Tam and Loebel, 2007). 
1.1.1 Gastrulation and formation of the mesoderm  
During gastrulation the three germ layers of the embryo are established and assume their proper 
position in the embryo.  It is from these germ layers that all of the fetal tissues will develop. 
Gastrulation commences at e6.5 with the formation of the primitive streak (PS) at the posterior 
end of the embryo. At the PS, epiblast cells down-regulate E-cadherin, undergo an epithelial-to-
mesenchymal transition (EMT) then ingress through the PS (Zohn et al., 2006). The PS extends 
anteriorly as cells continue to ingress and migrate away. Fgf8, Fgf receptor-1 (Fgfr1), and 
Eomesodermin (Eomes, a T-box transcription factor) are crucial for this process, as embryos 
lacking either Fgf8, Fgfr1 or Eomes signaling fail to undergo the necessary EMT, and cells 
accumulate in the vicinity of the PS but fail to ingress (Ciruna and Rossant, 2001; Deng et al., 
1994; Russ et al., 2000; Sun et al., 1999). 
The timing and position that cells exit the PS determine the type of mesoderm generated: 
axial (node, notochord), paraxial (somites), intermediate (kidneys, gonads), or lateral plate 
 2 
(splanchnic, somatic mesoderm) (Tam and Beddington, 1987). Our lab is primarily interested in 
the specification and patterning of the paraxial mesoderm (PAM). The presumptive PAM 
migrates out of the anterior portion of the PS and assumes a position lateral to the axial 
mesoderm thus establishing the bilateral presomitic mesoderm (PSM) (Hatada and Stern, 1994). 
After closure of the neuropore at e10.5, mesoderm, including PAM, is generated by the tailbud, a 
mass of cells at the caudal extremity of the embryo, which continues to extend the body axis 
until approximately e13.5 of development (Tam and Tan, 1992).  In the chick, removal of the PS 
and node terminates axis elongation (Packard, 1978). Similarly, in the early somite stage mouse 
embryo, removal of the PS terminates somite formation and truncates the body axis (Smith, 
1964).  These studies demonstrate the necessity of the PS for generating all posterior structures. 
Cells derived from the PS at e7.5 and transplanted under the kidney capsule generate 
teratomas that contain a variety of mature tissues originating from each of the three germ layers, 
demonstrating the pluripotent capacity of cells in the PS. Identical transplant experiments 
performed with caudal fragments of e8.5 and e9.5 embryos revealed a prominence of 
mesodermal derivatives such as muscle, adipose, and skeletal elements, as well as glandular and 
intestinal epithelium. These teratomas derived from later staged explants showed discernibly less 
mature neural tissue in e8.5 grafts and only trace amounts in e9.5 grafts, and displayed 
differentiated tissue types earlier than grafts from e7.5 embryos.  These observations indicate a 
progressive restriction of the histogenic capacity of the original progenitor populations, with the 
e7.5 fragments generating adult tissues belonging to both the cranial and caudal body levels, but 
older fragments giving rise to tissues predominantly found in the caudal level.  This progressive 
restriction of histogenetic capacity may be a genuine reflection of the functional capacity of the 
PS in normal anterior-posterior development of the embryo (Tam, 1984). 
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1.1.2 Somitogenesis 
A hallmark of vertebrate embryogenesis is the formation of the somites, regularly spaced blocks 
of tissue flanking either side of the central neural tube. Somites are formed as the PSM segments 
in an anterior-to-posterior fashion via a mesenchymal-to-epithelial transition (MET) (Duband et 
al., 1987).  The somite whose boundary is forming is denoted somite 0 (S0); the next somite 
anterior to this is S+1, and so on.  After segmentation, somites become patterned by signals from 
the notochord, neural tube, surface ectoderm, and lateral mesoderm. The dorsal part of the somite 
will differentiate into the dermamyotome under the influence of signals from the surface 
ectoderm and roof-plate of the neural tube, while the ventral portion receives signals from the 
notochord and floor-plate of the neural tube to become the sclerotome (Figure 1).  The 
dermamyotome, which will give rise to the dermatome and myotome, and sclerotome will 
ultimately go on to form the dermis, skeletal muscle, ribs, and vertebrae of the adult animal, 
respectively (Christ and Ordahl, 1995). 
Maturation of the PSM along the anterior-posterior axis coincides with changes in 
molecular properties of the cells and gene expression profiles. Within the PS/PSM, expression of 
the secreted signaling molecules wnt3a and Fgf8 is at the highest level posteriorly, with lower 
levels in the anterior (Aulehla et al., 2003; Dubrulle et al., 2001). Fgf8 plays a key role in 
maintaining the undifferentiated mesenchymal state of the PSM, and wnt3a is required for proper 
anterior-posterior boundary positioning in the segmenting PSM (Aulehla et al., 2003; Dubrulle et 
al., 2001; Dunty et al., 2008). Additionally, retinoic acid (RA, a signaling molecule derived from 
vitamin A) is found in a reverse gradient to that of Fgf8 and wnt3a and functions to coordinate 
somite formation across the left-right axis of the embryo (Moreno and Kintner, 2004).  Embryos 
that lack Retinaldehyde dehydrogenase type 2 (Raldh2), the gene encoding the retinoic 
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biosynthetic enzyme necessary for processing vitamin A to RA, display small somites with left-
right asymmetry defects due to a loss of coordination of clock oscillations across the left-right 
axis (Vermot and Pourquie, 2005).  
Expression of several other genes oscillates to comprise a molecular segmentation clock. 
Molecular evidence of the segmentation clock was first revealed with the discovery of the cyclic 
expression of c-hairy1 in the chick, which begins in as broad expression in the posterior (stage I) 
and progressively proceeds as a wavefront (stage II) which is subsequently restricted as an 
intensified band in the anterior PSM (stage III), and coincides with the amount of time it takes 
one somite to form embryo.  c-hairy1 is a transcription factor of the hairy/enhancer-of-split 
(HES) family that is downstream of the Notch signaling pathway (Palmeirim et al., 1997).  
In the mouse, hairy/HES family of transcription factors, Hes1 and Hey2, are expressed in 
a similar fashion to c-hairy (Jouve et al., 2000; Leimeister et al., 2000). Each wave of cycling 
genes are expressed every 90 minutes, and are progressively restricted to the anterior region of 
the PSM, where the next segment will form (Pourquie, 2001). Notch signaling pathway 
components play critical roles in somitogenesis and establishing the periodicity of the 
segmentation clock. Defects in somitogenesis have been reported in mice with mutations in 
Notch1, Dll1, Dll3, Lfgn, and RBP-Jκ (Conlon et al., 1995; Hrabe de Angelis et al., 1997; 
Kusumi et al., 1998; Oka et al., 1995; Zhang and Gridley, 1998), with mutations in Notch1, RBP-
Jκ, and Dll1 ultimately causing embryonic lethality.  Notch is a large transmembrane receptor.  
Upon binding of the membrane-bound Notch ligand, Delta (Dll), the receptor undergoes a γ-
secretase proteolytic cleavage event catalyzed by the presenilin family of proteins to release the 
Notch intracellular domain (NICD) (Selkoe and Kopan, 2003).   The NICD then translocates to 
the nucleus where it associates with the transcription factor RBP-Jκ to activate expression of 
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downstream targets (Artavanis-Tsakonas et al., 1999).  Affinity of Notch for its ligands can be 
modified by glycosylation in the Golgi by Fringe proteins (Artavanis-Tsakonas et al., 1999).  
Interestingly, the expression of Lunatic Fringe (Lfgn) in the mouse PSM is reminiscent of c-
hairy1 expression (Aulehla and Johnson, 1999; Evrard et al., 1998).  While Fringe family 
members can act to either potentiate or inhibit Notch signaling, Lfgn has been shown to inhibit 
Notch mediated signaling in the anterior PSM to allow segmentation (Dale et al., 2003). 
After each wave of Notch signaling, expression of Dll3 becomes stabilized in the anterior 
of the newly segmented somite, while Dll1 becomes stabilized in the posterior, setting up 
molecular differences between the anterior and posterior halves of somites.  These molecular 
differences are critical for both initial segmentation and later for resegmentation. During 
resegmentation the sclerotome region segments again with the posterior part of one somite fusing 
to the anterior half of the next somite to form the vertebral unit. Thus, a vertebral unit is 
composed of cells from two adjacent somites, resulting in the attachment of one muscle group to 
two consecutive vertebrae (Huang et al., 2000a) (Figure 1).  Additionally, proper anterior-
posterior specification is required for migration of the spinal ganglia, which migrate exclusively 
through the anterior somite halves. A defect in anterior-posterior patterning of the somites can 
therefore also have deleterious effects on the peripheral nervous system in addition to the 
vertebrae (Bronner-Fraser, 2000).   
The importance of proper somite patterning is highlighted by several human congenital 
birth defects. Mutations in DLL3 and a missense mutation in LFNG contribute to the etiology of 
spondylocostal dysostosis, a congenital birth defect that results in hemivertebrae and fusion of 
ribs resulting in a shortened body axis (Bulman et al., 2000; Sparrow et al., 2006). In addition, 
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improper pattering of the somites may lead to more common vertebral disorders, such as 
congenital scoliosis, which is genetically complex (Sewell and Kusumi, 2007).  
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Figure 1: Schematic of Mouse Somitogenesis  
(A) Somite segmentation from the mesenchymal tailbud (TB) forms an epithelial somite that flanks either 
side of the central neural tube (blue). Establishment of anterior (A) – posterior (P) polarity is essential for 
proper re-segmentation of the somites, which joins the posterior portion of each sclerotome with the 
anterior half of the next most posterior sclerotome, allowing for proper patterning of the vertebrae and 
attachment of muscles. (B) Cross-section depicting differences in anterior and posterior somite maturation. 
Somitic cells closest to the surface ectoderm become dermamyotome (DM), which gives rise to the 
dermatome and myotome. Ventral somitic cells receive signals from the notochord and ventral neural tube 
to become the sclerotome.  
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1.2 T-BOX GENES AND REGULATION OF DEVELOPMENT 
Tissue-specific transcription factors regulate distinct gene expression profiles in the developing 
embryo resulting in the generation of different cell types with unique behaviors. Genetic and 
molecular evidence has linked the T-box family of transcription factors to important processes in 
cell type specification, differentiation, and proliferation in a variety of different model organisms 
including humans. This family of transcription factors share a conserved DNA binding domain 
(DBD) comprised of approximately 180 amino acids (Tada and Smith, 2001).  
The T-box family of transcription factors play critical roles during embryonic 
development such that when mutated result in specific syndromes in humans (Naiche et al., 
2005b).  The common DBD shared between T-box transcription factors raises the question of 
how T-box transcription factors that are co-expressed establish specificity for downstream 
targets. Research has only begun to uncover the variety of ways in which T-box transcription 
factors interact when co-expressed to regulate transcription of downstream targets. Many studies 
have revealed synergistic, additive, and competitively antagonistic mechanisms in which T-box 
factors can interact with endogenous enhancers. 
1.2.1 Precedence for competition between T-box transcription factors 
The founding member of the T box transcription family is Brachyury, or T.  The role of T in 
development is discussed in more detail in section 1.3.  Initial experiments with T in a PCR-
based binding site selection experiment showed that T binds to the twenty nucleotide 
palindromic sequence T(G/C)ACACCTAGGTGTGAAATT (Kispert and Hermann, 1993).  All 
T-box proteins tested to date can bind the T palindromic target sequence in vitro, however in 
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vivo they have unique targets suggesting that other regions of T-box proteins or non-conserved 
changes within the T-domain determine target selection (Carreira et al., 1998; Hsueh et al., 2000; 
Macindoe et al., 2009; Tada et al., 1998; White and Chapman, 2005). The conserved nature of 
the T-box DBD allows for all T-box transcription factors to bind to the core half-site, 5’-
AGGTGT-3’, which is contained within the palindrome, with bases outside of this being more 
variable.   The crystal structure for the DBDs of Xenopus homolog of T, Xbra, and human TBX3 
bound to the canonical palindromic binding site revealed that conserved amino acids made 
contacts with the DNA, supporting the strong conservation of binding preferences (Coll et al., 
2002; Muller and Herrmann, 1997) (Figure 2).  In tissues where more than one T-box 
transcription factor are expressed, functional specificity is at least in part determined by 
preferences for orientation and spacing of the half-sites, differences in bases flanking the 
conserved core, and physical interactions with differing co-factors (Conlon et al., 2001; 
Messenger et al., 2005).   
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Figure 2: Crystal structures of Xbra and TBX3 in complex with the palindromic binding site 
Crystal structure of the DNA binding domain of Xenopus Brachyury (Xbra) and human TBX3 in complex 
with the 24 bp palindromic T-box binding site reveals strong conservation of overall structure and amino 
acids that directly contact the bases. Tbx3 binds as two monomers to the palindromic sequence, while Xbra 
homodimerizes.  Crystal structures were obtained from the protein data bank at www.pdb.org, and 
originally published in (Coll et al., 2002; Muller and Herrmann, 1997). 
There are 22 identified human T-box proteins, and thus there are many instances in vivo 
where multiple T-box proteins are co-expressed within a particular tissue. We are interested in 
how multiple T-box proteins coordinate the regulation of downstream targets. Due to the 
conserved nature of the DBD, it is possible for co-expressed T-box factors to compete with each 
other for targets, cooperate in activation or repression of targets, or have completely different 
targets due to differences in binding preferences. 
In vivo, many T-box proteins compete for binding sites within the enhancers of common 
target genes.  For example, in mouse heart formation, Tbx2, a transcriptional repressor, is 
expressed in a subdomain of cardiac progenitors that also express the transcriptional activator 
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Tbx5.  Tbx2 and Tbx5 compete for binding to T-box binding elements in the ANF enhancer 
(Habets et al., 2002). Additionally, Tbx18 (a transcriptional repressor) can compete with Tbx5 
for binding the ANF enhancer in the sinus horn mesenchyme of the heart, which is devoid of 
ANF expression (Farin et al., 2007).  Competition has also been observed between T-box 
transcription factors in zebrafish mesoderm formation.  The function of no-tail (ntl) is required in 
the dorsal mesoderm to promote differentiation of MyoD expressing adaxial cells, which is 
antagonized by tbx6 within the ventrolateral mesoderm.  Ectopic expression of tbx6 within the 
ntl expression domain is sufficient to elicit a ntl hypomorphic phenotype (Goering et al., 2003). 
Although it is apparent that the preferences of different T-box factors for orientation and 
spacing of half-sites and sequences flanking the core differ, what exactly contributes to the 
differences in specificity is still a point of contention. Conlon et al. (2001) suggested that 
specificity for differing targets could lie within non-conserved amino acid within the T-domain 
in residues that contact the DNA (Conlon et al., 2001). These studies in Xenopus with the co-
expressed mesoderm inducing T-box factors Xbra, Eomes, and VegT confirmed differing 
preferences for orientation and spacing of half-sites, and sequences flanking the core half-site.  
VegT and Eomes induced Pintovallavis, Xsox17α, goosecoid, Xwnt8, Mix1, Xwnt11, and Bix4, 
while Xbra induced only Xwnt11, Bix4, and weakly Pintavallavis.  Studies with chimeric 
versions of these proteins where the DBDs were swapped revealed that much of the specificity of 
T-box transcription factors lies within the DBD, such that chimeric versions of the proteins are 
able to activate downstream targets according to the T-box sequence they contain.  Superposition 
of the VegT and Eomes DBD onto the pre-exisiting Xbra crystal structure revealed two amino 
acid differences at DNA contact points.  The amino acid substitution at position 214 is 
conserved, replacing an alanine in Xbra with a glycine in Eomes and VegT, and was therefore 
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not further investigated. All T homologs contain a basic lysine (K) at residue 149, while VegT 
and Eomes contain the neutral polar asparagine (N), leading to the hypothesis that the amino acid 
at position 149 may confer specificity.  N149K mutations within VegT and Eomes resulted in 
loss of activation of the VegT and Eomes targets goosecoid, and Pintavallavis, but not the Xbra 
specific Xwnt11 and Bix4, suggesting that the residue at 149 may play a key role in specificity 
(Conlon et al., 2001).   
Whether amino acid 149 is involved in conferring specificity is debatable as residue 149 
contacts only the phosphate backbone, and does not make a base-specific contact (Muller and 
Herrmann, 1997). In addition, the reciprocal mutation (K149N) within Xbra does not result in 
activation of VegT and Eomes specific targets such as goosecoid.  Moreover, others have found 
that the N149K mutations within VegT and Eomes only confered an overall decrease in 
activation, not a switch in target gene preference (Messenger et al., 2005).  Altogether, the data 
suggests that specificity may not be conferred by this particular amino acid (Messenger et al., 
2005; Muller and Herrmann, 1997).   
If the specificity of Xbra, VegT, and Eomes does not lie within residue 149, where does 
the specificity come from?  Messenger et al. (2005) suggested that the specificity of Xbra lies 
within the N-terminal domain, and demonstrated that chimeric proteins where the N-terminal 
domains are swapped between VegT and Xbra behave differently. The N-terminal domain of 
Xbra directly interacts with Smad1, the BMP pathway component, in a BMP-dependent manner. 
Xbra, in conjunction with Smad1, activates the expression of Xenopus Eomesodermin (Xom), a 
direct repressor of goosecoid expression (Messenger et al., 2005; Trindade et al., 1999).  
Additionally, morpholino mediated knockdown of Xom allows Xbra to induce expression of 
goosecoid.  Therefore, it has been proposed that it is an indirect pathway that is responsible for 
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the apparent inability for Xbra to activate goosecoid, such that Xbra mediated expression of Xom 
represses any Xbra mediated expression of goosecoid (Messenger et al., 2005).   
More recent studies have investigated the binding kinetics of T-box factors (Macindoe et 
al., 2009).  As might be expected, differences in binding site affinity can contribute to 
transcriptional activity at specific enhancers. Although T-box factors all bind to the same 
consensus binding sequence, surface plasmon resonance (SPR) experiments with the DBDs of 
Tbx20, Tbx2, and Tbx5 and immobilized half-site core sequence revealed differences in the 
relative affinities and kinetics of binding between factors. Tbx5-DBD binds more tightly to the 
half-site, with a binding affinity of 0.2x10-6 M.  Tbx20-DBD and Tbx2-DBD bound with an 
affinity of 0.9x10-6 M and 1.5x10-6 M, respectively.  In addition, Tbx5-DBD associated with the 
oligonucleotide twenty times quicker than either Tbx20-DBD or Tbx2-DBD, and only 
disassociated five times quicker. This indicates that specificity for particular orientation and 
spacing of half-sites in addition to overall binding dynamics such as on- and off-rates contribute 
to the overall activation ability of T-box transcription factors (Macindoe et al., 2009).  
It is clear that different T-box transcription factors differentially activate targets and have 
differing preferences for orientation and spacing of half-sites.  Whether or not amino acid 
substitutions within the T-domain or other portions of the protein lend specificity for a particular 
target is currently unresolved.    
1.2.2 Interaction with co-factors partially determines transcriptional activity  
As the DBD is the only region of homology shared among T-box transcription factors, regions 
outside of the DBD can interact with a wide variety of other specific factors. For the most part, 
the activation and/or repression domains are found within the C-terminus of the protein (Conlon 
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et al., 2001).  Thus far most T-box factors have been found to act as a transcriptional activator or 
repressor (Kawamura et al., 2008), however Tbx20 contains both a strong activation and 
repression domain, and therefore can act as both a transcriptional activator or repressor 
depending on the context (Brown et al., 2005).  In the zebrafish, the Groucho/TLE associated co-
repressor, Ripply1, associates with No-tail (Ntl) and Tbx24 to convert them from transcriptional 
activators to repressors (Kawamura et al., 2008). 
 The interaction of T-box factors with other transcription factors can also result in 
synergistic activation of target genes.  T-box interacting factors include members of the 
homeodomain, GATA zinc finger, and LIM domain families (Naiche et al., 2005b). Tbx2 and 
Tbx5 both interact with Nkx2.5 in the developing heart (Habets et al., 2002), suggesting that 
competition for common co-factors could also potentially regulate their activity. T-box 
transcription factors can also heterodimerize. In the developing heart, it has been shown that 
Tbx20 and Tbx5 can directly interact via the N-terminal and T-box region to synergistically 
activate downstream targets (Brown et al., 2005).    
1.2.3 T-box transcription factors and human health 
Most of the known autosomal human syndromes related to mutation of T-box transcription 
factors occur in heterozygous individuals (haploinsufficiency). Presumably, homozygous 
mutations would result in embryonic lethality resulting in miscarriage (Naiche et al., 2005b).  A 
comparison of human and mouse phenotypes associated with mutation of T-box factors is 
presented in Table 1.  Similarities between mouse and human phenotypes associated with 
haploinsufficiency of T-box factors allow for the mouse to serve as an exceptional model system 
of human congenital disorders associated with T-box factors.   
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  Heterozygous mutations in human TBX1, TBX3, TBX4, TBX5, and TBX22 result in the 
human syndromes DiGeorge, ulna-mammary, small patella, Holt-Oram, and X-linked cleft palate 
with ankyloglossia, respectively (Baldini, 2003; Bamshad et al., 1997; Basson et al., 1997; 
Bongers et al., 2004; Braybrook et al., 2001). Recessive mutations in TBX15 and TBX19 result in 
Cousin’s syndrome and adrenocorticotrophic hormone (ACTH) deficiency, respectively (Asteria, 
2002; Lausch et al., 2008). We hypothesize that in syndromes associated with 
haploinsufficiency, the presence of other T-box transcription factors in the same tissues may play 
a role in the phenotypes observed. 
Investigation into ten different naturally occurring missense alleles of TBX22 reveals that 
those causing the X-linked cleft palate phenotype occur in residues within the DBD that are in or 
near predicted DNA contact points (Andreou et al., 2007).  This results in proteins that are 
unable to bind DNA stably as assayed by electrophoretic mobility shift assays (EMSAs). 
Interestingly, a G118C missense mutation within TBX22 occurs in a conserved DNA contact 
residue and results in the inability to bind to DNA (Andreou et al., 2007), similar to the situation 
with Tbx5, where a missense mutation at the same position (G80R) also abolishes DNA binding 
and leads to Holt-Oram syndrome (Ghosh et al., 2001).  Mutations within the DBD of TBX20 
also have been found to contribute to the etiology of congenital heart disease (Liu et al., 2008).  
In contrast, a mutation in TBX22 outside of DNA the contact points in α helix 2 (E187K) does 
not alter DNA binding (Andreou et al., 2007).  In total, this suggests that mutation of critical 
DNA contact residues of T-box transcription factors reduce binding ability and may contribute to 
the etiology of congenital birth defects. 
In addition to contributing to congenital birth defects, misregulation of several T-box 
transcription factors has been implicated in the development of cancer.  Several lines of evidence 
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link T-box transcription factors to control of cell proliferation and tumorigenesis.  TBX2 is 
located within a segment of DNA that is often upregulated in breast and pancreatic cancers, 
resulting in over-expression of TBX2 in 10% of breast tumors (Barlund et al., 2000). Murine 
Tbx2 represses the expression of N-myc1 in the atrioventricular canal and outflow tract of the 
developing heart, where low proliferation is observed (Cai et al., 2005).  N-myc is required for 
early cardiac proliferation, and over-expression has been linked to childhood tumors (Davis et 
al., 1993). Additionally, over-expression of both TBX2 and TBX3 has been molecularly linked to 
the p53 pathway and ultimately results in genomic instability (Carlson et al., 2001; Jacobs et al., 
2000).  Genomic rearrangements that increase the copy number of T, which is essential for 
notochord patterning, are implicated in the development of familial chordomas (Yang et al., 
2009).   
Clearly, unraveling how T-box factors interact when co-expressed to control transcription 
of downstream targets is of utmost importance to understand the developmental basis of several 
congenital birth defects, as well as some cases of cancer.  This makes understanding the T-box 
family of transcription factors of relevant to human health.  
 17 
 Table 1: Comparison of human and mouse phenotypes associated with mutation of T-box 
transcription factors 
Gene Human Syndrome Human Phenotype 
Mouse 
heterozygous 
phenoype 
Mouse 
homozygous 
phenotype 
T (Brachyury) 
Congenital vertebral 
malformations 
(haploinsufficiency) 
Fusions/malformations 
of vertebral column Shortened tail 
Severe 
truncation of 
body axis; lethal 
Tbx1 DiGeorge (haploinsufficiency) 
Craniofacial, 
glandular, vascular 
and heart 
abnormalities 
Thymus and 
vascular 
abnormalities 
Craniofacial, 
glandular, 
vascular, heart 
abnormalities; 
lethal 
Tbx3 Ulnar-mammary (haploinsufficiency) 
Hypoplastic mammary 
glands, abnormal 
external genitalia, 
limb abnormalities 
Hypoplastic 
mammary 
glands, 
abnormal 
external 
genitalia 
Yolk sac, limb, 
mammary gland 
defects; lethal 
Tbx4 Small patella (haploinsufficiency) Reduced patella 
Reduced 
allantois growth 
Allantois, 
hindlimb 
defects; lethal 
Tbx5 Holt-Oram (haploinsufficiency) 
Heart and hand 
abormalities 
Heart 
abnormalities 
Severe heart 
malformations; 
lethal 
Tbx15 Cousin’s (recessive) Craniofacial, limb malformations Normal 
Craniofacial 
defects, limb 
defects, pigment 
pattern 
alterations; 
viable 
Tbx19 ACTH deficiency (recssive) 
Deficient production 
of adrenocorticotropic 
hormone from 
pituitary 
Normal 
ACTH 
deficiency, 
pigment defects; 
viable 
Tbx22 
X-linked cleft palate 
with ankyloglossia 
(haploinsufficiency) 
Cleft palate, 
ankyloglossia Not known Not known 
Table adapted from (Naiche et al., 2005b). 
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1.3 BRACHYURY IS ESSENTIAL FOR MESODERM FORMATION 
Brachuyruy (T) was first discovered as a spontaneous mutation deleting a 160 kb region on 
chromosome 17, resulting in a short tail phenotype in heterozygotes and embryonic lethality in 
homozygotes with severe axis truncations (Dobrovolskaia-Zavadskaia, 1927). Early mutant 
analyses suggested that T played a critical role in mesoderm formation, although the specific 
function of T was not elucidated until the advent of modern molecular techniques.  Cloning of 
the T gene revealed that the original T mutation resulted from a 200 kilo-base (kb) deletion 
(Herrmann et al., 1990). Furthermore, cloning of T allowed for the first biochemical studies to 
elucidate the function of T as a tissue specific transcription factor which binds to a 24 base-pair 
(bp) palindromic sequence (Kispert and Hermann, 1993; Kispert et al., 1995). Other members of 
the family of T-box transcription factors were identified through their homology to the T-
domain. Degenerate PCR primers for conserved regions of the T-box amplified a family of 
transcription factors with similar DNA binding properties (Bollag et al., 1994).  Initial studies 
performed with T paved the way for similar studies performed with other later discovered T-box 
family members to further characterize the family.  
1.3.1 T expression patterns and mutant analysis 
In the mouse, T transcripts are first detectable at e5.5 in the proximal epiblast in a population of 
cells by the embryonic-extraembryonic junction (Thomas and Beddington, 1996). At e7.0, T is 
present within the nascent PS, and at later stages is present in the node and notochord, however it 
is down-regulated in the paraxial and lateral plate mesoderm. Expression of T persists in the 
tailbud until axis extension is complete at e13.5 (Wilkinson et al., 1990) (Figure 3B). 
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T heterozygous mutants have a short tail, while T homozygous null embryos display 
severe axis truncations posterior to the forelimb bud, suggesting dosage of T is critical (Figure 
3C). The homozygous mutant phenotype is first morphologically apparent at e8.5 as mutants fail 
to extend the notochord, and have a small allantois (Chesley, 1935). T homozygous mutants have 
a discontinuous notochord and form only 7-9 abnormal, anterior somites.  The allantois, 
notochord, and PAM are all derived from the PS (Beddington et al., 1992). Ultimately, 
embryonic death at e10.0 occurs due to failure of the allantois, the embryonic precursor to the 
umbilical cord, to connect to the chorion.  
The phenotypes observed in T mutants are likely the result of defective mesodermal cell 
movements in the PS, which results in cells accumulating in the streak.  T/T mutant embryonic 
stem (ES) cells injected into a wild-type blastocyst displayed migration defects reminiscent of T 
null embryos at gastrulation and do not colonize trunk paraxial or lateral mesoderm, suggesting 
that T acts cell autonomously (Beddington et al., 1992; Wilson et al., 1995).  These observations 
led to the hypothesis that the T protein could be required to alter cell adhesion molecules during 
EMT so that nascent mesoderm can properly migrate out of the PS.  Cell mobility studies with 
zebrafish ntl, the ortholog of T, also support this hypothesis, noting that later staged convergent-
extension movements were defective, suggesting conservation of function (Glickman et al., 
2003).  Additionally, the T mutant phenotype is strikingly similar to the phenotype of integrin α5 
null embryos, suggesting that T may act upstream.  Integrin α5 is involved in cell-matrix 
recognition, and may therefore play a role in cell migration during gastrulation (Goh et al., 
1997). 
Further evidence for migration defects in the T null mutant embryos comes from studies 
of explanted PS tissue.  Mesodermal cells isolated from PS-staged mouse embryos cultured in 
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vitro on extracellular matrix (ECM) exhibit behaviors similar to that inside of the embryo in 
terms of cell shape, rate of movement, and cell division (Hashimoto et al., 1987).  PS tissue 
explanted from a T null mutant displayed identical cell morphology and rate of cell division, but 
had a slower rate of movement as compared to wild-type cells (39.4 μm/h and 52.8 μm/h, 
respectively).  In wild-type populations approximately 10% of cells moved rapidly (over 80 
μm/h), whereas no cells moved rapidly in T null populations, further suggesting that loss of T 
affects cell migration that contributes to the T mutant phenotype. 
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Figure 3: T expression patterns and mutant phenotypes 
(A) Domain structure of T.  Activation (A) and repression (R) domains are depicted (Kispert et al., 1995).  
Truncation of the protein in the TWis allele occurs at amino acid 345. (B) In situ hybridization at e7.5 
reveals T expression within the PS and node.  At e10.5, T is expressed within the tailbud (arrowhead).  (C) 
In situ hybridization for Tbx6 reveals expression in the tailbud (closed arrowhead) and PSM (open 
arrowhead), and myogenin (red arrows) in a normal (N) e10.5 embryo.  In a T mutant, expression of Tbx6 is 
lost.  Myogenin expression is restricted to two irregular anterior somites (arrowhead) and truncation of the 
body axis occurs shortly after the forelimb bud (fl). 
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1.3.2 Biochemical studies reveal that T functions as tissue-specific transcription factor 
Landmark biochemical studies revealed that T binds to 24 bp almost perfect palindromic 
sequence, with a core half-site sequence of 5’-AGGTGT-3’, with the TGT triplet providing the 
majority of the physical contact points. This DNA binding property is conferred by the first 227 
amino acids (AA) of the protein (out of 436 AA total), identical to that of the Xenopus and 
zebrafish orthologs (Kispert and Hermann, 1993). Furthermore, T functions as a tissue-specific 
transcription factor, with two transcriptional activation and two repression domains contained 
within the C-terminus of the protein (AA 230-436) and a cryptic nuclear localization sequence 
(NLS) contained between AA 137 and 320 (Kispert et al., 1995) (Figure 3A). 
Crystallographic studies of the T-domain (DBD) of Xbra in complex with the 24 bp 
palindromic sequence revealed T bound as a dimer.  Each monomer consisted of a seven-
stranded β−barrel, with a novel sequence specific DNA recognition motif in which protein 
contacts are made both in the major and minor grooves of the DNA, contacting the phosphate 
backbone over 22 of the 24 bp.  Additionally, the T-domain was found to be a monomer in 
solution, and dimerized only upon contact with DNA (Muller and Herrmann, 1997) (Figure2). 
1.3.3 Placing T in a genetic pathway during mesoderm formation 
Although much is known about the mutant phenotypes, expression patterns, and biochemical 
properties of T, surprisingly little is known about the genetic pathways employed by T to elicit 
such effects. Several direct targets of T orthologs in Xenopus and zebrafish have been identified; 
but only Dll1 has been suggested to be a direct downstream target of T within the mouse genome 
(Hofmann et al., 2004).   Despite the paucity of known murine T targets, Xbra, the Xenopus 
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ortholog, is known to activate the expression of eFGF, Xwnt11 and Brachyury-induced-
homeobox (Bix4) in the marginal zone (Casey et al., 1998; Tada et al., 1998; Tada and Smith, 
2000).  eFGF and Bix4 are required for mesoderm formation and patterning, and Xwnt11 is 
required for gastrulation and convergent-extension movements via the non-canonical Wnt 
pathway.  Despite the identification of targets in Xenopus, a direct correlation between targets in 
other species cannot be made, as the mouse ortholog of the Bix/Mix family, Mml, which is 
expressed in the visceral endoderm, has been suggested to be a direct target of another T-box 
gene, Eomesodermin (Russ et al., 2000).   
 Targets of No-tail (Ntl), the zebrafish homolog of T have been elucidated using a 
chromatin immunoprecipitation followed by microarray analysis technique (ChIP-chip), utilizing 
mid-gastrula staged embryos (Morley et al., 2009).  This revealed that a homeobox transcription 
factor floating head (flh) is a direct target of Ntl in the notochord and is required to specify 
notochordal fate.  Additional targets identified by this method included genes required for 
specification of posterior fate, muscle cell fate, cell movements, and establishment of left-right 
asymmetry, with 27% of the genes identified encoding transcription factors including Hox, 
forkhead, and T-box factors.  Further investigation is required to understand the full degree of 
overlap between regulation of mesoderm formation by T orthologs in Xenopus, zebrafish, and 
other vertebrates.  
 Although there is only one suggested direct target of T in the mouse, the signaling 
pathways that control expression of T are better documented. wnt3a is expressed within the PS 
and is required for proper trunk and tail paraxial mesoderm, such that wnt3a mutants only form 
7-9 abnormal anterior somites. In wnt3a mutants, posterior somites do not form and instead an 
ectopic neural tube forms ventral to the normal axial neural tube. wnt3a embryos, initially 
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express T, but expression is lost by e8.5 (Takada et al., 1994). Elements necessary to drive the 
expression of T in the PS, but not in the node or notochord, lie 500 bp upstream of the start of 
transcription (Stott et al., 1993). Within this region are two canonical LEF1 binding sites.  
LEF/TCF transcription factors are the effector molecules of the Wnt signaling pathway, 
suggesting that wnt3a directly regulates expression of T in the PS. (Yamaguchi et al., 1999).  
Fgf8 is a secreted signaling molecule that is expressed in the epiblast at e5.75, and 
subsequently in the PS.  Fgf8 is critical for gastrulation and expression of T (Crossley and 
Martin, 1995).  Like the T mutant embryos, mesoderm fails to migrate away from the PS in Fgf8 
mutants.  A similar phenotype is also observed in Fgf Receptor-1 (Fgfr1) mutants, suggesting 
that Fgf8 binds to Fgfr1 during gastrulation to exert its effect (Ciruna et al., 1997; Yamaguchi et 
al., 1994).  Additionally, T is not expressed in Fgf8 or Fgfr1 mutants, suggesting that Fgf8 and 
Fgfr1 are upstream of T and are required for proper expression of T.  
1.3.4  TWis, an allele of T 
Six alleles of T have been characterized.  Through this analysis, there appears to be a direct 
correlation between the strength of the allele and the anterior range of the phenotype 
(Beddington et al., 1992). The TWis allele arose as a spontaneous insertion of a transposable 
element into exon 7 that results in transcripts that bypass the exon 7 splice donor site.  Although 
TWis is transcribed and translated in the same pattern as wild-type T, the insertion results in the 
formation of a primary mRNA product that results in a truncated protein at AA 345 (Kispert et 
al., 1995; Shedlovsky et al., 1988) (Figure 3A). Up to eight different mutant transcripts are made 
from the TWis allele, although no wild-type transcripts are made (Goldin and Papaioannou, 2003). 
TWis heterozygous mice display a shortened to no tail phenotype that is highly variable.  TWis 
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homozygous embryos completely lack somites, an allantois, and notochord, and display a kinked 
neural tube.  In contrast, T null embryos form 7-9 abnormal anterior somites, a small, malformed 
allantois, and lack only posterior notochord (Chesley, 1935). The increased severity of the 
TWis/TWis phenotype as compared to the T null phenotype suggests that TWis acts as a dominant-
negative to interfere with a co-expressed T-box transcription factor.  We hypothesized that this is 
T-box 6 (Tbx6).  Tbx6 is a T-box transcription factor that is co-expressed with T and is discussed 
in section 1.4.  
1.3.5 Implications for T in human health  
A heterozygous 1013C>T missense mutation in human T has been linked to congenital vertebral 
malformations (CVMs) found in three genetically unrelated individuals diagnosed with sacral 
agenesis, Klippel-Feil syndrome, and multiple cervical and thoracic vertebral malformations. 
The missense mutation changes a moderately conserved alanine residue to valine (Ghebranious 
et al., 2008). Although the phenotypes are variable amongst individuals, heterozygous mutations 
in T may lead to CVMs, like congenital scoliosis.  
Additionally, T has been linked to some forms of cancer.  T can induce tumor cells to 
undergo an EMT, an important step in metastasis of tumors. Specifically, T induces a down-
regulation of E-cadherin, and was found to be up-regulated in a variety of cancerous tumors 
(Fernando et al., 2010).  Secondly, T has been identified as the major susceptibility gene for 
familial chrodomas, a rare bone cancer arising from cells of notochordal origin. Genomic 
duplications of the region containing T has been isolated within chordoma affected families, and 
T transcripts are specifically up-regulated in chordomas in microarray assays, but not in other 
related bone cancers (Vujovic et al., 2006; Yang et al., 2009). 
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Identification of direct downstream targets of T as well as further understanding 
transcriptional regulation of downstream targets will help to elucidate the etiology of CVMs 
related to mutations in T, and in human cancers where T is implicated. 
1.4 TBX6 IS CRITICAL FOR POSTERIOR PARAXIAL MESODERM FORMATION 
AND PATTERNING 
Tbx6 encodes a T-box transcription factor that is critical in patterning the mesoderm, and is co-
expressed with T in the PS and tailbud.  Unlike T, Tbx6 heterozygous mice are apparently 
normal.  Tbx6 null embryos do not form paraxial mesoderm posterior to the forelimb bud, 
suggesting Tbx6 is critical for the specification of this tissue (Chapman and Papaioannou, 1998).  
1.4.1 Tbx6 expression patterns and mutant analysis 
In the mouse, Tbx6 transcripts are first detectable at e7.0 within the PS and paraxial mesoderm 
cells migrating out of the PS (Chapman et al., 1996).  At e9.5, Tbx6 is detected in the PSM and 
tailbud.  Expression of Tbx6 transcript and protein is sharply down-regulated upon segmentation 
of the PSM into somites (Chapman et al., 1996; White et al., 2003).  Expression in the tailbud 
persists until axis extension is complete at e13.5. The expression of T and Tbx6 overlap within 
PS and tailbud (Chapman et al., 1996) (compare Figure 3B and Figure 4B). 
Tbx6 heterozygotes are normal and fertile.  Mutant analyses of null and hypomorphic 
alleles in embryos reveal a role for Tbx6 in both patterning and specification of the paraxial 
mesoderm (Chapman et al., 2003; Chapman and Papaioannou, 1998; White et al., 2003).  The 
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enlarged tailbud phenotype of Tbx6 null embryos is first apparent at e9.5 (Figure 4D).  In 
addition, null mutant embryos display kinked neural tubes, multiple hematomas and vascular 
anomalies, which eventually lead to embryonic death by e12.5.  Like the wnt3a null, the Tbx6 
null forms only 7-9 abnormal anterior somites.  Ectopic neural tubes form in place of the paraxial 
mesoderm posterior to the forelimb bud (Figure 3D).  Additionally, PS specific markers such as 
T, wnt3a, and Fgf8 are all expressed in a Tbx6 null mutant, but paraxial mesoderm markers such 
as Notch1, Dll1, and paraxis are not, suggesting that PS cells are established, but are unable to 
differentiate into PSM (Chapman and Papaioannou, 1998).  The levels of cell proliferation and 
apoptosis in Tbx6 null embryos is similar to normal littermates, suggesting that Tbx6 is 
necessary for cells exiting the PS to adopt a paraxial mesoderm fate (Chapman et al., 2003). 
Analysis of chimeric embryos consisting of Tbx6 null ES and wild-type cells revealed 
that Tbx6 mutant cells had wide distribution throughout the embryo but did not contribute to the 
forming somites, and the central portion of the bulbous tailbud consisted almost entirely of 
mutant cells (Chapman et al., 2003).  This suggests a cell-autonomous requirement for 
differentiation into paraxial mesoderm, and that cells lacking Tbx6 may be defective in exiting 
the PS and instead remain within the tailbud. 
Examination of Tbx6 hypomorphs lends evidence for a role in patterning the PAM.  rib-
vertebrae (Tbx6rv) is a hypomorphic allele of Tbx6 that is caused by a 185 bp insertion within the 
regulatory region of Tbx6 (Theiler and Varnum, 1985; White et al., 2003).  This results in 
expression of less than heterozygous levels of Tbx6 that ultimately causes malformations of 
vertebrae and ribs, a shortened trunk, and kinked tail  (Figure 4E).  Additional evidence for 
Tbx6’s role in patterning the paraxial mesoderm lies in partial transgene rescues of Tbx6 null 
embryos.  Null embryos harboring a trangene containing the entire Tbx6 coding region and 
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upstream sequences necessary to drive a reporter construct in a Tbx6 specific pattern results in 
partial rescue of the Tbx6 null phenotype (White et al., 2003).  Similar to the Tbx6rv hypomorphs, 
these embryos express less than heterozygous levels of Tbx6, and display fusions of the ribs and 
vertebrae.  Additionally, defects in expression of Myogenin were noted within partially rescued 
embryos.  Myogenin is a marker specific for the myotome compartment of the somite. 
Altogether, this suggests that multiple somite compartments are affected in Tbx6 hypomorphs. 
Severity of the phenotype directly corresponds to level of transgene expression, suggesting 
dosage of this gene is critical during development (White et al., 2003).  
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Figure 4: Tbx6 expression patterns and mutant phenotype 
 (A) Domain structure of Tbx6. (B) In situ hybridization showing Tbx6 expression within the PS and PSM 
cells lateral to the PS at e7.5, and within the tailbud (closed arrowhead) and PSM (open arrowhead) at e9.5 
(Chapman et al., 1996). (C) A normal embryo at e10.5.  The red line denotes the level of cross-section in 
the corresponding histological section.  Hemotoxylin and Eosin stained histological section shows 
epithelial somites (asterisk) flanking either side of the central neural tube (Chapman and Papaioannou, 
1998).  (D) A bulbous tailbud is apparent in a Tbx6 null mutant, and histological sections reveal somites are 
replaced by ectopic neural tubes (asterisk) (Chapman and Papaioannou, 1998). (E,F) Gross morphology of 
the incomplete rescue of Tbx6-/-; Tg46/+ as compared to Tbx6+/-; Tg46/+ reveals shortened tail and axis.  
Skeletal preparations reveal fused vertebrae and ribs along the entire body axis (White et al., 2003).  (G) 
Skeletal preparation of the Tbx6 hypomorph, rv/rv, reveals fusions and malformations of the ribs and 
vertebrae (White et al., 2003). 
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1.4.2 Biochemical analyses of Tbx6 
EMSA experiments demonstrate that Tbx6 can bind to the same 24 bp palindromic binding 
sequence and half-site selected by T (White and Chapman, 2005).  Tbx6 is able to bind to the 
palindromic site as a monomer, however upon the addition of increased amounts of Tbx6 relative 
to the probe, a second shifted band became obvious, suggesting that two Tbx6 monomers can 
bind simultaneously (White and Chapman, 2005).  This is distinct from T which dimerized in the 
presence of the palindromic sequence (Muller and Herrmann, 1997).  Binding as two separate 
monomers to the palindromic site was also observed for Tbx3 (Coll et al., 2002) (Figure 2). 
PCR-based binding site selection assays performed with Tbx6 demonstrated a consensus binding 
sequence for Tbx6 of: 5’-AGGTGTBRNNNN-3’ where B is anything but A, and R is a purine.  
Despite the isolation of the core 5’-AGGTGT-3’ sequence common to T-box transcription 
factors, sequences exactly matching the T half-site were not recovered for Tbx6 (White and 
Chapman, 2005).  
1.4.3 The Notch pathway regulates expression of Tbx6 
Identification of the rv mutation as a Tbx6 allele highlights the importance of proper regulation 
of signaling pathways that control expression of Tbx6 during development. A sequence 
comparison of Tbx6 homologs in human, mouse, rat, and dog revealed a conserved region 
upstream of the start of transcription that contained a binding site for RBP-Jκ, the downstream 
effector of the Notch signaling pathway (White et al., 2005).  Transgenic reporter constructs 
containing a single point mutation within the RBP-Jκ binding site which abolishes binding 
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revealed little to no activity of the reporter in vivo between e9.5 to e12.5, when the reporter 
would normally be active (White et al., 2005). 
T is expressed earlier than Tbx6 within the PS, suggesting T may regulate expression of 
Tbx6. Tbx6 is initially expressed at e7.0 in a T mutant, however as the T null phenotype becomes 
apparent at e8.5 and the PS fails to continue to produce mesoderm, expression of Tbx6 is lost 
(Chapman et al., 1996). The presence of T-box binding sites within introns 1 and 5 of Tbx6 
suggests that maintenance of Tbx6 expression may be dependent on T (Hofmann et al., 2004), 
although the loss of expression of Tbx6 in the T null also may result from the loss of mesoderm 
production rather than a direct effect of T on Tbx6 transcription.  It is therefore unresolved 
whether T directly regulates Tbx6 expression. 
1.4.4 Downstream targets of Tbx6 
Four direct downstream targets of Tbx6 are known, including Dll1, the ligand for the Notch 
receptor, placing the Notch signaling pathway both upstream and downstream of Tbx6 (White 
and Chapman, 2005).  The other three targets also encode proteins essential for somitogenesis, 
and include Mesoderm Posterior-2, (Mesp2), Mesogenin1 (Msgn1), and Ripply2.  Interestingly, 
all of these targets also require input from other signaling molecules for their proper expression, 
and appear to be a part of a complicated feedback pathway existing within the PSM (Dunty et al., 
2008; Hofmann et al., 2004; Wittler et al., 2007; Yasuhiko et al., 2006). 
1.4.4.1 Dll1 
Dll1 is expressed in the PS and PSM, and is subsequently is restricted to the posterior halves of 
somites (Bettenhausen et al., 1995). The overlapping expression of Dll1 with Tbx6, along with 
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the absence of Dll1 in the Tbx6 mutant, led to the hypothesis that Dll1 is a direct target of Tbx6 
(Chapman et al., 1996). Additionally, Tbx6rv/Tbx6rv embryos displayed reduced expression of 
Dll1 (White et al., 2003). A strong genetic interaction is observed between Tbx6 and Dll1; 
compound heterozygotes display fusions of the vertebrae that resulted in a kinked tail and 
occasional missing portions of the proximal ribs (White and Chapman, 2005).  
Previous studies identified a 1.5 kb regulatory element from the Dll1 gene that was 
capable of driving expression of a minimal promoter-lacZ reporter in the PSM beginning at e7.5 
(Beckers et al., 2000a).  Within this 1.5 kb mesoderm (msd) enhancer are four putative T-box 
binding sites (BS1-4) located in a 100 bp region; two of which are targets for Tbx6 (White and 
Chapman, 2005).  The enhancer element also contains multiple potential LEF/TCF binding sites 
that are required for activity of the enhancer element (Hofmann et al., 2004).  Loss of either the 
T-box binding sites or the LEF/TCF binding sites was sufficient to cause loss of expression of a 
transgenic reporter in vivo, suggesting input from both the Wnt signaling pathway and Tbx6 is 
required for proper expression of Dll1 and thus Notch signaling (Hofmann et al., 2004). 
Altogether, the genetic, transcriptional, and biochemical data indicates that Dll1 is a 
direct downstream target of Tbx6 in the PS and PSM.   
1.4.4.2 Mesp2   
The basic helix-loop-helix transcription factor Mesp2 also has a critical role in somitogenesis 
and establishment of anterior-posterior polarity of the somites (Saga et al., 1997).  Mesp2 is 
expressed in a dynamic pattern in the anterior PSM, and is down-regulated as the PAM 
segments.  Mesp2 functions to define the anterior border of the forming somite, via Lfng 
mediated suppression of Notch signaling (Morimoto et al., 2005).  Mesp2 mutant embryos lack 
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segmented somites that results in fusions of the ribs and vertebrae, a shortened body axis, and 
perinatal death (Saga et al., 1997). 
 Transgenic reporter analysis, transcriptional studies, and EMSA experiments identified 
T-box binding sites essential for expression of Mesp2 (Yasuhiko et al., 2006).  Chromatin 
immunoprecipitation (ChIP) experiments demonstrated that Tbx6 was able to bind to these sites 
in vivo (Yasuhiko et al., 2008).  RBP-Jκ binding sites were also found within the Mesp2 
enhancer region, and transcriptional assays demonstrated a synergistic activation of the enhancer 
upon addition of the NICD and Tbx6.  Since the expression of Mesp2 overlaps only in the 
anterior limit of Tbx6 expression, this suggests that a threshold amount of Notch signaling in 
addition to Tbx6 is required for proper Mesp2 expression (Yasuhiko et al., 2006). 
 Mesp2 has also been implicated in the ubiquitin-mediated proteosomal degradation of 
Tbx6.  Loss of Mesp2 results in an expansion of the Tbx6 protein domain, but not Tbx6 mRNA 
in the mouse (Oginuma et al., 2008).  Furthermore, the T-domain of Xenopus Tbx6 directly 
interacts with the MH2 domain of Smad6, which in turn mediates the ubiquitination and 
proteosomal degradation of Tbx6 via the E3 ligase, Smurf1 (Smad-ubiquitin regulator factor 1) 
(Chen et al., 2009).  It is unknown how Smurf1 is linked to Mesp2-mediated Tbx6 proteosomal 
degradation. This suggests that a complicated feedback mechanism exists between Notch 
signaling, Mesp2, and Tbx6 at the border between the nascent somite and the PSM.   
1.4.4.3 Ripply2 
Work in zebrafish and Xenopus identified the Ripply-Bowline-Ledgerline (RBL) family of 
proteins as being essential for somitogenesis (Kawamura et al., 2005; Kondow et al., 2006). The 
RBL family of proteins serve as adaptors for the interaction of transcription factors and the 
Groucho/TLE family of co-repressors. Loss of Ripply1 in zebrafish leads to improper anterior-
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posterior somite patterning, due to an inability to repress mesp-b, the Mesp2 ortholog 
(Kawamura et al., 2005).   
In mouse embryos, Ripply2 is expressed at e8.5 within the anterior PSM, in a dynamic 
pattern that exists as either one stripe within S-1, or two stripes, one within S-1 and a weaker 
stripe in the anterior portion of S0 (Biris et al., 2007). The expression of Ripply2 is temporally 
activated in S-1 following Mesp2 expression. Loss of Ripply2 function results in persistent 
expression of Mesp2, causing a shortened body axis, rib and vertebral defects, and results in 
perinatal death (Chan et al., 2007; Dunty et al., 2008). Comparison of the human and mouse 
enhancer elements of Ripply2 uncovered conserved putative binding sites for Tbx6 and an E-box 
binding site specific for Mesp2 (Dunty et al., 2008).  Synergistic activation from the enhancer 
element by Tbx6 and Mesp2 was observed in luciferase transcriptional assays, with the presence 
of both the E-box and T-box binding sites essential to drive expression from the enhancer 
element. As was observed in zebrafish, mouse Ripply2 negatively regulates expression of Mesp2 
in a Groucho-dependent manner (Dunty et al., 2008; Morimoto et al., 2007).  
Interestingly, a physical interaction between Tbx6 and mesp-b was necessary for the 
activation of Bowline (Ripply2 homolog) in Xenopus (Hitachi et al., 2008). Whether Mesp2 and 
Tbx6 directly interact in the mouse is not known. Bowline has also been proposed to mediate a 
physical interaction between Xgrg-4 (a Groucho/TLE family member) and Tbx6 to negatively 
regulate expression of Thylacine-1 (Thy1), an ortholog of Mesp2, suggesting that Tbx6 has both 
activation and repression abilities at the Thy1 promoter (Kondow et al., 2007).  In total, this 
suggests yet another complicated feedback mechanism occurs between Tbx6, Mesp2, and 
Ripply2 at the border between the PSM and nascent somite. 
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1.4.4.4 Msgn1 
Msgn1 is a basic helix-loop-helix transcription factor that is expressed throughout the PS and 
PSM, and has a critical role in specification of the PSM.  Similar to the Tbx6 mutant, Msgn1 null 
embryos fail to form posterior somites, exhibit a kinked neural tube, an enlarged tailbud, and die 
in utero by e14.5 (Yoon and Wold, 2000). Msgn1 has a critical role in promoting the maturation 
of the PSM by feeding back to suppress wnt3a signaling, demonstrating another complicated 
feedback loop during somitogenesis. Msgn1 also acts synergistically with Notch to promote 
maturation of the PSM via activation of cyclic expression of Lfng (Yamaguchi, personal 
communication). Examination of the enhancer region upstream of Msgn1 revealed four 
conserved binding sites for T-box transcription factors and LEF/TCF factors clustered within 1.2 
kb of the start of transcription site.  Transgenic reporter experiments demonstrated that this 
region drove expression in the PSM, with mutation of either the T-box binding sites or the 
LEF/TCF sites abolishing the activity of a transgenic reporter construct in vivo (Wittler et al., 
2007).  This suggests that input from both Tbx6 and the Wnt signaling pathway is required for 
proper expression of Msgn1.   
1.4.5 Implications for Tbx6 in human health 
Clinical investigation of a 593 kb microdeletion containing TBX6 has been associated in one 
patient with mental retardation, developmental delay, hemivertebrae, and rib anomalies 
(Shimojima et al., 2009). Due to the fact that mice harboring a hypomorphic allele of Tbx6 
display rib and vertebral fusions (White et al., 2005), DNA from this one patient was examined 
for mutations that may result in a hypomorphic allele, however no mutations within the TBX6 
coding region were identified (Shimojima et al., 2009).  The phenotype and associated 
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microdeletion are suggestive, but not conclusive, of the phenotype being caused by 
haploinsufficiency of TBX6.  Because only the coding region was analyzed, it is possible that 
mutations within the regulatory region have acted to reduce TBX6 below heterozygous levels.   
Currently, no other mutations within TBX6 are known to cause vertebral disorders. It is 
possibly that idiopathic cases of congenital vertebral malformations such as spondylocostal and 
spondlylothoracic dysostosis may be caused by mutations in TBX6. Alternatively, mutations in 
other genes required to regulate levels of TBX6 could also cause these types of disorders. Given 
the homozygous null embryonic lethal phenotype observed in the mouse embryo it is likely that 
similar mutations in humans would result in spontaneous miscarriages.  
1.5 AIMS OF DISSERTATION RESEARCH 
The objective of my thesis research is to elucidate the role of competition between co-expressed 
T-box transcription factors.  Perceived competition may occur in two manners: first, T-box 
transcription factors may compete for binding to consensus binding sequences within 
endogenous enhancers, where the two factors may have inherently different activities. For 
example, one factor my serve as a transcriptional activator, while another may serve as a 
repressor.  As a second non-exclusive alternative, these factors may compete for binding to a 
common co-factor.   In this way, one factor may reduce the other’s transcriptional ability by 
sequestering a co-factor necessary for its transcriptional ability. Both of these possibilities have 
been previously observed with other T-box transcription factors, although prior to this work the 
dynamics between T and Tbx6 within the PS was unknown.   
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Investigation of this dynamic was accomplished using a combination of tissue culture, 
biochemical, and in vivo genetic approaches, allowing for a more powerful analysis. Data 
generated in vivo lends validity to the in vitro results, signifying that the results are most likely 
not an artifact of the particular assay.  The significance of this work extends beyond the obvious 
further characterization of how T and Tbx6 interact in patterning the mesoderm. We propose that 
all T-box transcription factors have the ability to compete for downstream targets when co-
expressed and that competition may play a role in the phenotypes observed in human birth 
defects associated with mutations in T-box transcription factors. While this work focuses on the 
T-box family of transcription factors, it implies that other transcription factors that share a 
conserved DNA binding domain may also compete for downstream targets in vivo when they are 
co-expressed and that this competition contributes to the overall developmental dynamics of the 
organism. 
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2.0  T AND TBX6 COMPETE FOR BINDING AT THE DLL1 ENHANCER IN VIVO 
2.1 INTRODUCTION 
We hypothesized that T and Tbx6 compete for binding sites in target gene enhancers in the PS 
and tailbud, and that this competition regulates the PS to PAM transition.  Furthermore, we 
hypothesized that T is responsible for maintaining cells in a PS-like state, while Tbx6 is required 
for cells to adopt a PAM fate. In this scheme, T and Tbx6 may have both common and unique 
target genes. We predict that T and Tbx6 have different activities at a subset of common targets 
due to differing transactivation/repression domains and/or binding affinities. 
2.1.1 Genetic interactions between T and Tbx6 suggest that they compete in vivo 
Understanding the genetic relationship between Tbx6 and T is essential to unraveling how they 
interact in the formation and patterning of the mesoderm. Although expression of T precedes that 
of Tbx6 during development, T does not directly regulate initiation of Tbx6 expression, because 
Tbx6 is initially expressed in a T null mutant.  Expression of Tbx6 is lost once the T mutant 
phenotype is obvious, suggesting that T may be required for the maintenance of Tbx6 expression, 
however since T mutants fail to maintain a PS, loss of Tbx6 expression is likely to be an indirect 
effect of the loss of the PS (Chapman et al., 1996).   
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 Both T and Tbx6 have been implicated in the regulation of Dll1 expression.  It is 
extremely likely that Tbx6 directly regulates Dll1 expression in vivo, as its mesoderm expression 
is lost in a Tbx6 mutant, and a strong genetic interaction is observed in Tbx6+/-; Dll1+/- mice, 
which display kinky tails (Figure 5A) (White et al., 2003). Additionally, Tbx6 is able to bind to 
two binding sites within the Dll1 enhancer region in EMSA experiments (White and Chapman, 
2005; White et al., 2003).  Based on luciferase transcriptional assays, Hofmann et al. suggested 
that Dll1 is also a downstream target of T. Dll1 expression is also lost in a T mutant, however the 
loss of Tbx6 expression confounds this analysis (Hofmann et al., 2004).  Experiments to 
determine if T is able to physically bind to the identified binding sites within Dll1 were not 
performed, leaving the issue of whether Dll1 is indeed a true target of T unresolved. 
Although T and Tbx6 are expressed in a partially overlapping domain within the PS and 
tailbud, and are able to bind similar sequences in vitro, genetic studies have demonstrated that 
they are not functionally redundant.  Heterozygous ES cells with Tbx6 knocked into the T locus 
(TTbx6KI/+) were injected into a wild-type blastocyst to generate chimeras.  Mice with a low 
percentage of chimerism displayed kinky tails and a shortened trunk, while higher percentage 
chimeric embryos were not obtained, presumably because chimeras with a high percentage of 
TTbx6KI/+ cells result in embryonic lethality. Injection of the TTbx6KI/+ ES cells into blastocysts 
that ubiquitously express GFP confirmed that high percentage chimeras resulted in severe axis 
truncations leading to embryonic death.  This result suggested that Tbx6 is not able to 
compensate for the loss of one allele of T. Since T heterozygous mice displayed a short tail 
phenotype, but were viable, this also suggested that early expression of Tbx6 within the PS or an 
increased level of Tbx6 was deleterious for normal development of the embryo. Phenotypes of 
chimeric embryos generated with TTbx6KI ES cells were similar to those generated with T/T ES 
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cells (Beddington et al., 1992).  This suggests that excess Tbx6 within the PS is able to compete 
with T for downstream targets (Chapman, unpublished). 
 In the converse experiment, T was knocked into the Tbx6 locus (Tbx6TKI/+).  Again, high 
percentage chimeras were not obtained, suggesting an increased expression of T within the PS 
and novel expression in the PSM results in embryonic lethality.  Chimeras dissected at e10.5 
displayed disorganized somites, suggesting expression of T within the PSM results in somite 
anomalies. Chimeras with a low percentage of ES cell contribution (~30%) were viable, and 
displayed tail kinks.  These results also suggest that T and Tbx6 are not functionally redundant 
and that expression of T within the PSM maybe detrimental to the normal development of the 
embryo (Chapman, unpublished). 
Previous genetic analyses with T and Tbx6 were performed with the original T mutation 
that contained a large deletion of several genes, complicating phenotypic analysis of double 
mutants. To further investigate the genetic relationship between T and Tbx6, an allele of T that 
deletes the second and third exon (TΔ2-3), and therefore the majority of the T-domain, was made. 
(Kwan, Chapman, and Behringer, unpublished). Embryos that are homozygous for TΔ2-3and Tbx6 
reveal that the T mutation is epistatic to the Tbx6 mutation.  TWis homozygotes that were wild-
type, heterozygous, or a homozygous null mutant for Tbx6 revealed no morphological 
differences between the genotypes; all lacked an allantois and displayed severe axis truncations, 
indicating that similar to the TΔ2-3 allele, TWis is epistatic to Tbx6 (Chapman et al., 2003).  
Interestingly, while the tailbud of Tbx6-/- embryos is enlarged, the Tbx6-/-; TWis/+ embryos did 
not have a bulbous tailbud, suggesting that the dominant-negative nature of the TWis allele is able 
to reduce the effectiveness of wild-type T allele, thus reducing the tailbud size (Chapman et al., 
2003).   
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 An interesting genetic relationship suggestive of competition for binding to common 
downstream targets exists in TWis;Tbx6 compound heterozygous mice.  While Tbx6/+ mice are 
phenotypically normal, and TWis/+ mice display a short tail phenotype but no rib or vertebral 
defects, Tbx6/+; TWis/+ mice exhibit fusions of the ribs and vertebrae, reminiscent of Tbx6rv/rv 
(Figure 5B) (Chapman, unpublished).  We hypothesize that this genetic interaction is likely due 
to the dominant-negative nature of TWis, which competes with Tbx6 for binding to a common 
subset of downstream targets shared by Tbx6 and T. In this scheme, TWis binding to a shared 
target would result in down-regulation of that particular target, thus phenocopying a Tbx6 
hypomorph to elicit this phenotype in vivo.   These phenotypes are not seen in Tbx6/+; T/+ 
embryos. 
Additional genetic evidence for a potential competition between T and Tbx6 in vivo lies 
in transgenic embryos (Tg46) that over-express Tbx6.  The Tg46 transgene expresses Tbx6 
within its endogenous domain in the PS and PSM at less than heterozygous levels.  
Homozygosity for the Tg46 transgene resulted in a truncated axis that displayed a filamentous 
tail structure, reminiscent of the TWis heterozygous phenotypes (Figure 5C). Most Tg46/Tg46 
embryos die perinatally for unknown reasons, as all internal organs appear normal. The axis 
truncation phenotype of Tg46/Tg46 embryos suggests that excess Tbx6 may compete with T in 
the PS to reduce the ability of T to function in axis extension.   
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 Figure 5:  Tbx6 genetic interactions 
(A) A strong genetic interaction is observed in Tbx6/+; Dll1/+ mice, which display kinky tails, not 
observed in Tbx6/+ or Dll1/+ mice (White and Chapman, 2005).  (B) TWis/+ embryos have a short tail 
phenotype, but normal ribs and vertebrae, while TWis/+; Tbx6/+ embryos display fusions of the ribs 
(arrow).  (C) Embryos that over express Tbx6 within its endogenous domain via the Tg46 transgene display 
a truncated body axis, resulting in a shortened tail (arrow) or thin, filamentous tail (arrowhead). 
 43 
2.1.2 Aims of these studies 
The above genetic data suggests T and Tbx6 may compete for a common set of downstream 
targets in vivo. Additionally, both T and Tbx6 have been implicated in regulating expression of 
Dll1 (Hofmann et al., 2004; White and Chapman, 2005). I sought to confirm and further 
characterize this potential competition using a combination of transcriptional and biochemical 
assays.  To begin to unravel these relationships, I performed luciferase transcriptional assays, 
ChIPs, and quantitative eletrophoretic mobility shift assays (qEMSAs) to determine 
transcriptional activity and target specificities of T and Tbx6. We chose to use the Dll1 enhancer 
region as a representative model system to characterize potential competition between T and 
Tbx6 for these experiments because Dll1 is expressed in an overlapping domain (the PS) with 
both T and Tbx6. In addition, Dll1 is a bona fide target of Tbx6 with four potential T-box binding 
sites within the enhancer region, two that Tbx6 can directly bind (White and Chapman, 2005). 
2.2 T AND TBX6 DIFFERENTIALLY ACTIVATE ENHANCERS IN LUCIFERASE 
ASSAYS  
It has been previously reported that both T and Tbx6 serve as transcriptional activators. We 
sought to determine if these two proteins were able to activate transcription at the same level 
using several enhancers cloned into pGL4.10M luciferase vector (Promega).  These include: the 
24 bp palindromic T-bind element cloned upstream of the β−globin minimal promoter 
(Tbind−luc), the ~200 bp region of Dll1-msd containing four T-box binding sites cloned upstream 
of the β−globin minimal promoter (Dll1-msd-luc), and a 300 bp region of the Mesp2 enhancer 
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and promoter (Mesp2P/E-luc). I subsequently constructed several versions of Tbx6 and T 
mammalian expression constructs to characterize the activity of T and Tbx6 at these enhancers. 
All experiments were performed in human epithelial kidney (HEK) 293T cells, a common cell 
line for performing luciferase assays with T and Tbx6, as a true “primitive streak” cell line does 
not exist.   
2.2.1 Determining relative levels of T and Tbx6 expression from mammalian expression 
vectors 
HEK293T cells were transfected with an equivalent amount of pCS2mt-Tbx6, pCS3mt-T, or 
pCS3mt-T- and pCS3mt-Tbx6- Gal4 activation domain (Gal4AD) fusion proteins. To interpret 
the relative activity of the luciferase reporter, it is essential to know how much protein was made 
from each construct in HEK293T cells.  The relative levels of protein expressed from each 
construct were determined by Western blotting using an anti-myc antibody (Figure 6A). The N-
terminal myc epitope tag allows for comparison of expression levels of these constructs.  Lysates 
were prepared from transfected cells, and equal amounts of total protein (as determined by 
Bradford dye assay) were loaded onto a 7.5% SDS-PAGE gel.  Western blotting was performed 
using the 9E10 myc antibody. Subsequently, the blot was stripped and re-probed with an anti-
tubulin antibody to serve as a loading control. Use of ImageGauge to quantitate the results 
revealed that myc-Tbx6, myc-T, and myc-Gal4AD-T produce approximately equivalent amounts 
of protein, while myc-Gal4AD-Tbx6 produced at least 4.5-fold less protein (Figure 6B).  The 
difference in expression level of myc-Gal4AD-Tbx6 may be more dramatic because the other 
bands may have reached maximum pixel intensity prior to the myc-Gal4AD-Tbx6 band 
becoming apparent.   
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 Figure 6: Western blotting reveals relative levels of T and Tbx6 fusion proteins in transfected cells 
(A) Depiction of Tbx6 and T constructs for mammalian expression. (B) Western blotting of HEK293T cells 
transfected with equivalent amounts of each expression construct reveals that myc-Gal4AD-Tbx6 produces 
approximately 4.5 times less protein than the other constructs, which produce equivalent amounts of 
protein. 
2.2.2 T and Tbx6 act as transcriptional activators 
To determine how T and Tbx6 affect transcription, Tbind-luc was co-transfected into HEK293T 
cells with equivalent amounts of myc-Tbx6, myc-T, myc-Gal4AD-T, or myc-Gal4AD-Tbx6.  
pRL-CMV (Promega), which constitutively expresses Renilla luciferase, was co-transfected to 
serve as an internal control to normalize for differing levels of transfection or number of cells.  
Transfections were performed in triplicate in a 96-well plate, and repeated once.  Results 
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depicted are the average of two independent experiments.  Relative luciferase units (RLUs) and 
standard error were calculated over the six data points. 
Myc-Tbx6 and myc-T were able to activate transcription weakly from the Tbind enhancer, 
activating at approximately 5.8 and 7.5 fold over background, respectively. While full-length 
myc-T and myc-Tbx6 activate transcription weakly at approximately equivalent levels, myc-
Gal4AD-T activated transcription at 30.1 fold, myc-Gal4AD-Tbx6 activated transcription at 14.4 
fold (Figure 7).  It should be noted that this difference in activity with the Gal4AD fusion 
constructs most likely reflects the different expression levels of myc-Gal4AD-Tbx6 and myc-
Gal4AD-T protein produced (Figure 6).   
Equal levels of activation from myc-Tbx6 and myc-T at this synthetic enhancer was not 
surprising, as both T and Tbx6 are able to bind to the enhancer, with T binding as a dimer across 
the two half-sites (Muller and Herrmann, 1997), and Tbx6 binding as two monomers to the two 
half-sites (White and Chapman, 2005), although the relative affinities for these sites are 
unknown.   
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 Figure 7: T and Tbx6 act as transcriptional activators 
Graphical analysis of relative luciferase units (RLUs) produced from 25ng of indicated protein expression 
vector co-transfected with 25ng of Tbind-luc. The empty protein expression vector (EV) negative control 
was set to 1.  
2.2.3 T and Tbx6 activate transcription from the Dll1-msd enhancer at different levels 
To further investigate the transcriptional role of T and Tbx6 in vitro, we chose to use the Dll1-
msd enhancer, which contains four T-box binding sites clustered within 100 bp upstream of the 
β-globin minimal promoter and luciferase reporter (Figure 8A).  Contrary to the results obtained 
with the T-bind enhancer, myc-T and myc-Tbx6 activated at very different levels from the Dll1-
msd enhancer.  Myc-Tbx6 activated at approximately 261-fold over background, while myc-T 
activated at a 10-fold lower level of 22-fold over background.  Myc-Gal4AD-Tbx6 and myc-
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Gal4AD-T also showed different activation abilities, with myc-Gal4AD-Tbx6 activating at 2132 
fold over background and myc-Gal4AD-T activating at 414 fold (Figure 8B).  It is interesting to 
note that myc-Gal4AD-Tbx6 activates at a higher level than myc-Gal4AD-T when equivalent 
amounts of expression plasmid was transfected, even though less protein is produced from this 
construct. 
It is not surprising that both T and Tbx6 were able to activate transcription from this 
enhancer, as Dll1 is expressed in the overlapping domain with T and Tbx6 (the PS and tailbud), 
and both T and Tbx6 have been suggested to regulate expression of Dll1 (Hofmann et al., 2004; 
White and Chapman, 2005).  Our data shows that although both T and Tbx6 are able to activate 
transcription from Dll1-msd, Tbx6 serves as a better activator of transcription than T at this 
enhancer. Differential activation by T and Tbx6 could occur for several reasons that are not 
necessarily mutually exclusive.  First, Tbx6 may simply be a stronger activator of transcription 
than T.  Secondly, T may require a co-factor for more robust activity that may not be expressed 
in HEK293T cells. Finally, it is unclear from these experiments whether T is binding to the same 
binding sites as Tbx6 within the Dll1-msd enhancer region, or different ones. T may bind to 
fewer sites of have a lower affinity for the sites in the Dll1-msd as compared to Tbx6.  These 
possibilities are further addressed in section 2.4.   
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 Figure 8: Tbx6 and T activate at different levels from the Dll1-msd enhancer 
(A) Dll1-msd consists of a 200 bp region of the Dll1 enhancer that contains four T-box binding sites (BS1-
4), two of which Tbx6 binds to (green asterisks), and two of which Tbx6 is unable to bind (red asterisks).  
BS3 and BS4 contain deviations from Tbx6’s preferred binding sequence (red letters). The Dll1-msd was 
cloned upstream of the β-globin minimal promoter and luciferase reporter for use in luciferase assays. (B) 
Graphical analysis of relative luciferase units (RLUs) produced from 25ng of indicated protein expression 
vector co-transfected with 25ng of Dll1-msd-luc.  Empty protein expression vector (EV) negative control 
set to 1.    
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2.2.4 T and Tbx6 differentially activate from the Mesp2 enhancer 
Mesp2 is a confirmed downstream target of Tbx6, and is expressed within the anterior portion of 
the PSM as the somite segments (Yasuhiko et al., 2006).  Although Dll1 is expressed in an 
overlapping domain with T and Tbx6, Mesp2 is co-expressed only with Tbx6. I therefore sought 
to determine how T and Tbx6 acted at this enhancer. The Mesp2E/P enhancer contains four 
putative T-box binding sites within 300 bp upstream of the start of transcription, and the 
endogenous promoter sequences (Figure 9A).  
These studies revealed that myc-T activated transcription from this construct at a 10-fold 
lower level than myc-Tbx6 (71.6 and 713.6 fold activation levels, respectively), similar to the 
activation levels from the Dll1-msd enhancer.  Myc-Gal4AD-Tbx6 activated transcription 3146.7 
fold while myc-Gal4AD-T activated transcription at 1322.3 fold (Figure 9B).  This trend was 
very similar to that observed with at the Dll1-msd enhancer, which is surprising since Mesp2 is 
most likely exclusively a Tbx6 target, as T is not expressed in the same domain as Mesp2. 
Activation of the Mesp2 enhancer by myc-T may not reflect a physiologically relevant event, 
since T is not expressed in the anterior PSM. However, T may bind the Mesp2 enhancer in the 
PS/tailbud and serve to block Tbx6 from binding. It is likely that Tbx6’s activation of the 
reporter construct reflects the endogenous situation, as chromatin immunoprecipitation 
experiments have demonstrated that Tbx6 binds to the Mesp2 enhancer in vivo (Yasuhiko et al., 
2006).   
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 Figure 9: T and Tbx6 activate transcription from the Mesp2 promoter/enhancer 
(A) A 300 base-pair region of the Mesp2 promoter/enhancer (P/E) containing four T-box binding sites 
(BS1-4) was cloned upstream of the luciferase reporter.  Bases that deviate from Tbx6’s consensus are red. 
Tbx6 can to bind to all four binding sites in EMSA experiments (Yasuhiko et al., 2006; Yasuhiko et al., 
2008).  (B) Graphical analysis of relative luciferase units (RLUs) produced from 25ng of indicated protein 
expression vector co-transfected with 25ng of Mesp2P/E-luc.  Empty protein expression vector (EV) 
negative control set to 1.     
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2.3 T REDUCES TBX6’S TRANSCRIPTIONAL ABILITY 
The above luciferase assays demonstrate that T and Tbx6 differentially activate transcription 
from the Dll1-msd enhancer and the Mesp2P/E reporter constructs, but not from the Tbind 
palindromic enhancer.  We therefore hypothesized that addition of T to a constant amount of 
Tbx6 would compete for binding sites within the enhancers and effectively reduce the activity of 
Tbx6 from the Dll1-msd and Mesp2P/E reporter constructs, but not from the Tbind enhancer.  
Competition luciferase assays were performed to test this hypothesis, whereby increasing 
amounts of myc-T were added to constant amounts of myc-Tbx6 and the relative luciferase 
reporter activity was measured.  To determine if this was a feasible method for observing 
competition between T and Tbx6, we first constructed a dominant-negative version of Tbx6 that 
should be able to compete with wild-type Tbx6 in luciferase assays to test the efficacy of our 
competition luciferase assays. 
2.3.1 Dominant-negative Tbx6 is nuclear localized and able to bind DNA 
To first test the efficacy of competition luciferase experiments, we designed a putative dominant-
negative version of Tbx6.  Most T-box transcription factors contain their activation/repression 
domains within the C-terminus of the protein (Conlon et al., 2001).  We therefore created a 
version of Tbx6 with a C-terminal truncation after the T-domain, with an N-terminal myc-tag 
and nuclear localization sequence (NLS), myc-Tbx6NLSΔC (Figure 10A).  We searched for 
canonical NLS sequences within Tbx6, but were unable to identify any.  Without an added NLS 
myc-Tbx6ΔC did not consistently localize to the nucleus (data not shown), implying that Tbx6’s 
nuclear localization sequence may lie within the C-terminus of the protein.  In contrast, 
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HEK293T cells transfected with myc-Tbx6NLSΔC and processed for immunofluorescence with 
anti-myc and our N-terminal anti-Tbx6 antibody revealed co-localization of the myc-Tbx6NLSΔC 
protein and the TO-PRO3 nuclear stain in 100% of the cells, indicating that myc-Tbx6NLSΔC is 
nuclear localized (Figure 10A).  
Western blotting performed using HEK293T cells transfected with myc-Tbx6NLSΔC 
revealed that the myc-Tbx6NLSΔC protein had a higher molecular weight than the predicted size of 
47kDa.  Sequencing of the myc-Tbx6NLSΔC construct confirmed proper cloning and presence of 
several stop codons at the C-terminal end.  Additionally, Western blotting of cells transfected 
with myc-Tbx6NLSΔC as compared to myc-Tbx6ΔC (lacking the NLS) revealed that the myc-
Tbx6ΔC protein ran much closer to the expected size, indicating the charged nature of the NLS 
(consisting of mainly lysines and arginines) may retard proper migration within the SDS-PAGE 
(data not shown).  Although myc-Tbx6NLSΔC may run much higher than expected on a Western 
blot, we are confident that we are producing the appropriate protein within the cells.   
We predicted that myc-Tbx6NLSΔC would still be able to bind DNA, as it retains its T-box 
DNA binding domain.  To test this, I prepared nuclear extracts from cells transfected with myc-
Tbx6, myc-Tbx6NLSΔC, or untransfected cells. These nuclear extracts were used in EMSA 
experiments with radiolabeled Tbind, Thalf (T-half site binding sequence), or Tmut, a mutated 
verson of Tbind. Both myc-Tbx6NLSΔC and full-length myc-Tbx6 were able to bind to Tbind and 
Thalf, and only weakly to Tmut. Super-shift with anti-Tbx6 antibody further demonstrated that the 
presence of myc-Tbx6 and myc- Tbx6NLSΔC within the nuclear lysates were causing the observed 
shifting of the radioactive probe (Figure 10C).  Binding to Tmut was likely due to the presence of 
one intact binding site within the palindrome (see section 6.4 for sequences of oligonucleotides 
used).  
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 Figure 10: Myc-Tbx6NLSΔC is localized to the nucleus and can bind to DNA.   
(A) The myc-tagged Tbx6NLSΔC with an N-terminal nuclear localization sequence (NLS) was transfected 
into HEK293T cells.  Immunofluorescence was performed with anti-Tbx6 and anti-myc antibodies. 
Tbx6NLSΔCco-localized with the TOPRO DNA stain in the nucleus.  (B) Western blotting reveals that myc-
Tbx6NLSΔC runs at a higher molecular weight than the expected size of 47 kDa.  The proteins were detected 
with both anti-Tbx6 and anti-myc antibodies.  (C) Nuclear extracts from HEK293T cells were used in 
EMSAs with radiolabeled Tbind (palindromic T site), Thalf (T half-site), and a mutated version of Tbind, Tmut.  
Both myc-Tbx6 and myc-Tbx6NLSΔC were able to bind to the palindromic Tbind and half-site (Thalf), and 
weakly to the mutated site. A shift was not observed using nuclear extracts from untransfected (UnX) cells.  
Super-shifts with anti-Tbx6 antibody further demonstrated that the presence of myc-Tbx6 and myc- 
Tbx6NLSΔC within the nuclear lysates were causing the observed shifting of the radioactive probe. 
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2.3.2 A dominant-negative version of Tbx6 decreases the transcriptional ability of full-
length Tbx6 
Part of our goal was to create a dominant-negative version of Tbx6 that was still able to bind to 
DNA, but not transactivate.  Since many T-box transcription factors contain their activation 
and/or repression domains within the C-terminus of the protein (Conlon et al., 2001),  we 
therefore hypothesized that the activation domain of Tbx6 would be also contained within its C-
terminus.  To confirm this, I tested the transcriptional activity of myc-Tbx6NLSΔC in luciferase 
assays at the Dll1-msd enhancer.  Consistent with previous observations for other T-box factors, 
myc-Tbx6NLSΔC activated at a mere four-fold over background as compared to myc-Tbx6 and 
myc-Gal4AD-Tbx6 which activated at 1541-fold and 3931-fold over background, respectively, 
thus demonstrating a loss of transcriptional activity by myc-Tbx6NLSΔC.  Addition of increasing 
amounts of myc-Tbx6NLSΔC (range of 5ng-50ng) to a constant 25ng of myc-Tbx6 or myc-
Gal4AD-Tbx6 resulted in a linear decrease in RLUs, suggesting that myc-Tbx6NLSΔC is able to 
compete for binding at the Dll1-msd enhancer (Figure 11).  Although it appears myc-Tbx6NLSΔC 
is better at competing with myc-Gal4AD-Tbx6, myc-Gal4AD-Tbx6 is produced at ~4 fold lower 
than myc-Tbx6 and myc-Tbx6NLSΔC, which most likely accounts for the observed effect (see 
Figure 6B, 10B).  
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 Figure 11: Increasing amounts of myc-Tbx6NLSΔC lowers the transcriptional activity of myc-Tbx6 and 
myc-Gal4AD-Tbx6. 
(A) Competition luciferase assay adding increasing amount of myc-Tbx6NLSΔC to constant amounts of myc-
Tbx6 (A) or myc-Gal4AD-Tbx6 (B). 25ng Dll1-msd-luc co-transfected for all data points. Red asterisks 
above bars indicate p<0.05.    
2.3.3 T decreases Tbx6’s transcriptional activity at Dll1-msd and Mesp2P/E, but not at 
Tbind  
Previously described genetic data (section 2.1.1) led us to hypothesize that T competes for 
binding at the enhancers of common target genes in vivo.  Data obtained with myc-Tbx6NLSΔC 
demonstrated the efficacy of our competition luciferase assays, allowing us to take a similar 
approach to determine if T could compete with Tbx6 at Dll1-msd, Mesp2P/E, and Tbind to 
effectively lower the transcriptional activity of Tbx6.  Competition luciferase assays were 
performed as described above whereby increasing amounts of myc-T (5ng-50ng range) were 
added to a constant amount of myc-Tbx6 or myc-Gal4AD-Tbx6 using the Dll1-msd, Mesp2P/E, 
or Tbind luciferase constructs.  Addition of increasing amounts of myc-T to a steady amount of 
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myc-Tbx6 or myc-Gal4AD-Tbx6 resulted in a decrease in luciferase units from the Dll1-msd and 
Mesp2P/E luciferase reporters, but not the Tbind reporter (Figure 12).  Myc-T may not effectively 
compete to lower luciferase units at the Tbind enhancer simply because the activity levels of myc-
T and myc-Tbx6 at this enhancer are approximately equivalent.  At Tbind, a somewhat additive 
effect is noted, whereby a combination of 25ng of myc-T and 25ng of Tbx6 resulted in 9.6 fold 
activation over background, which is slightly less than the sum of the 5.4 and 5.8 fold activation 
of 25ng of myc-T and myc-Tbx6 on their own, respectively (Figure 12E). To determine if myc-T 
could reduce the activity level of myc-Gal4AD-Tbx6 at the Tbind enhancer, increasing amounts of 
myc-T were added to a constant amount of myc-Gal4AD-Tbx6.  Increasing amounts of myc-T 
reduced the RLUs from the Tbind enhancer (Figure 12F), suggesting that since the activity level 
of myc-T is considerably lower than either myc-Tbx6 or myc-Gal4AD-Tbx6 at the Dll1-msd and 
Mesp2P/E enhancers, increasing amounts of T could lower Tbx6 transcription ability simply by 
displacing either myc-Tbx6 or myc-Gal4AD-Tbx6 from the enhancer. Again, in this case, the 
dramatic drop in luciferase units observed when 5ng of myc-T is added as a competitor to myc-
Gal4AD-Tbx6 is likely due to the low levels produced by the myc-Gal4AD-Tbx6 plasmid. 
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 Figure 12: myc-T competes with myc-Tbx6 and myc-Gal4AD-Tbx6 at Dll1-msd and Mesp2P/E but 
not Tbind.   
(A) Competition luciferase assay adding increasing amounts of myc-T to a constant amount of myc-
Gal4AD-Tbx6 (A,C,E) or myc-Tbx6 (B,D,F) to 25ng of Dll1-msd-luc (A,B), Mesp2P/E-luc (C,D) or Tbind-
luc (E,F). Red asterisks above bars indicate p<0.05. 
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2.3.4 TWis competes with both Tbx6 and T 
TWis encodes a truncated T protein (Figure 13A), which is thought to act as a dominant-negative 
since it can still bind to DNA but cannot transactivate (the TWis allele is discussed in more detail 
in section 1.3.4). We therefore PCR amplified the region of T encoding the TWis protein and 
cloned it into the pCS3mT vector, allowing for expression of a myc-tagged fusion protein in 
mammalian cells.  Immunofluorescence performed with HEK293T cells transfected with the 
pCS3-myc-TWis construct and stained with anti-T and anti-myc antibodies revealed that the myc-
TWis protein is nuclear localized (Figure 13B).  Western blotting of equivalent amounts of total 
protein from lysates of transfected HEK293T cells with an anti-myc and anti-T antibodies 
revealed the myc-TWis construct produced a protein that ran at a slightly higher molecular weight 
than the predicted size (~50 kDa) (Figure 13C). Despite this, we are confident we are making the 
appropriate protein as the construct has been verified by sequencing. 
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 Figure 13: myc-TWis is nuclear localized in transfected HEK293T cells. 
(A) Depiction of the myc-TWis construct.  The TWis protein contains a stop codon after amino acid 345. (B) 
Immunofluorescence of transiently transfected HEK293T cells and stained with anti-T (green) and anti-
myc (red) antibodies reveals co-localization of myc-TWis with the nuclear stain, TOPRO (blue).  (C) 
Western blotting of lysates prepared from transiently transfected HEK293T cells.  The myc-TWis protein 
can be detected with both an anti-myc and anti-T antibody.  UnX = untransfected. 
To determine whether TWis can indeed act as a dominant-negative by interfering with T 
and Tbx6’s ability to bind enhancers, we performed competition luciferase assays using the 
Mesp2P/E luciferase construct. On its own, myc-TWis did not significantly activate transcription, 
(2.5-fold over background) as compared to 139.2 and 49.2 for myc-Tbx6 and myc-T, 
respectively (Figure 14).  Addition of increasing amount of myc-TWis to constant amounts of 
either myc-T (Figure 14A) or myc-Tbx6 (Figure 14B) effectively decreased the activity level 
from the Mesp2P/E enhancer.   
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 Figure 14: myc-TWis is unable to activate transcription from Mesp2P/E and lowers transcriptional 
activity of myc-T and myc-Tbx6.   
(A) Competition luciferase assay adding in increasing amounts of myc-TWis to a constant amount of myc-
Gal4AD-Tbx6 (A) or myc-Tbx6 (B) to 25ng of the Mesp2P/E-luc. Red asterisks above bars indicate 
p<0.05. 
2.4 CHROMATIN IMMUNOPRECIPITATION EXPERIMENTS DEMONSTRATE 
BOTH T AND TBX6 BIND TO THE DLL1-MSD ENHANCER IN VIVO 
The above luciferase assays suggest that T and Tbx6 can compete at the Dll1-msd and Mesp2P/E 
enhancers. There are several possible ways that T and Tbx6 can compete at the Dll1-msd and 
Mesp2P/E enhancers including at the level of DNA binding or by competing for common co-
factors. We hypothesized that the observed competition at least partially occurs at the level of 
DNA binding. To test this hypothesis, we performed chromatin immunoprecipitation (ChIP) to 
determine whether T and Tbx6 are bound to the Dll1-msd enhancer in vivo.  
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2.4.1 Tbx6 binds at the Dll1-msd enhancer in cultured cells 
As a preliminary experiment, fibroblasts were derived from our three-component embryos that 
inducibly express myc-Tbx6 (see Chapter 3 for full details on three-component mice). The 
fibroblasts were grown in the presence of doxycycline (DOX) to induce expression of myc-Tbx6, 
while cells grown without DOX (and thus not expressing myc-Tbx6) served as a negative 
control. Immunoprecipitations were performed with the cross-linked DNA/proteins and our N-
terminal anti-Tbx6 antibody, as well as no antibody controls.  After purification of bound 
fragments, radioactive PCR was performed with primers designed to amplify a 358 base-pair 
region flanking all four T-box binding sites in the Dll1 enhancer. Primers for a genomic region 
of Wnt7a served as a negative control and should amplifiy a 208 bp fragment in input chromatin 
only. ChIP in this cell culture based assay revealed that Tbx6 was bound to the Dll1-msd region, 
but not to Wnt7a (Figure 15).  This suggested that Tbx6 could bind to the Dll1-msd enhancer in 
vivo, although over-expression of myc-Tbx6 in this cell culture system may allow for Tbx6 to 
bind to sites it would not normally bind to under physiological conditions. 
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Figure 15: ChIP demonstrates Tbx6 binds to the Dll1-msd enhancer region in cultured cells 
ChIP from fibroblasts inducibly expressing myc-Tbx6 reveals that myc-Tbx6 bound to the Dll1-msd 
enhancer region, but not to an unrelated control genomic region (Wnt7a).  Amplification of the Dll1-msd 
enhancer region is observed only in cells treated with doxycycline (DOX) to induce expression of myc-
Tbx6 and anti-Tbx6 antibody. 
2.4.2 T binds to the Dll1-msd in transfected tissue culture cells 
NIH3T3 cells transfected with pCS3T.10, served as source of cells expressing T, with 
untransfected cells serving as a negative control. NIH3T3 cells were used in these experiments 
because they are a readily transfectable mouse fibroblastic cell line. Immunoprecipitations were 
performed with anti-T and radioactive PCR was performed as described above. ChIP in this cell 
culture based assay revealed that T was also able to bind within the Dll1-msd region, but not 
within Wnt7a, the unrelated genomic control (Figure 16).  This suggests that T is able to bind to 
the Dll1-msd enhancer in vivo.  However, over expression may result in promiscuous binding in 
this experiment.  
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 Figure 16: ChIP demonstrates T can bind to the Dll1-msd region 
ChIP was performed using T antibody and chromatin prepared from NIH3T3 cells transfected with 
pCS3T.10.  Untransfected cells served as a negative control.  Amplification of the Dll1-msd enhancer 
region is observed only in cells transfected with pCS3T.10 and anti-T antibody. 
2.4.3 ChIP experiments using tailbuds confirm T and Tbx6 bind to the Dll1-msd in vivo 
Over expression of T and Tbx6 in the above cell culture ChIP experiments may result in 
promiscuous binding.  Therefore, we sought to repeat these experiments using dissected tissue 
expressing endogenous T and Tbx6 as a source for our ChIP experiments. Use of an endogenous 
tissue allows us to conclusively determine whether or not both T and Tbx6 bind to the Dll1-msd 
region in vivo. Tailbud tissue, which expresses T and Tbx6, was dissected from approximately 
fifty e10.5 wild-type embryos and used as a source of chromatin for ChIP assays.  An equivalent 
amount of somitic tissue, which does not express Tbx6 or T, was used as a negative control.  
Immunoprecipitations were performed as described above. Use of endogenous tailbud tissue 
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revealed that both T and Tbx6 bound to the Dll1-msd under physiological conditions during 
mouse development (Figure 17). 
 
Figure 17: ChIPs performed with embryonic dissected tissues demonstrate that both Tbx6 and T 
bind to the Dll1-msd enhancer in vivo. 
Chromatin isolated from e10.5 tailbud tissue (TB), and somitic tissue (S) was used for ChIP. A PCR 
amplified fragment corresponding to Dll1-msd was observed in ChIPs performed with TB tissue with anti-
Tbx6 (A) and anti-T antibody (B) but not in somitic tissue or when antibody was not added.  The Wnt7a 
fragment was only amplified in input samples and not under any other conditions.  Genomic DNA was 
used as a positive control for the PCR reaction. 
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2.5 T AND TBX6 HAVE DIFFERENT AFFINITIES FOR THE BINDING SITES 
WITHIN DLL1-MSD 
As both T and Tbx6 bind within the Dll1-msd region, we questioned if T and Tbx6 were able to 
bind to the same sites, thus revealing a mechanism for competition.  It has been previously 
shown that Tbx6 binds to BS1 and BS2, but not BS3 or BS4 (White and Chapman, 2005).  We 
hypothesized that T could bind to at least one of the same binding sites as Tbx6, thus resulting in 
the observed competition in our luciferase assays.  To test this hypothesis, I performed EMSA 
experiments using radiolabeled oligonucleotides corresponding to each of the four Dll1-msd 
binding sites and purified recombinant DBDs of Tbx6 and T.  These purified proteins allowed us 
to determine the affinity of each protein for the individual binding sites. 
2.5.1 Tbx6-DBD and T-DBD have different binding preferences within Dll1-msd 
EMSAs were performed by adding 100ng (400 nM final concentration) of purified His-Tbx6-
DBD or His-T-DBD was added to radioactively end-labeled double-stranded oligonucleotides 
(40 μM final concentration) corresponding to each of the four T-box binding sites within Dll1-
msd plus ~8-10 flanking nucleotides  (Figure 18A). As expected, Tbx6-DBD bound to both BS1 
and BS2.  In contrast, T-DBD bound to BS2, but only weakly if at all to BS1.  Neither Tbx6-
DBD nor T-DBD bound to BS3 or BS4 (Figure 18B).   Because the oligonucleotide probe was 
included in excess, the shifted band observed most likely corresponds to one monomer of His-
Tbx6-DBD or T-DBD bound.  A second, higher molecular weight band (indicating possible 
dimerization of the DBDs) was not observed under the conditions tested in this experiment. 
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 Figure 18: His-Tbx6-DBD and His-T-DBD have different binding preferences within Dll1-msd 
(A) Tbx6 and T’s binding preferences and corresponding sequences of BS1-4 in Dll1-msd used for EMSA.  
Putative T-box binding sites are underlined. (B) His-Tbx6-DBD or T-DBD was added to double-stranded 
radiolabeled probes corresponding to BS1-4 and reactions were allowed to reach equilibrium. His-Tbx6-
DBD binds BS1 and BS2, but not BS3 or BS4.  His-T weakly bound to BS1, bound better to BS2, and did 
not bind BS3 or BS4.   
2.5.2 Tbx6-DBD and T-DBD have different affinities for Dll1-msd BS2 
We sought to determine the binding affinities of Tbx6-DBD for BS1 and BS2 and T-DBD for 
BS2.  We employed a quantitative EMSA approach whereby increasing amount of Tbx6-DBD 
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(range: 2.1 x 10-8 – 2.1 x 10-5M) or T-DBD (range: 4.0 x 10-6 – 2.4 x 10-5M) were added to a 
constant, limiting amount of labeled BS1-4 oligonucleotides (10pM). Since the DNA 
concentrations were negligible compared to the protein, the protein concentration required to 
bind half the DNA can be taken as an approximation of the disassociation constant, Kd (Harada et 
al., 1994). The percentage of DNA bound was plotted versus the concentration of each DBD, and 
the best fit of the data was determined to be the three-parameter Hill equation. Fitting of the data 
and determination of the Hill co-efficient and Kd was performed with Sigmaplot.   
Strong cooperativity was observed for both Tbx6-DBD and T-DBD, as determined by a 
Hill co-efficient value greater than one.   The Hill co-efficient of Tbx6-DBD was 2.97 and 3.18 
at BS1 and BS2, respectively (Figure 19A,B).  The Hill co-efficient of T-DBD was 14.42 for 
BS2 (Figure 19C).  This cooperativity is most likely the result of the increased protein 
concentrations causing dimerization and non-specific contacts of a second monomer with 
nucleotides outside of the core 5’-AGGTGT-3’ sequences.   The T-DBD has previously been 
shown to exist as a monomer in solution, but bind to the palindromic binding sequence as a 
dimer (Muller and Herrmann, 1997).  Although T-DBD can bind the palindromic binding 
sequence as a dimer, under conditions of lower protein concentrations it can also bind as a 
monomer (Kispert and Hermann, 1993). 
Ultimately, we sought to determine whether differences in the binding affinities between 
His-Tbx6-DBD and T-DBD for Dll1-msd BS2 could explain the different levels of activation 
between myc-Tbx6 and myc-T at the Dll1-msd enhancer in our luciferase assays.  The Kd of His-
Tbx6-DBD for BS1 and BS2 were similar, at 1.53μM and 1.30μM, respectively (Figure 19A,B).  
The T-DBD had a ten-fold lower affinity for BS2, at 13.88μM (Figure 19C).  The binding 
affinity of T-DBD for BS1 could not be measured, as our protein preparation did not allow for 
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high enough concentrations to be obtained in order to achieve enough data points to fit to a 
curve.  
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Figure 19: Tbx6-DBD and T-DBD have different affinities for Dll1-msd BS2. 
Increasing amount of His-Tbx6-DBD (range 0.21nM– 2.1 μM) or T-DBD (range: 4.0μM – 2.4μM) was 
added to a constant 10pM of double-stranded labeled oligonucleotide corresponding to Dll1-msd BS1 or 
BS2.  Percentage DNA bound versus concentration of protein was plotted and fitted to a three-parameter 
Hill equation to determine binding affinity (Kd), Hill co-efficient, and maximum percentage bound (max).  
(A, B) His-Tbx6-DBD has a similar binding affinity for BS1 and BS2 at 1.53μM and 1.30μM, respectively.  
A Hill co-efficient of ~3 indicates cooperativity of binding, and that the shifted band most likely represents 
a dimer.  (C) T-DBD binds BS2 with a ten-fold lower affinity than Tbx6-DBD, at 13.88μM, although 
exhibits stronger cooperativity of binding with a Hill co-efficient of 14.42. 
 71 
2.6 DISCUSSION  
Establishment of the luciferase assay protocol opened up a wealth of possibilities to quickly test 
hypotheses about how T and Tbx6 could be interacting in vivo to generate the observed 
phenotypes when levels of T or Tbx6 are altered, or between different alleles of T and Tbx6.  
The combination of our luciferase assays with biochemical techniques such as EMSAs and 
ChIPs have generated a powerful way to investigate target gene selection and the transcriptional 
control of these target genes by T and Tbx6.   
2.6.1 T and Tbx6 compete for a common set of downstream targets 
Results from our ChIP experiments using embryonic tissues as the source of endogenously 
expressed T and Tbx6 confirm that Dll1 is a downstream target of both.  It is essential to perform 
these experiments with endogenously expressing tissue, as over-expression of transcription 
factors in cultured cells can lead to false positive results due to non-specific binding.  Use of 
endogenous tissue allows us a much greater confidence in determining whether T and Tbx6 are 
present at the enhancers of endogenous targets. Although it is possible that either factor could be 
interacting indirectly with Dll1-msd, we believe this interaction is direct as our EMSA data 
indicated that both T-DBD and Tbx6-DBD could bind to Dll1-msd BS2. We have focused on 
Dll1 as a model of competition because it is a confirmed downstream target of both T and Tbx6 
and is co-expressed in the tailbud with both T-box factors.  It is plausible that other common 
downstream targets of both transcription factors exist, although none are known to date. Future 
strategies to determine more common and unique targets of both T and Tbx6 are discussed in 
section 5.2.3.   
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Results of our luciferase assays indicate that although both T and Tbx6 can activate 
transcription from the Dll1-msd enhancer, they activate at ten-fold different levels.  This 
differential level of activation was also observed with the Mesp2P/E reporter, suggesting that T 
and Tbx6 may have inherently different transcriptional activities.  T was also able to compete 
with Tbx6 at both enhancers in competition luciferase assays to effectively decrease the 
transcription activity of Tbx6 when T and Tbx6 were co-expressed (Figure 12B,D).  Contrary to 
this, both T and Tbx6 weakly activated transcription from the synthetic Tbind enhancer at 
approximately equivalent levels and act in an additive fashion in competition luciferase assays. 
As the Tbind sequence represents an ‘optimal’ binding site for both T and Tbx6, this 
suggests that the context of the binding sites and flanking sequences may influence the ability of 
T or Tbx6 to bind efficiently.  Preferences for different flanking sequences surrounding the core 
5’-AGGTGT-3’ sequence has been previously noted (Conlon et al., 2001).  Despite the apparent 
differential preferences for nucleotides outside of the core sequence, examination of the two 
published crystal structures of the T-domain of T and Tbx3 in complex with the palindromic 
binding sequence reveals that the amino acids that make specific contacts with the bases are 
highly conserved across all T-box proteins, as well as a high degree of structural conservation of 
the T-domain (Coll et al., 2002; Muller and Herrmann, 1997).  This raises the question of how 
exactly differential specificity for nucleotides outside of the core sequence arises.  It is possible 
that addition of the N- and C-termini could potentially add the complexity of interacting proteins 
to the mix, as the published crystal structures were obtained with only the T-domain in contact 
with the palindromic binding sequence.  Alternatively, slight differences in structure between the 
published crystal structures and what occurs in vivo may account for differential selection of 
targets.  It is also important to note that although the palindromic binding sequence was selected 
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by T in PCR-based binding site selection experiments and was used to generate the crystal 
structures of the T-domain of T and Tbx3 (Coll et al., 2002; Muller and Herrmann, 1997), the 
palindromic sequence does not exist in vivo, and therefore represents an artificial condition.   
Although examination of structural data on the T-domain reveals that it is unclear why or 
how T-box proteins differentially select target genes, our EMSA data suggested that T-DBD and 
Tbx6-DBD have differential ability to bind to T-box binding sites within the Dll1-msd enhancer. 
Tbx6-DBD bound with similar affinity to both Dll1-msd BS1 and BS2.  In contrast, T-DBD 
bound weakly to BS2 weakly, if at all, to BS1.  These results were not entirely surprising since 
PCR-based binding site selection data indicated that Tbx6 prefers any nucleotide and then a 
purine, respectively, in positions +1 and +2 following the core 5’-AGGTGT-3’sequence (White 
and Chapman, 2005).  In contrast, T prefers 5’-GAAA-3’ following the core sequence (Kispert 
and Hermann, 1993).  Examination of the structural model of T and Tbx3 T-domains revealed 
that the majority of the contacts outside of the core sequence occur on the opposite strand to the 
core sequence (Coll et al., 2002; Muller and Herrmann, 1997).   
For T, BS1 contains an unfavorable TG sequence in the +1 and +2 positions following 
the core.  Based on PCR-based binding site data, this TG dinucleotide following BS1 would still 
allow Tbx6 to bind, which is consistent with our EMSA results.  In contrast, BS2 contains a GA 
dinucleotide in the +1 and +2 positions, allowing for binding by both Tbx6 and T.  Neither T nor 
Tbx6 bound BS3 despite containing the core 5’-AGGTGT-3’ sequence. However, BS3 has a CC 
dinucleotide in the +1 and +2 positions, which is unfavorable for both T and Tbx6 based on 
PCR-based binding site selection data. Altogether, these data suggest that sequences outside of 
the core are indeed important. BS4 consists of an unfavorable 5’-AGGGTGTG-3’ sequence, 
which does not match the core sequence because the core TGT triplet is separated by an extra G. 
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The majority of DNA contacts occur at the TGT triplet via a conserved arginine residue (Muller 
and Herrmann, 1997).  It is therefore not surprising that neither T nor Tbx6 binds to BS4.  
Although the EMSA experiments give us an idea of which binding sites Tbx6-DBD and T-DBD 
prefer, they do not allow us to examine potential cooperative binding of multiple sites. Future 
directions to address cooperative binding of multiple sites are addressed in section 5.2.2. 
Although Dll1-msd BS2 is an exact match for both T and Tbx6, T-DBD binds with a ten-
fold lower affinity than Tbx6-DBD (Kd= 13.88μM as compared to 1.3μM).  As there is currently 
no structural data for Tbx6-DBD, reasons for the decreased affinity of T-DBD for BS2 relative to 
Tbx6-DBD are unknown.  Based on the high degree of similarity between the structure of the T-
domain of Tbx3 and T, and the highly conserved nature of amino acids that make direct contact 
with the bases, we would expect that the structure of Tbx6-DBD to be very similar to the T-DBD 
structure.  
Overall, this data indicated that there might be a common subset of targets that are shared 
by T and Tbx6 within the PS and tailbud.  An example of this is Dll1, where Tbx6-DBD can 
bind two of the four T-box binding sites (BS1 and BS2), while T-DBD is only able to bind BS2 
with a reasonable affinity and BS1 with a much lower affinity.  On its own, BS1 would not 
appear to contribute significantly to T’s activity at Dll1-msd, although it is possible that T may 
bind cooperatively to BS1 after binding BS2 in vivo. In addition, T-DBD binds with a ten-fold 
lower affinity to BS2 than does Tbx6-DBD.  These differences in binding preferences between 
Tbx6 and T may translate into differences in activity level from the Dll1-msd enhancer in our 
luciferase assays.  As a non-exclusive alternative, T and Tbx6 may share a common, unknown 
co-factor necessary for their transcriptional ability.  In this scenario, addition of increasing 
amount of T relative to Tbx6 would serve to sequester the common co-factor from Tbx6 to T, 
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thus reducing its transcriptional ability.  To date, there are no known co-factors of murine Tbx6 
or T, making this a difficult hypothesis to investigate further at this time.  It is certainly possible 
that competition for a common co-factor may in combination with competition for binding to the 
enhancer lead to the in vitro behavior and in vivo phenotypes that we observe.  In the case of 
Dll1, we have shown that both factors can to bind to the enhancer region in vivo, and that 
competition for binding to the enhancer region itself partially, if not entirely, can explain our 
competition luciferase data.  This signifies that competition for binding to the enhancer region of 
common target genes is a potential mechanism for T-box factor regulation of target gene 
expression.   
We predict that T and Tbx6 share at least some common targets in their common 
expression domain, the PS/tailbud. The lower activity of T as compared to Tbx6 at a common 
subset of targets may serve to attenuate a Tbx6-based transcriptional program in vivo.  We 
hypothesize that T is required to maintain cells in a PS-like state and continue to generate 
mesoderm to extend the body axis, while Tbx6 is required to push cells towards a PAM fate. 
Therefore, changes in intracellular concentrations of Tbx6 and T relative to each other can 
influence cell fate decisions and result in the observed phenotypes.  This is especially apparent in 
our Tg46/Tg46 embryos that over-express Tbx6 within its endogenous domain, and display 
truncated axis similar to T heterozygotes. Here, we hypothesize that the increased levels of Tbx6 
relative to T results in an increased Tbx6 transcriptional program pushing cells towards a PAM 
fate relative to maintenance of a PS-fate.  Additionally, the bulbous tailbud phenotype observed 
in Tbx6 null embryos may be the result of an dramatically increased level of T and absence of 
Tbx6 resulting in an excess of cells maintained in a PS-like state. This is further supported by the 
reduction of the bulbous tailbud phenotype in T/+; Tbx6-/- embryos. Overall, the observed 
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competition between T and Tbx6 for a common subset of genes may regulate the transition 
between PS and PAM fate in vivo.  
2.6.2 TWis acts as a dominant-negative and competes with both T and Tbx6 
TWis is an allele of T that produces a protein capable of binding DNA but not transactivating, and 
has been proposed to act as a dominant-negative by preventing related proteins from binding 
similar targets (Kispert et al., 1995; Shedlovsky et al., 1988).  Luciferase assays performed with 
myc-TWis at the Mesp2P/E reporter verified that myc-TWis did not activate transcription. When 
tested in competition luciferase assays, myc-TWis effectively lowers the transcriptional activity of 
myc-T from the Mesp2P/E enhancer.    Although it is expected that a dominant-negative allele of 
T such as TWis would be able to compete with the full-length T, the increased severity of the 
TWis/TWis phenotype (no somites formed) as compared to the T null phenotype (0-5 abnormal, 
anterior somites formed) suggested that TWis can also compete with a related transcription factor 
(likely Tbx6) for binding to a common subset of downstream targets. Competition luciferase 
assays performed with increasing amounts of myc-TWis and a constant amount of myc-Tbx6 
demonstrated that myc-TWis could also lower the transcription activity of myc-Tbx6 from the 
Mesp2P/E reporter.  These competition luciferase assays support the genetic interaction observed 
in TWis/+; Tbx6/+ mice, which display fusions of the ribs and vertebrae that are not observed in 
Tbx6/+ or TWis/+ mice, which are similar to the Tbx6 hypomorphic phenotype.  Importantly, this 
genetic interaction is not observed in T/+; Tbx6/+ mice, TWis/+; Dll1/+ mice or in TWis/+; 
wnt3a/+ mice (data not shown), indicating this interaction is specific to Tbx6.  Alternatively, 
TWis may function as a neomorph, gaining activity at genes that T does not usually affect.  The 
binding preferences and affinities of TWis relative to T are also not known.    
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 In conclusion, the genetic interactions observed when relative levels of T and Tbx6 are 
altered in TWis/+; Tbx6/+ mice support our hypothesis that these two T-box transcription factors 
compete for a common subset of downstream targets in vivo. This implies that the developing 
embryo is exquisitely sensitive to relative levels of T and Tbx6.  Our hypothesis is further 
supported by our competition luciferase data and biochemical data, suggesting that Dll1 is one 
common target of both T and Tbx6 in the PS and tailbud where they have different activity 
levels.  In our luciferase assays with the Dll1-msd enhancer, we observed a ten-fold difference in 
transcriptional activity between Tbx6 and T.   This difference in activity may serve to attenuate a 
high transcriptional level of Dll1 within the tailbud, allowing for tightly regulated expression 
levels both spatially and temporally. Identification of other common targets of T and Tbx6 
awaits ChIP followed by next-generation sequencing (ChIP-seq) experiments with our protocols 
for use of dissected embryonic tissue.   
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3.0  GENERATION OF DLL1-MSD-CRE TRANSGENIC MICE 
3.1 INTRODUCTION 
To study PAM formation in the mouse, transgenic lines that can be used to either selectively 
delete or express genes of interest in the paraxial mesoderm are required. To develop a reagent 
for studying PAM in the mouse, we cloned the Dll1 mesoderm (msd) enhancer upstream of a 
minimal promoter and Cre recombinase to generate Dll1-msd Cre transgenic mouse lines.  The 
Dll1 enhancer is a good candidate for driving ectopic expression within the PAM due to its 
expression within the PSM and the posterior halves of the somites (Bettenhausen et al., 1995).  
Previous studies identified a 1.5 kb regulatory element from the Dll1 gene that was capable of 
driving expression of a minimal promoter-lacZ reporter in the PSM beginning at e7.5 (Beckers et 
al., 2000a).  This 1.5 kb mesoderm (msd) enhancer element contains binding sites for Tbx6 and 
LEF/TCF (Wnt signaling pathway) transcription factors (Hofmann et al., 2004; White and 
Chapman, 2005).  Genetic evidence along with EMSA and transcriptional assays demonstrate the 
importance of both Tbx6 and Wnt signaling in controlling expression from the Dll-msd enhancer 
(Beckers et al., 2000b; Hofmann et al., 2004; White and Chapman, 2005; White et al., 2003).  
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3.1.1 Aims of these studies 
Our lab is interested in the specification and patterning of the PAM.  In the mouse, knockout 
studies can reveal the requirement of genes in specific processes with the caveat that usually only 
the first critical role of the gene product is revealed due to early embryonic lethality.  The use of 
different Cre recombinase transgenic lines to create tissue-specific knockouts has thus become 
critical for the study of the roles of gene products in a specific tissue.  In addition to the use of 
knockouts, Cre recombinase transgenic lines can be used to selectively activate gene expression 
in transgenic systems.  We sought to investigate the phenotypic consequences of mis-expression 
or deletion of a gene of interest in the PAM in the mouse. We established Dll1-msd Cre 
transgenic lines and thoroughly characterized one line, Dll1-msd Cre Tg33, by describing the 
domain of Cre recombinase activity during mouse embryogenesis. It is notoriously difficult to 
achieve high transfection efficiency in primary fibroblasts and therefore expression of a gene of 
interest in a large number of primary fibroblasts was not previously possible.  We used this Dll1-
msd Cre line together with a conditional reverse tet-transactivator transgenic line to generate 
fibroblasts for inducible expression of myc-tagged full length Tbx6 in mesoderm-derived cells. 
We tested the efficacy of this 3-component scheme to generate fibroblasts that inducibly express 
myc-tagged, full-length Tbx6 in a significant proportion of fibroblasts (70-75%) for use in 
chromatin immunoprecipitation studies.   
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3.2 EXPRESSION OF DLL1-MSD CRE IN VIVO 
To examine the spatial and temporal activity of the Dll1-msd Cre recombinase in this Dll1-msd 
Cre Tg33 line, transgenic mice were mated to ROSA26-lacZ reporter mice in which the 
expression of lacZ is silenced until the floxed stop of transcription is removed by Cre 
recombinase activity (Soriano, 1999).  Embryos from these matings were dissected and stained 
for β-galactosidase activity.  Once the stop of transcription is removed, the lacZ reporter is 
expressed in the cells expressing the Cre recombinase and all of their descendants (Figure 20).   
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Figure 20: Schematic of Dll1-msd Cre; ROSA26-LacZ reporter 
(A) Expression of Cre recombinase from the Dll1-msd enhancer beginning at e7.0 results in the excision of 
the floxed stop of transcription cassette upstream of the lacZ reporter inserted at the ubiquitously expressed 
ROSA26 locus, allowing for expression of lacZ. (B) Examination of lacZ expression domain at e9.5 via β-
galactosidase staining of Dll1-msd Cre/+; ROSA26-rtTA/+ embryo reveals the initial domain of Cre 
recombinase activity and all their derivatives. 
At e7.0, very few cells in the embryonic portion of the embryo stained positive for β-
galactosidase activity.  Between e7.5 and e8.5, β-galactosidase activity was apparent in the 
posterior of the embryo in the mesoderm, consistent with the appearance of PAM, although 
robust staining was not observed until the headfold stage.  At this stage β-galactosidase activity 
was found in the PAM and its derivatives, but was not observed in the node or allantois (Figure 
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21A-C).  By e8.5, both PSM and somites stained positive, while the tip of the tail, which 
contains the PS, did not stain (Figure 21D).  By e9.5 and at later stages, staining was more 
widespread and was found in the lateral plate (limb buds) and intermediate mesoderm, in 
addition to the somites and PSM.  Staining, however, was not detected in the heart, notochord, 
neural tissue, surface ectoderm or endoderm, as expected (Figure 21E,F).  At later stages, 
staining was also observed in the vasculature and mesenchyme of the lungs, pancreas and other 
gut-derived organs, but not in ectoderm or endoderm derived tissue (Figure 21G-I).  In summary, 
the Dll1-msd Cre transgene results in recombination beginning at e7.0 in the PAM and later in its 
derivatives, in particular the somites.  At later stages, reporter gene activity was not limited to 
PAM-derived tissues, but was also observed in a wide-variety of mesoderm derivatives. 
Apoptosis induced by high levels of Cre recombinase has been reported for some Cre transgenic 
lines (Naiche et al., 2005a).  Although we did not directly assay for apoptosis, we have not 
observed an obvious increase in cell death in hemizygous or in homozygous animals, which are 
both viable and fertile. 
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 Figure 21:  Dll1-msd Cre recombinase activity.  
Activity of Cre recombinase driven by the Dll1-msd enhancer was assayed by staining for β-galactosidase 
activity in Dll1-msd Cre/+; ROSA26-lacZ/+ embryos dissected between e7.0-14.5 and stained for β-
galactosidase activity.  At e7.0 (A) to early e7.5 (B, posterior view B’), few cells in the posterior of the 
embryo were stained.  By the early headfold stage (C, posterior view C’), staining was detected in the 
posterior of the embryos and extended laterally, but was not observed in the node (n).  At e8.5 (D, side 
view and D’, dorsal view), staining was detected throughout the PSM and somitic mesoderm, but not in the 
allantois (al) or at the tip of the tail where the PS resides.  (E) e9.5 embryo (~16 somites) stained overnight 
for β-galactosidase activity showed staining in the posterior half of the embryo but not in the heart (h) or 
the tail tip containing the PS.  A thick section through the trunk region (dotted line in the embryo shows the 
approximate plane of section) shows staining in the somitic (s) and lateral plate mesoderm (lpm), but not in 
the gut (g), neural tube (nt) or surface ectoderm.  Similarly, a later stage e9.5 embryo (F, F’ high 
magnification of the tail) had staining through all the somites, PSM and forelimb bud (flb), but no staining 
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in the PS.  (G) By e10.5 staining is obvious through much of the posterior half of the embryos including the 
fore- and hindlimb buds (hlb).  The inset shows the staining in the mesenchymal layer of the hlb but not the 
surface ectoderm (arrowhead).  (G’) High magnification of an e10.5 tail showing β-galactosidase staining 
in the PSM and somites along with approximate planes of sections (dotted lines) for those shown in G”, 
which were counterstained with eosin.  The tip of the tail (iii and iv) is largely devoid of stained cells, 
whereas cells in the PSM (ii) and somite (J) are stained.  (H-I) Cryosections of an e14.5 embryo stained for 
β-galactosidase activity revealed staining in the mesenchyme of the lung (H), pancreas and stomach (panel 
I), but not in the endoderm components of these organs. Staining was also observed throughout the kidney 
(I).  Abbreviations used: al, allantois; flb, forelimb bud; g, gut; h, heart; hf, headfolds; hlb, hindlimb bud; k, 
kidney; lpm, lateral plate mesoderm; nt, neural tube; nc, notochord; n, node; psm, presomitic mesoderm; p, 
pancreas; ov, otic vesicle; s, somite; st, stomach. 
3.3 GENERATION OF DLL1-MSD CRE; ROSA26-RTTA EMBRYONIC 
FIBROBLASTS 
The widespread expression of the lacZ reporter in mesoderm derivatives prompted us to test 
whether we could use the Dll1-msd Cre transgenic line to drive mesoderm-specific expression of 
a conditional reverse tet-transactivator (rtTA) in embryos and in fibroblasts derived from these 
embryos.  The reverse tet-transactivator activates transcription from tet-responsive elements 
(TRE) in the presence of doxycycline (DOX), a tetracycline derivative, and therefore can be used 
to control the expression of a gene of interest that is cloned downstream of the TRE.  To do this, 
embryos were dissected from crosses of Dll1-msd-Cre/+ mice with mice homozygous for 
ROSA26-rtTA EGFP.  Similar to the lacZ reporter line, expression of the rtTA and EGFP, whose 
expression is linked to rtTA via an IRES, are silenced until excision of the floxed stop of 
transcription by Cre recombinase.  Embryos were dissected at e13.5 and Dll1-msd Cre/+; 
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ROSA26-rtTA EGFP/+ embryos were used to prepare fibroblasts.  In the first set of experiments, 
the head and liver were removed, and fibroblasts were made from the remaining portion of the 
embryo.  In the second set of experiments, neural tissue, heart and lungs were also removed in an 
attempt to increase the proportion of cells expressing rtTA (Figure 22A).  Fibroblasts were 
expanded and at the fourth passage plated onto coverslips.  In both sets of fibroblast 
preparations, cells were stained with the nuclear stain TO-PRO 3 to obtain the total number of 
cells, and either examined for EGFP directly or stained with anti-GFP to determine the 
percentage of cells expressing EGFP.  Fibroblasts derived from embryos with only the head and 
liver removed had an average of 72.4% EGFP positive cells (n=216 total cells counted).  
Fibroblasts derived from embryos in which heart, lungs, and neural tube were also removed had 
an average of 70.1% EGFP positive cells (n=239 total cells counted).  Visualizing EGFP directly 
(above results) or via anti-GFP immunofluorescence gave similar results with approximately 
74.7% (n=234) of the population being EGFP positive (Figure 22B).  Overall, this indicates that 
between 70-75% of fibroblasts isolated by this method are EGFP and therefore rtTA positive 
thus demonstrating the feasibility of using the Dll1-msd Cre mice for generating mesoderm-
derived embryonic fibroblasts that express the reverse tet-transactivator in a high percentage of 
cells.  
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Figure 22: Derivation of Dll1-msd Cre rtTA fibroblasts.   
Embryos isolated at e13.5 from crosses of Dll1-msd Cre/+ and ROSA26-rtTA EGFP (R26-rtTA) transgenic 
mice were used to generate embryonic fibroblasts.  (A) β-galactosidase stained Dll1-msd Cre/+; ROSA26-
lacZ embryo at e13.5. Cells that have undergone a Cre recombination event along with their progeny are 
stained blue. The EGFP serves as a reporter of Cre recombination since its expression is linked to rtTA via 
an IRES. To derive fibroblasts, the head and liver were removed (red dotted lines) and in some cases the 
heart, lungs, and neural tube, to create the cell suspension. (B) Fibroblasts derived from Dl11-msd Cre/+; 
ROSA26-rtTA EGFP/+ embryos were plated on coverslips and stained with anti-GFP (green) and TOPRO 
nuclear stain (blue).  GFP positive fibroblasts represent those cells that are expressing rtTA (70-75% of the 
total population), while TO-PRO3 marks the nucleus of all cells.  
3.4 GENERATION OF TRE:MYC-TBX6 FIBROBLASTS 
Since a high percentage of fibroblasts were positive for the recombination event we decided to 
test whether they were also useful to inducibly express myc-Tbx6 in a mesodermally derived 
embryonic fibroblast line. In experiments described in Chapter 4, we generated another 
transgenic line of mice, Tetracycline-responsive-element (TRE):Myc-Tbx6, which express a full-
 87 
length Myc-tagged version of Tbx6 upon addition of the tetracycline (Tet)-transactivator (TA).  
To initially test whether the TRE:Myc-Tbx6 embryos are responsive to the Tet-TA and do not 
express Myc-Tbx6 in the absence of the Tet-TA, we generated fibroblasts from e13.5 TRE:Myc-
Tbx6 embryos.  These fibroblasts were transfected with the tet-TA expression plasmid and 
processed for either immunofluorescence or Western blotting.  Immunofluorescent staining of 
transfected fibroblasts revealed a low percentage (~10%) of fibroblasts that expressed a nuclear 
Myc-Tbx6 (Figure 23A). The low percentage of transfected cells is most likely because primary 
cell lines are notoriously hard to transfect with high efficiency.   Nuclear localization is 
important because this is critical for Myc-Tbx6 to elicit a transcriptional effect in experiments 
described in Chapter 4. Western blotting revealed that myc-Tbx6 was produced only in the 
presence of the Tet-TA, and that the protein was the correct size (70 kDa) (Figure 23B).  
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 Figure 23:  Generation of TRE:Myc-Tbx6 fibroblasts 
(A) Fibroblasts derived from TRE:Myc-Tbx6/+ embryos were transfected with a tet-TA expression 
plasmid, and processed for immunofluorescence and stained with anti-myc (green), anti-Tbx6 (red) and 
TO-PRO3 (blue). The merge panel reveals nuclear localized Myc-Tbx6 staining in ~10% of cells.  (B) 
Western blotting of two separate TRE:Myc-Tbx6 fibroblast lines revealed that Myc-Tbx6 is expressed only 
when the tet-TA is transfected.   
3.5 GENERATION OF DLL1-MSD CRE; ROSA26-RTTA; TRE:MYC-TBX6 
FIBROBLASTS  
Lastly, we desired to create a system by which we could inducibly express a gene of interest in 
mesodermal fibroblasts. To generate these fibroblasts, we dissected embryos carrying all three 
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transgenes: Dll1-msd Cre; ROSA26-rtTA; and TRE:Myc-Tbx6 (Figure 24A).   In this system, 
rtTA is inactive until DOX is added to the culture media, therefore these cells were cultured 
either in the presence or absence of DOX for 36 hours, before performing immunofluorescence 
and Western blotting experiments.  Immunofluorescence experiments revealed approximately 
50% of the cells expressed a nuclear Myc-Tbx6 (Figure 24B), although approximately 70-75% 
of cells expressed EGFP (and thus rtTA).  All cells expressing Myc-Tbx6 also expressed EGFP, 
demonstrating that the expression of TRE:Myc-Tbx6 was dependent on rtTA and DOX.  Western 
blotting revealed proper expression of Myc-Tbx6 in the presence of DOX, but not in its absence 
(Figure 24C).   
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 Figure 24: Generation of mesodermal fibroblasts that inducibly express Myc-Tbx6 
(A) Schematic representing Dll1-msd:Cre; ROSA26-rtTA-EGFP; TRE:Myc-Tbx6-based gene expression in 
fibroblasts.  Expression of Cre recombinase in mesoderm derivatives excises the floxed stop (STOP) of 
transcription cassette, allowing expression of rtTA-IRES-EGFP.  The loxP sites are represented by black 
triangles.  rtTA binds to the Tet-responsive element (TRE) but is inactive until DOX (D, teal box) is added 
to tissue culture media.  Once activated, rtTA-DOX drives expression of myc-Tbx6.  (B) Fibroblasts 
derived from Dll1-msd:Cre; ROSA26-rtTA-EGFP; TRE:Myc-Tbx6 embryos plated onto coverslips and 
stained with anti-GFP (green), anti-myc (red) and the nuclear stain TO-PRO 3 (blue). Individual and 
merged channels are shown.  Approximately 50% of the fibroblasts inducibly express Tbx6, while 70-75% 
express EGFP.  (C) Fibroblast cell lines derived from four different transgenic embryos were cultured in 
the absence or presence of DOX, and processed for Western blotting using the anti-myc antibody to detect 
the fusion protein.  Expression of myc-Tbx6 was observed only with addition of DOX. 
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3.6 DISCUSSION 
As assayed by the ROSA26-lacZ reporter, Dll1-msd Cre transgenic mice possess Cre 
recombinase activity in the PSM and its derivatives, as well as other mesoderm derivatives.  As 
this enhancer element has previously been shown to be expressed only in PAM (Beckers et al., 
2000a), expression of the reporter in other mesoderm tissues, namely lateral plate and 
intermediate mesoderm, suggests that a common precursor to the lateral plate, intermediate and 
somitic mesoderm underwent a recombination event.  Cre activity was not observed in the PS, 
suggesting that activity in the lateral plate and intermediate mesoderm was not due to a PS 
recombination event.  Alternatively, the specific integration site of this transgene could be 
altering its expression, thus allowing more widespread expression of Cre recombinase in other 
mesoderm derivatives.  Although we initially obtained two Dll1-msd Cre transgenic lines that 
had similar reporter gene expression domains, we only thoroughly characterized one of the lines, 
as the second line was subsequently lost.  Interestingly, reporter gene expression was not 
observed in all mesoderm, as the notochord (axial mesoderm) and cardiac mesoderm were not 
stained.  Furthermore, although activity of Cre in this transgenic line is not limited to PAM, it is 
limited to mesoderm derivatives, as the neural tube, surface ectoderm, and gut did not stain with 
β-galactosidase.  
Other Cre recombinase lines that are currently available to study mesoderm formation in 
the mouse include the T-Cre line (Perantoni et al., 2005) and the Meox1-Cre line (Jukkola et al., 
2005).  The T-Cre line is active beginning at e7.5 in the PS and migrating mesoderm.  By e8.5, 
reporter gene expression was observed in all mesodermal lineages including the extraembryonic 
mesoderm, the allantois, in addition to the notochord, floorplate of the neural tube, part of the 
heart, intermediate, and lateral plate mesoderm (Perantoni et al., 2005).  Recombination driven 
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by T-Cre is therefore more extensive than we observed for the Dll1-msd-Cre.  Meox1-Cre is a 
knock-in allele that shows reporter gene expression in the somitic mesoderm but this is limited to 
the formed somites and does not appear to be active prior to segmentation of the PAM.  Later 
reporter gene expression was also observed in the somitic derivatives, including the dermis of the 
back, myotome and capillaries in the neural tube (Jukkola et al., 2005).  Altogether these 
comparisons demonstrate that although the Dll1-msd Cre shows extensive recombination in 
many mesodermal cell types, it is less extensive than the T-Cre and is active in the PSM, where 
the Meox1-Cre is not.  Therefore the Dll1-msd Cre line provides a unique tool for researchers 
who desire to study mesoderm formation in the mouse. 
Seventy to 75% of the fibroblasts derived from the posterior portions of Dll1-msd Cre, 
ROSA26-rtTA EGFP embryos were EGFP positive and were therefore descendants of cells that 
had experienced a Cre recombination event.  In an attempt to increase the percentage of cells 
expressing rtTA/EGFP, we dissected away the neural tube, heart and lungs in addition to the 
head and liver.  This extra step did not improve isolation of rtTA/EGFP expressing cells 
suggesting that those mesoderm-derived cells exposed to Cre recombinase and their progeny, 
which includes paraxial, lateral plate and intermediate mesoderm, as well as cells of the vascular 
cells, mesenchymal cells of the lung and other gut-derived organs represent a high percentage of 
cells to start, are selectively retained in these cultures, or proliferate at a higher rate than the 
other cell types.   
The high percentage of cells positive for the recombination event in the expanded 
fibroblast pool support the use of Dll1-msd Cre and ROSA26-rtTA EGFP mice with transgenic 
mice harboring a TRE driving expression of a gene of interest to generate embryonic fibroblast 
cells from mesoderm-derived tissues. The rtTA is inactive until DOX is added to the culture 
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media; therefore expression of the gene of interest is inducible.  These fibroblasts may be more 
similar to embryonic mesoderm cells than existing cell lines, for example NIH/3T3, COS-7, 
293T and MDCK, which are often deemed irrelevant to embryonic mesoderm studies.  In 
addition, it is notoriously difficult to achieve high transfection efficiency in primary fibroblasts 
and therefore expression of a gene of interest in a large number of primary fibroblasts is not 
possible.  We have used this scheme to perform ChIPs (see section 2.4.1), and believe it is useful 
when the transcription factor of interest is normally expressed in a limited region of the embryo, 
for example the PSM.  These cell lines may also be useful for studies to identify interacting 
proteins and protein modifications in a more relevant embryonic mesoderm cell type.  
It is interesting to note that although 70-75% of fibroblasts generated express EGFP (thus 
rtTA), only 50% of the cells express Myc-Tbx6 in Dll1-msd Cre; ROSA26-rtTA; TRE:Myc-Tbx6 
fibroblasts.  All cells expressing Myc-Tbx6 also express EGFP, demonstrating the need for rtTA 
for expression of Myc-Tbx6, although not all cells expressing EGFP express Myc-Tbx6.  This 
may represent a delay in expression of Myc-Tbx6 after initial expression of rtTA, an insufficient 
concentration of DOX in the culture media, or partial silencing of the transgene.   
Altogether our results show that the Dll1-msd Cre transgenic line will drive Cre 
expression in the PAM, as well as other mesoderm derivatives and is therefore a useful reagent 
for studying not only PAM development but also lateral plate and intermediate mesoderm.   
A detailed analysis of the phenotypic consequences of mis-expression of myc-Tbx6 in the PAM 
appears in Chapter 4, where we further demonstrate the feasibility of using this transgenic line to 
drive expression of a gene of interest in embryonic mesoderm in vivo. 
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4.0  MIS-EXPRESSION OF TBX6 RESULTS IN TBX18 AND TBX15 NULL-LIKE 
PHENOTYPES 
4.1 INTRODUCTION 
We developed a system to misexpress full-length myc-tagged Tbx6 in a variety of mesoderm 
derivatives during development using a 3-component system to gain both spatial and temporal 
control of expression within the mouse embryo.  This system consists of three separate 
transgenic lines. The first is Cre recombinase under the control of the Dll1-msd enhancer.  As 
described in Chapter 3, this enhancer drives expression of Cre recombinase within the PSM and 
all downstream derivatives, in addition to other mesoderm derivatives including the lateral plate 
and intermediate mesoderm (Wehn et al., 2009). The second transgenic line consists of reverse 
tetracycline-transactivator (rtTA) inserted at the ROSA26 locus downstream of a floxed stop of 
transcription cassette.  rtTA is only active when it associates with DOX (Belteki et al., 2005).  
The third transgenic line contains a full-length myc-tagged Tbx6 under the control of the 
tetracycline-responsive element (TRE:myc-Tbx6).  
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4.1.1 Aims of these studies 
We sought to determine the phenotypic and molecular consequences of ectopic Tbx6 expression 
within the segmented PAM and its derivatives, where it is normally not expressed.  Using a 3-
component transgenic system we drove ectopic expression of Tbx6 in the formed somites and 
limb buds. Maintenance of Tbx6 expression within the segmented PAM resulted in distinct 
skeletal phenotypes of the ribs, vertebral column, and appendicular skeleton resembling that of 
Tbx18 and Tbx15 null embryos.  We hypothesize that these phenotypes arise due to competition 
between the ectopically expressed Tbx6 with endogenous Tbx18 and Tbx15 at the binding sites 
of target genes. We further support this hypothesis in vitro with luciferase transcriptional assays. 
4.2 EXPRESSION OF MYC-TBX6 IN 3-COMPONENT EMBRYOS 
To generate embryos containing all three transgenes, we mated TRE:myc-Tbx6/+; rtTA/rtTA 
mice to mice homozygous for the Dll1-msd:Cre transgene.  Pregnant mice were administered 
DOX in their drinking water beginning at e6.5 and embryos were dissected from e10.5 to e13.5.  
At e10.5, whole mount in situ hybridization (WISH) revealed the expression domain of both 
endogenous and ectopic Tbx6 mRNA.  Endogenous Tbx6 is limited to the PS and PSM, located 
in the tip of the tail (Figure 25A).  In addition to this expression domain, 3-component embryos 
had mosaic expression of Tbx6 in the formed somites and limb buds (Figure 25A’-A”).  
Interestingly, somites in 3-component embryos appeared morphologically normal.  Whole-mount 
antibody staining for Tbx6 at e10.5 revealed a wide gap between the tailbud and the ectopic 
expression domain (Figure 25B-B”).  Robust expression was not observed until somite 4 (S4), 
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with S1 considered the most recently formed somite.  To determine relative levels of endogenous 
and ectopic Tbx6 protein in these embryos, we dissected tailbuds, somites 1-3, somites 4-5, and 
limb buds from e10.5 embryos and used these for Western blot analysis.  The myc-Tbx6 protein 
is larger than the endogenous Tbx6 and thus endogenous and ectopic Tbx6 protein can be 
distinguished by Western blotting using a Tbx6 antibody (Figure 25D).  Endogenous Tbx6 
protein was detected in isolated tailbuds, however myc-Tbx6 was absent.  Low but detectable 
levels of myc-Tbx6 were found in somites 1-3, which corresponds to the gap observed in the 
whole-mount antibody staining.  Somites 4-5 expressed increased levels of myc-Tbx6, and limb 
buds showed robust expression. 
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Figure 25:  Mosaic expression of myc-Tbx6 in 3-component embryos. 
WISH of Tbx6 expression in a control (A) and 3-component (A’-A”) e10.5 embryos. Tbx6 expression in 
the control embryo is restricted to the tailbud and PSM (staining in the head is trapped color reactants).  
(A’-A”) Two different 3-component embryos with Tbx6 transcripts in the tailbud and mosaic Tbx6 mRNA 
expression throughout the somitic mesoderm and limb buds. Whole mount antibody staining using a Tbx6 
antibody in control (B) and 3-component (B’-B”) e10.5 embryos.  Anti-Tbx6 staining revealed Tbx6 
protein localization in the tailbud (B), while ectopic myc-Tbx6 protein mimics the mRNA expression in 3-
component embryos (B’-B”).  (b”) A wide gap in Tbx6 endogenous and ectopic expression can be seen 
between the tailbud and somite 4.  Somites 1-3 lie between the red arrows.  (C) Tail region from an e10.5 
embryo showing the planes of dissection of tissues used for Western blot analysis shown in panel D: 
tailbud (TB), somites 1-3 (S1-3), somites 4-6 (S4-6) and the limb bud (LB). (D) Westerns blotted with 
either anti-Tbx6 (α-Tbx6), anti-myc (α-myc), or α-Tubulin antibodies.  Tubulin served as a loading 
control.  Endogenous Tbx6, which is a smaller molecular weight (red asterisk), was only detected in tailbud 
tissue, while ectopic myc-Tbx6 was found at low levels in S1-3, higher levels in S4-6, and was robust 
within the limb buds.  Ectopic Myc-Tbx6 was not detected in the tailbud tissue. 
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4.3 3-COMPONENT EMBRYOS DISPLAY AXIAL AND APPENDICULAR 
SKELETAL DEFECTS 
To examine the consequences of ectopic myc-Tbx6 expression in the formed somite, pregnant 
females were treated with DOX at e6.5 and embryos were dissected at e13.5 and examined for 
both gross and skeletal morphology.  Despite the apparent normal segmentation of the PAM, 3-
component embryos exhibit striking skeletal defects at e13.5.  Although the phenotypes were 
somewhat variable, common defects were noted within the vertebral column and appendicular 
skeleton.  Of the thirty-four 3-component embryos examined, 100% had vertebral abnormalities 
including fusion and/or malformation of the atlas and axis, the most anterior somitic derivatives, 
and fusions of the vertebral pedicles in the anterior of the embryo (Figure 26C).  The most 
severely affected embryos displayed fusions along the entire body axis (85%).  Additionally, the 
distal portions of the ribs were often missing or underdeveloped (91%).  Beyond e13.5, 3-
component embryos become edemic, and died shortly thereafter in utero which precluded 
analysis at later developmental stages.  To increase the level and presumably the number of cells 
that express myc-Tbx6, we generated embryos that were hemizygous for the Dll1-msd:Cre and 
rtTA transgenes, but homozyogous for the TRE:myc-Tbx6 transgene.  These homozygous 
embryos had more severe phenotypes than the hemizygotes; specifically pedicle morphology 
was affected along the entire axis and vertebral bodies were also malformed (Figure 26D-D’).  
Gross morphological examination of 3-component embryos revealed underdeveloped 
limbs when compared to control littermates (Figure 26A).  By e13.5 control littermates display 
distinguishable digits and cartilage condensation within the limb bud, whereas 3-component 
embryos still had paddle-shaped limbs without distinguishable digit condensations (94%).  
Skeletal analysis of these limbs revealed shortened and malformed humerus, radius and ulna 
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(100%), as well as femur, tibia and fibula (97%), and occasionally the distal limb elements were 
missing altogether (Figure 26F).  3-component embryos also had hypoplastic scapulae (91%), 
which contained an ectopic foramen within the center of the blade in 21% of the embryos.  
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Figure 26: Three-component embryos display limb and vertebral anomalies. 
Gross morphology and skeletal preparations of control and 3-component (Tg) embryos dissected at e13.5.  
(A) 3-component embryos were smaller than normal littermates, and had paddle-shaped limb buds, whereas 
control littermates had begun to form distinct digits (forelimb, fl; hindlimb, hl).  Alcian blue-stained 
skeletons of control (B, C) and 3-component embryos (C, D, F).  Panel C shows an embryo hemizygous for 
TRE:myc-Tbx6, while the embryo in panel D is homozygous for the TRE:myc-Tbx6 transgene.  Primed 
panels show a higher magnification of the embryos in panels B-D.  The atlas (at) and axis (ax) are clearly 
distinct structures in the control embryo (B, B’). (C and D) 3-component embryos displayed fusions and 
malformations of the atlas and axis (at/ax, C’) and expansion and fusions of the vertebral pedicles (red 
arrow and asterisk, C’). Vertebral body morphology was also affected in 3-component embryos, with more 
severe phenotypes observed in the embryo homozygous for the TRE:myc-Tbx6 transgene (D’).  Skeletal 
preparations of the forelimbs revealed shortened and malformed forelimb bones in the 3-component (F) 
embryos compared to the littermate control (E).  An ectopic foramen in the scapula (arrow) was evident in 
21% of 3-component embryos (F). 
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 4.4 OVEREXPRESSION OF TBX6 PHENOCOPIES TBX18 AND TBX15 NULL 
EMBRYOS 
Ectopic expression of myc-Tbx6 within the limbs and somitic tissue results in severe skeletal 
phenotypes.  One explanation for these phenotypes is that misexpression of Tbx6 drives 
expression of its own downstream targets and it is the ectopic expression of these targets that 
causes the observed phenotypes.  We therefore examined the expression of the four confirmed 
downstream targets of Tbx6: Dll1, Mesp2, Msgn1, and Ripply2 (Hitachi et al., 2008; White and 
Chapman, 2005; Wittler et al., 2007; Yasuhiko et al., 2006).  Expression of these targets at e10.5 
was found only in their endogenous expression domain (Figure 27 and data not shown), 
suggesting that phenotypes were not due to misexpression of Tbx6 target genes.  It is important 
to note that even in the limb buds where the level of myc-Tbx6 was highest, there was no ectopic 
expression of Tbx6 target genes.   
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Figure 27: Tbx6 downstream target gene expression in control and 3-component embryos is 
indistinguishable. 
The expression of Tbx6 target genes in 3-component embryos (Tg) is indistinguishable from control 
littermates at e10.5. (A) Dll1 is expressed in the tailbud, PSM, caudal portion of each somite, and in neural 
tissue. mesp2 (B) and Ripply2 (C) are both expressed at the anterior somitic boundary.  There is no ectopic 
expression of Dll1 or mesp2 in the limb buds where the highest levels of ectopic myc-Tbx6 are found. 
 To further investigate the cause of the observed phenotypes, we examined other T-box 
transcription factors that are expressed within the somites and limb buds, hypothesizing that 
ectopic Tbx6 could either directly alter the expression of these T-box factors or compete for 
binding at their downstream targets, as has been observed for other T-box transcription factors 
(Goering et al., 2003; Habets et al., 2002).  The phenotypes observed in 3-component embryos 
closely resemble Tbx15 and Tbx18 null embryos, as well as embryos in which Tbx5 function is 
removed after initiation of the limb bud.  Tbx15 null embryos show abnormalities within the atlas 
and axis (Singh et al., 2005).  Tbx18 null embryos also display phenotypes that overlap with our 
3-component embryos, specifically caudalization of the somites, which leads to expanded and 
fused pedicles of the vertebrae (Bussen et al., 2004).  Late removal of Tbx5 results in a scapular 
foramen, and shortening and malformations of the forelimbs (Hasson et al., 2007). 
Tbx5 and Tbx4 initiate and maintain outgrowth of the fore- and hindlimb, respectively, 
via a feedback loop where direct activation of Fgf10 expression within the lateral plate 
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mesenchyme maintains Fgf8 expression in the overlying apical ectodermal ridge (AER) 
(Agarwal et al., 2003).  Loss of Tbx5 results in loss of Fgf10 and consequently loss of Fgf8 
expression in the AER thus halting limb outgrowth (Naiche and Papaioannou, 2003; Rallis et al., 
2003; Takeuchi et al., 2003).  We examined Fgf8 expression at e10.5 in 3-component embryos to 
indirectly assess Tbx5 function.  Fgf8 was expressed in the AER of both control and 3-
component embryos (Figure 28A), suggesting that misexpression of Tbx6 does not inhibit this 
function of Tbx5.  While Tbx18 null embryos do not display limb defects, Tbx15 null embryos 
display a delay in endochondral bone formation in the limbs with alterations in bone shape and 
size.  Tbx15 null embryos also exhibit hypoplastic scapulae with ectopic foramen (Singh et al., 
2005), similar to phenotypes observed in the 3-component embryos.  Altogether this suggests 
that Tbx15 may be a primary T-box transcription factor affected by ectopic expression of Tbx6 
in the limbs. 
Misexpression of myc-Tbx6 in the PAM and limb buds phenocopies aspects of the Tbx18 
and Tbx15 null embryos.  It is conceivable that in these embryos ectopic Tbx6 results in the 
down-regulation of Tbx15 and Tbx18 expression and this down-regulation results in the observed 
phenotypes.  To test this, we examined Tbx15 and Tbx18 expression in 3-component embryos at 
e10.5, focusing on changes in limb and somitic expression domains that might be altered due to 
ectopic Tbx6 expression.  At this stage, Tbx15 is normally expressed within the limb buds, while 
Tbx18 is expressed in the rostral portion of each somite, in addition to the limb buds (Agulnik et 
al., 1998; Kraus et al., 2001; Singh et al., 2005).  Expression of Tbx15 and Tbx18 appeared 
unaffected in our 3-component embryos (Figure 28B-C), suggesting that ectopic Tbx6 is not 
causing these phenotypes by down-regulating Tbx15 or Tbx18 expression.  
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The vertebral defects in Tbx18 null embryos are thought to arise from a failure to 
maintain rostral somite identity, with the hypothesis that the more caudal cells eventually invade 
the rostral region (Bussen et al., 2004).  Expression of uncx4.1, which is normally restricted to 
the caudal portion of each somite, expands slightly into the rostral portion of the Tbx18 null 
somites.  This expansion occurs only in the more anterior and thus more mature somites, 
suggesting that Tbx18 is not required for the initial repression of uncx4.1 expression, but is 
instead required to maintain rostral-caudal patterning.  In Tbx6 3-component embryos uncx4.1 
expression was still confined to the caudal portion of each somite, suggesting that rostral-caudal 
somite identity is initially established in these embryos.  Interestingly, uncx4.1 staining appeared 
darker suggesting that it was expressed higher in the 3-component embryos compared to control 
littermates (Figure 28D).  Somitic defects in the Tbx18 nulls are limited to the sclerotome 
compartment as expression of myogenin within the myotome was unaltered (Bussen et al., 2004).  
Similarly, myogenin expression in the 3-component embryos was unaltered (Figure 28E). 
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 Figure 28: Spatial expression of limb and somitic markers is maintained in 3-component embryos 
(A) Fgf8 expression in the AER of control and 3-component (Tg) embryonic limb buds are 
indistinguishable. (B) Tbx15 is expressed within the fore- and hindlimb buds of control embryos. (C) Tbx18 
is expressed within the limb buds and the anterior of each somite.  There are no observable differences in 
Tbx15 or Tbx18 expression levels or pattern between control and 3-component embryos in the limb buds or 
somites. (E) uncx4.1 is expressed within the posterior portion of each somite in both control and 3-
component embryos, however expression levels are higher in 3-component embryos. (F) myogenin 
expression in the myotome compartment of the somites was similar in both control and in 3-component 
embryos. Abbreviations used: fl, forelimb bud; hl, hindlimb bud; h, heart. 
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4.5 MYC-TBX6 COMPETES WITH TBX18 AT THE ANF AND DLL1 ENHANCERS 
IN LUCIFERASE ASSAYS 
Both Tbx15 and Tbx18 encode transcriptional repressors.  We hypothesize that ectopic Tbx6 in 
3-component embryos interferes with Tbx15 and Tbx18 function at the level of binding to the 
enhancer of downstream targets.  To test this, we first cloned full-length Tbx15 and Tbx18 into 
the pCS3mT expression vector to produce myc-tagged fusion proteins.  Constructs were 
transfected into COS-7 cells and protein size and expression levels were verified by Western 
blotting.  While the myc-Tbx15 and myc-Tbx18 proteins were of the predicted molecular 
weights (Figure 29A), myc-Tbx18 was produced at approximately two-fold greater than myc-
Tbx6, and myc-Tbx15 was produced at 1.7-fold less than myc-Tbx6 when equivalent amounts of 
expression plasmids were transfected.   
Dll1 is a bona fide target of Tbx6 and is also thought to be a target of Tbx18 in the 
somites.  In the segmented PAM, Dll1 expression is confined to the posterior of each somite via 
repression by Tbx18 in the anterior compartment (Bussen et al., 2004).  We performed 
transcriptional assays using Dll1-msd-luc (see section 2.2.3).  Our luciferase assays revealed that 
on its own myc-Tbx6 activates transcription from the Dll1-msd enhancer (Figure 29B).  The 
RLUs for myc-Tbx18 and myc-Tbx15 alone were less than background, suggesting that in our 
assay system they functioned as repressors (Figure 29B-C).  To test whether Tbx15 and Tbx18 
could compete with Tbx6, increasing amounts of myc-Tbx18 or myc-Tbx15 expression 
constructs were added to a constant amount of myc-Tbx6.  This resulted in a decrease in 
luciferase activity (Figure 29B-C).   
We further confirmed these results using a second known target of Tbx18, atrial 
natriuretic factor (ANF), which is expressed during cardiac morphogenesis.  The ANF enhancer 
 107 
contains two consensus T-box binding sites in inverted orientation relative to each other (Brown 
et al., 2005).  Although ANF is not an endogenous target of Tbx6, myc-Tbx6 weakly activated 
transcription from this enhancer (Figure 29E).  Neither Tbx18 nor Tbx15 had significant activity 
at the ANF on their own (Figure 29E and Figure 30A).  Addition of increasing amounts of myc-
Tbx18 lowered the transcriptional activity of myc-Tbx6 from this promoter as well (Figure 29E).  
Curiously, adding increasing amounts of myc-Tbx15 did not cause a linear decrease in RLUs, 
and only repressed myc-Tbx6 mediated transcription a maximum of 2-fold (Figure 30A).  
Altogether, these results suggest that a competition between T-box factors occurs for binding 
sites found in enhancers of target genes, however the robustness of competition is likely to be T-
box factor dependent.  
To further examine whether this competition occurred at the level of DNA binding, we 
used the DNA binding domains of Tbx15 and Tbx18 fused to an N-terminal myc tag and nuclear 
localization sequence (NLS) in our luciferase assays. Interestingly, the DBD alone of Tbx15 and 
Tbx18 were sufficient to compete with Tbx6, further supporting that the apparent competition 
between Tbx6 and Tbx15 or Tbx18 occurs at the level of DNA binding (Figure 29F and 30B; 
Tbx15DBD at Dll1-msd). 
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 Figure 29: Luciferase assays reveal that Tbx15 and Tbx18 compete with Tbx6 at multiple enhancers. 
(A) Lysates from 293T cells transfected with equal amounts of myc-Tbx6, -Tbx15 or -Tbx18 expression 
vectors were Western blotted with an anti-myc antibody.  Twice as much myc-Tbx18 was produced as 
compared to myc-Tbx6, while 1.7-fold less myc-Tbx15 was produced as compared to myc-Tbx6.  (B) 
Western blotting of lysates from 293T cells transfected with equal amounts of myc-Tbx6, myc-Tbx15-
DNA binding domain (myc-T15-DBD) or myc-Tbx18-DNA binding domain (myc-T18-DBD).  myc-T15-
DBD and myc-T18-DBD were produced at approximately the same level, while myc-Tbx6 was produced at 
approximately 37% more than either myc-T15-DBD or myc-T18-DBD.  (C-D) myc-Tbx18 and myc-Tbx15 
slightly repressed transcription from the Dll1-msd enhancer, while myc-Tbx6 activated transcription.  
Addition of increasing amounts of myc-Tbx18 or myc-Tbx15 to a constant amount of myc-Tbx6 lowered 
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overall RLUs.  (E) myc-Tbx6 activated low levels of transcription from the enhancer of the Tbx18 target 
ANF, while myc-Tbx18 did not significantly activate transcription.  Addition of increasing amounts of 
myc-Tbx18 to a constant amount of myc-Tbx6 lowered the overall RLUs from the ANF enhancer. (f) The 
myc-Tbx18-DBD had no significant effect on luciferase expression from the Dll1-msd enhancer.  Addition 
of increasing amounts of myc-Tbx18-DBD to a constant amount of myc-Tbx6 led to a linear decrease in 
luciferase activity. Asteriks indicate p<0.05.   
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Figure 30:  myc-Tbx15 and myc-Tbx15-DBD weakly repress myc-Tbx6 mediated transcription 
(A) myc-Tbx6 activated low levels of transcription from the ANF enhancer, while myc-Tbx15 had no 
significant effect on transcription from the ANF enhancer.  Addition of increasing amounts myc-Tbx15 to a 
constant amount of myc-Tbx6 had little effect on the overall RLUs, and only maximally lowered the RLU 
2-fold.  (B) The myc-Tbx15-DBD had no significant effect on luciferase expression from the Dll1-msd 
enhancer.  Addition of increasing amounts of myc-Tbx15-DBD to a constant amount of myc-Tbx6 led to a 
linear decrease in luciferase activity.  Asteriks indicate p<0.05.   
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4.6 DISCUSSION 
We investigated the phenotypic consequences of ectopically expressing a full-length, myc-
tagged Tbx6 in the segmented PAM and LPM.  This resulted in axial skeletal phenotypes 
including fusion and/or malformations of the atlas and axis, fusions of the vertebral pedicles, and 
underdeveloped distal portions of the ribs.  Limb phenotypes included delayed digit formation, 
shortened and malformed fore- and hindlimb bones.  Underdevelopment of the ribs and digits 
may reflect a developmental delay of 3-component embryos, as they were noticeably smaller 
than the control littermates at e13.5.  Additionally, these embryos also displayed hypoplastic 
scapulae, which contained an ectopic foramen within the center of the blade 21% of the time.  
The scapula is derived from both lateral plate and somitic tissue (Huang et al., 2000b), both of 
which expressed myc-Tbx6 in our 3-component embryos.  The observed phenotypes were highly 
variable most likely due to the high degree of mosaic myc-Tbx6 expression observed by both 
WISH and whole mount antibody staining.  By e13.5, embryos became edemic, precluding 
analysis at later developmental stages.  The cause of the edema and embryonic death has yet to 
be investigated, although it is interesting to note that the Dll1-msd:Cre drives expression within 
the vasculature (Wehn et al., 2009), which may contribute to the edema. 
To understand the mechanisms underlying the observed phenotypes, we first examined 
the expression of the Tbx6 target genes Dll1, Mesp2, Ripply2 and Msgn1.  As none of these were 
misexpressed in 3-component embryos, we concluded that the phenotypes did not result from up-
regulation of Tbx6 targets.  It is not surprising that Tbx6 target genes were not ectopically 
expressed in these embryos since their expression is not solely dependent on Tbx6.  In addition 
to Tbx6, Mesp2 expression is also dependent on Notch and FGF signaling (Oginuma et al., 2008; 
Yasuhiko et al., 2006).  Expression of both Dll1 and Msgn1 requires cooperation between Tbx6 
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and LEF/TCF transcription factors, and hence Wnt signaling (Hofmann et al., 2004; Wittler et 
al., 2007).  Regulation of Ripply2 expression requires both Tbx6 and Mesp2 (Dunty et al., 2008; 
Hitachi et al., 2008).   This complex regulatory network ensures that target genes are expressed 
in the correct time and place during development, effectively prohibiting ectopic expression in 
the absence of the other necessary factors.   
Since ectopic expression of Tbx6 did not induce ectopic expression of its own 
downstream targets, the question of how these phenotypes arose remained. Four T-box 
transcription factors (Tbx2, Tbx15, Tbx18, Tbx22, all transcriptional repressors) are expressed in 
the somites.  Tbx2 function is required for formation of the intersomitic blood vessels (Harrelson 
and Papaioannou, 2006), and therefore does not contribute to the patterning of the vertebral 
column or ribs.  Similarly, Tbx22 null embryos do not exhibit vertebral or rib defects, but rather 
display a cleft-palate phenotype (Bush et al., 2002).  Strikingly, the observed phenotypes of 3-
component embryos resembled those of Tbx15 and Tbx18 null embryos.  We showed that Tbx15 
and Tbx18 expression domains were not altered in our 3-component embryos, indicating that 
ectopic myc-Tbx6 did not down-regulate their expression to generate the observed phenotypes.  
Tbx15 and Tbx18 are both transcriptional repressors; however there are no known targets of 
Tbx15, and ANF and Dll1 are the only known targets of Tbx18.  Although Tbx18 is thought to 
directly repress Dll1 expression in the rostral region of each somite, thereby limiting its 
expression to the caudal portion, the loss of Tbx18 does not result in the expansion of Dll1 
expression (Bussen et al., 2004).  Instead, ectopic expression of Tbx18 in the somites leads to the 
eventual reduction in Dll1 expression in the caudal somitic compartment.  We did not observe a 
detectable expansion of Dll1 expression in our Tbx6 3-component embryos. 
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Bussen and colleagues (2004) showed that Tbx18 is not responsible for the initial R-C 
patterning of the somites; instead, it appears to be required for maintenance of R-C patterning.  
To this end, loss of Tbx18 results in the eventual expansion of the uncx4.1 expression domain (a 
caudal somite marker) into the rostral region, and the subsequent fusion of pedicle regions of the 
vertebrae, which is indicative of a loss of rostral sclerotome identity.  This expansion is subtle 
and the authors suggest that it is due to caudal somitic cells expressing uncx4.1 migrating into 
the rostral region.  In our experiments, ectopic myc-Tbx6 also results in the expansion and fusion 
of pedicles, but we did not observe a detectable expansion of uncx4.1 transcripts into the rostral 
region of the somite.  Instead, we observed an up-regulation of uncx4.1 expression in the caudal 
halves of the somites.  It is conceivable that this may lead to the eventual expansion and fusion 
of the pedicles.  The mosaic expression of myc-Tbx6 in the 3-component embryos may 
contribute to differences in phenotypes or intensity of phenotypes when compared to the Tbx18 
null embryo.  Although marker gene expression patterns were not strikingly different in our 3-
component embryos compared to controls, the phenotypic consequences of misexpression were 
apparent.  Due to the similarity of phenotypes observed in the Tbx15 and Tbx18 null embryos 
with that of our 3-component embryos, we proposed that a competition between the ectopically 
expressed myc-Tbx6 and endogenous Tbx15 and Tbx18 exists. In addition, alignment of the 
DBD of Tbx6, Tbx15, and Tbx18 reveals the high level of conservation between the three T-
domains (more than 54% of residues are completely conserved between all three factors), 
indicating the feasibility of competition between Tbx6 and Tbx15 or Tbx18 (Figure 31). 
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 Figure 31: Alignment of the DNA binding domain of Tbx6, Tbx18, and Tbx15 
Aligning the DNA binding domain of T, Tbx6, Tbx15 and Tbx18 reveals a high level of conservation. 
Greater than 54% of residues are completely conserved between all four factors.  Residues marked with a 
red asterik make direct contact with the DNA base, while those marked with a blue asterik make contact 
with the phosphate backbone, based on the published crystal structure of the T-DBD (Muller and 
Herrmann, 1997). 
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Tbx15 and Tbx18 are co-expressed within the proximal portion of the limb bud 
mesenchyme (Bussen et al., 2004; Singh et al., 2005). Several T-box factors are also expressed in 
the limb buds, including Tbx2, Tbx3, Tbx4 (hindlimb only), Tbx5 (forelimb only), Tbx15, and 
Tbx18.  Tbx2 and Tbx3 are expressed within a strip of cells at the anterior and posterior margins 
of the limb bud and are involved in posterior digit identity (Davenport et al., 2003; Suzuki et al., 
2004).  The lack of limb abnormalities in Tbx18 null embryos could stem from functional 
redundancy within this expression domain.  Ectopic Tbx6 expression in our 3-component 
embryos results in limb phenotypes that are similar to a loss of Tbx15, namely changes in the 
size and shape of the limb bones and a hole in the scapula blade. Tbx15 functions as a 
transcriptional repressor, however direct targets of Tbx15 are currently unknown.  The hole or 
foramen in the scapula is common to both null mutations in Tbx15 and conditional removal of 
Tbx5 after the initiation of limb bud outgrowth (Hasson et al., 2007).  Fgf10 is a direct target of 
Tbx5 in limb bud mesenchyme, and functions to maintain Fgf8 expression in the AER in a 
feedback loop (Agarwal et al., 2003).  We observed normal expression of Fgf8, indicating that 
Tbx5 function is not likely to be affected, however we cannot exclude the possibility that ectopic 
Tbx6 affects binding of Tbx5 to other downstream targets or Tbx5 transcriptional ability at a 
level that cannot be observed by in situ hybridization.   
Competition between T-box transcription factors for binding to endogenous targets 
within overlapping expression domains is not a novel concept.  During mouse heart 
development, Tbx2, a transcriptional repressor, competes with Tbx5, a transcriptional activator 
for binding to the ANF promoter within the atrio-ventricular canal and outflow tract (Habets et 
al., 2002).  We propose a similar competitive mechanism in our 3-component embryos, where 
ectopic expression of Tbx6 within the limb buds and somites interferes with the transcriptional 
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repressors Tbx15 and Tbx18 through a competition for binding sites in the enhancers of 
downstream targets.  Competition between Tbx6 and Tbx18 for binding to the T-box binding 
sites within the Dll1 enhancer has been previously proposed (Farin et al., 2007).  Herein we 
provide in vivo support of such competition.   
Our luciferase assays suggest that Tbx6 and Tbx18 directly compete at the Dll1-msd 
promoter.  This could indeed reflect the in vivo situation observed in our 3-component embryos.  
Tbx6 is required in the PSM to activate Dll1 expression (White and Chapman, 2005), and Tbx18 
directly represses Dll1 within the rostral portion of each somite, restricting its expression to the 
caudal half (Bussen et al., 2004).  Similar competition is observed at the Dll1-msd enhancer 
between Tbx6 and Tbx15, suggesting a common mechanism to compete for binding to enhancer 
regions.  We proposed that this competition occurs via direct binding of Tbx6 to the enhancer 
regions of Tbx15/Tbx18 downstream targets, thus precluding Tbx15/Tbx18 binding.  This 
competition is not exclusive to the Dll1 enhancer, as we also noted that competition could occur 
at the ANF enhancer in luciferase assays.  Farin et al. hypothesized that Tbx18 may compete with 
Tbx5 at the ANF promoter in the heart to inhibit expression within the sinus horn mesenchyme 
(Farin et al., 2007).  Tbx6 only weakly activates transcription from the ANF promoter, however 
ANF is not an endogenous Tbx6 target.  Nevertheless, Tbx6-mediated activation decreased in a 
linear fashion with the addition of Tbx18.  Addition of Tbx15 did not decrease Tbx6 activation, 
which could reflect inefficient binding of Tbx15 to the ANF promoter, or may be because 
considerably less myc-Tbx15 is produced compared to myc-Tbx6 when equivalent amounts of 
plasmid were transfected.   
It is interesting to note that although the closely related Tbx18 and Tbx15 both interact 
with the Groucho co-repressor via a conserved eh1 domain within the N-terminus of the protein 
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to serve as transcriptional repressors (Farin et al., 2007), Tbx18 competes more efficiently than 
Tbx15 in our luciferase assays at both tested enhancers. Again, this result may be due to the 
amount of protein produced: Tbx18 is expressed at a 2-fold greater level than Tbx6, while Tbx15 
is expressed at a 1.7-fold lower level than Tbx6.  These differences in expression level could 
contribute to their ability to compete with Tbx6 in our luciferase transcriptional assays.   
PCR-based binding site selection assays demonstrated that both Tbx15 and Tbx18 bind to 
the canonical 5’-AGGTGT-3’ sequences and prefer a GA dinucleotide 3’ of the half-site. 
Differences in binding site selection between Tbx18 and Tbx15 may lie in preferences for 
orientation of multiple half-sites.  Tbx18 exclusively preferred a palindromic binding sequence, 
while Tbx15 equally selected palindromic sequences and direct repeats of the core sequence 
(Farin et al., 2007).  This may result in differential ability to compete with Tbx6 at each of the 
enhancers tested.  Another possibility that is not mutually exclusive is that Tbx18 could simply 
serve as a stronger transcriptional repressor than Tbx15.  This is consistent with previous 
observations whereby Tbx18 fused to the Gal4 DNA binding domain repressed transcription 
from a Gal4-UAS synthetic enhancer more effectively than Tbx15 (Farin et al., 2007).  
In the absence of additional targets for these transcription factors and antibodies suitable 
for ChIP, we can only speculate at the mechanism underlying the phenotypes generated by 
ectopic Tbx6 expression.  Based on these phenotypes and our luciferase assay results, we suggest 
that competition for binding to endogenous enhancers occurs between the ectopically expressed 
Tbx6 and endogenously expressed Tbx15 and Tbx18 within somitic tissue and the limb bud 
mesenchyme.  The DNA binding domain of Tbx18 and Tbx15 are also able to compete with 
Tbx6 to effectively lower its activity, further suggesting that the observed competition occurs at 
the level of DNA binding.  Alternatively, ectopic expression of Tbx6 may compete for a 
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common co-factor of Tbx15 and Tbx18 that binds within the DNA binding domain.  Previous 
studies have suggested that Tbx15 and Tbx18 may interact with the paired box transcription 
factor, Pax3 via the DNA binding domain (Farin et al., 2008).  It is not known whether Tbx6 can 
interact with Pax3.  
In tissues where multiple T-box factors are normally co-expressed, competition likely 
represents a mechanism that controls proper transcription of target genes.  This competition 
would be held in check when all factors are expressed at their proper levels; however in 
situations whereby the relative levels of T-box transcription factors are altered would result in 
inappropriate target gene expression.  Haploinsufficiency for human TBX1, TBX3, TBX4, TBX5, 
and TBX22 result in the syndromes DiGeorge, ulna-mammary, Small Patella, Holt-Oram, and X-
linked cleft palate with ankyloglossia, respectively (Baldini, 2003; Bamshad et al., 1997; Basson 
et al., 1997; Bongers et al., 2004; Braybrook et al., 2001).  Developmental processes are 
therefore exquisitely sensitive to the levels of T-box transcription factors.  Accordingly, reducing 
the effective amount of any particular T-box factor could allow for competition between resident 
T-box factors and this competition could contribute to the observed phenotypes.  This highlights 
the importance of maintaining not only proper expression domains, but also the appropriate 
levels of T-box transcription factors during development.  
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5.0  CONCLUSIONS AND FUTURE DIRECTIONS 
T-box transcription factors are critical regulators of cell type specification, differentiation, and 
proliferation during embryonic development.  My thesis work has centered around two particular 
family members; T and Tbx6 and how they control cell fate decisions in their endogenous 
domains.  In addition, we investigated how Tbx6 interacts with other T-box transcription factors 
when it is ectopically expressed.  While this work focuses on one family of transcription factors, 
it implies that transcription factors that share a conserved DBD may also compete for 
downstream targets in vivo when they are co-expressed and that this competition contributes to 
the overall developmental dynamics of the organism.    
5.1 CONCLUSIONS 
5.1.1 T and Tbx6 compete for binding at the Dll1-msd enhancer 
T and Tbx6 are expressed in an overlapping domain in the PS and tailbud, and bind to the same 
core 5’-AGGTGT-3’ sequence, leading to the hypothesis that T and Tbx6 compete for a common 
subset of shared targets in vivo.  Additional genetic evidence for competition between these two 
factors in vivo is discussed in detail in section 2.1.1. We chose to use the Dll1-msd enhancer as a 
model to further characterize the potential competition between these two factors because Dll1 is 
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a known downstream target of Tbx6 and is co-expressed in the PS and tailbud with both T and 
Tbx6 (White and Chapman, 2005).  The work described in this thesis has demonstrated that Dll1 
is not only a target of Tbx6, but also of T, the first known downstream target of T in the mouse 
embryo.  Furthermore, we demonstrated that Tbx6 and T can differentially activate the Dll1-msd 
enhancer in luciferase transcriptional assays, and that addition of increasing amounts of T to a 
constant amount of Tbx6 lowers the overall RLUs observed in a dose-dependent manner.  We 
propose that the observed differential activity is the result of distinctive binding preferences of T 
and Tbx6 for the four putative T-box binding sites within the Dll1-msd enhancer. In addition, as 
a non-exclusive alternative, T and Tbx6 may compete for a common co-factor that could result in 
the observed competition in our luciferase assays.  We believe that in the case of Dll1-msd, 
competition for physically binding at the enhancer plays a role in the transcriptional activity of T 
and Tbx6 when co-expressed in our luciferase assays based on ChIP and EMSA data, although 
competition for a common co-factor may also contribute. 
Tbx6 binds to BS1 and BS2 with similar affinity, while T only binds significantly to BS2, 
with a ten-fold lower affinity than Tbx6. This difference in binding affinity may account for the 
differences in transcriptional activity levels noted in our luciferase assays.  We therefore 
hypothesize that the observed competition between T and Tbx6 in our luciferase assays is due to 
the fact that addition of increasing amounts of T simply increases the stochastic chance that T 
will be bound at BS2 rather than Tbx6.  These assays do not take into account the possibility that 
either T or Tbx6 may bind any combination of the four binding sites in Dll1-msd cooperatively.  
Cooperative binding of Tbx6 to the Dll1-msd enhancer may explain why such a significant drop 
in RLUs is observed upon the addition of relatively small amounts of T in our luciferase assays.  
Future experiments to address potential cooperativity are outlined in section 5.2.2. 
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It has been previously noted that T-box transcription factors prefer different flanking 
sequences outside of the core 5’-AGGTGT-3’ sequence and also orientation of the half-sites.  
Contrary to this observation, inspection of the crystal structures of the DBD of T and Tbx3 
reveals no obvious structural reasons why T-box transcription factors should prefer different 
flanking nucleotides, as all amino acids that make direct contact with the DNA are highly 
conserved (Coll et al., 2002; Muller and Herrmann, 1997).  Despite this, PCR based binding site 
selection experiments have demonstrated that T prefers a GA dinucleotide in the +1 and +2 
positions 3’ to the core sequence, while Tbx6 prefers N(A/G), (where N is any nucleotide) 
(Kispert and Hermann, 1993; White and Chapman, 2005).  Accordingly, both T and Tbx6 are 
able to bind BS2, which contains a GA dinucleotide 3’ to the core sequence, while T does not 
significantly bind BS1, which contains a TG dinucleotide.  Interestingly, neither T nor Tbx6 
bound BS3, which contains a consensus core sequence followed by a 3’ CC dinucleotide that is 
not preferred by either.  This demonstrates that nucleotides 3’ to the core sequence are indeed 
important for T-box factor specificity, although perhaps this is an artifact of the in vitro assay 
system.  It is possible that yet unknown, distinct factors may interact with T and Tbx6 to 
influence the binding preferences for flanking sequences.   
Overall, this work has contributed to our understanding of how co-expressed T-box 
transcription factors may interact when co-expressed in a tissue in vivo. Prior to this work, it was 
unknown how T and Tbx6 interacted in the PS where they are co-expressed.  Several studies 
have documented competition for binding to enhancer regions and common co-factors between 
co-expressed T-box transcription factors in other tissues (Farin et al., 2007; Goering et al., 2003; 
Habets et al., 2002).  Specifically, this work implies that there is a common subset of genes 
shared between T and Tbx6, and that a competition may exist in vivo for binding at the enhancers 
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of these genes. Additional competition between T and Tbx6 may occur via competing for a 
common co-factor, although this is difficult to investigate further as there is no known 
interacting partners of murine T or Tbx6 known to date.  Experimental strategies to elucidate 
both common and unique downstream targets of both Tbx6 and T are outlined in section 5.2.3. 
5.1.2 In vivo relevance of T and Tbx6 competition 
We hypothesize that T is required to maintain cells in a PS-like state, while Tbx6 is required to 
push cells toward a PSM fate.  In this scheme, maintaining the correct relative levels of Tbx6 and 
T is essential for the proper cell fate determination.  The phenotypes of embryos with altered 
levels of Tbx6 and T relative to each other also support this hypothesis.  For example, increased 
amounts of Tbx6 relative to T in the Tg46 homozygous embryos resulted in axis truncations 
similar to a T heterozygous phenotype, perhaps indicating that cells are prematurely exiting the 
PS and adopting a PSM fate. 
 Furthermore, we hypothesize that there is a common subset of transcriptional targets 
shared between Tbx6 and T in the tailbud, where they may have inherently different 
transcriptional activities.  T may function at these targets to attenuate a Tbx6-based 
transcriptional program, thereby allowing cells to maintain a PS-like fate and continue to extend 
the body axis.  Cells that accumulate more Tbx6 relative to T would then exit the PS and adopt a 
PSM fate.  In this manner, transcriptional interplay between Tbx6 and T may regulate the 
transition between PS and PSM fate in vivo. 
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5.1.3 Ectopic expression of Tbx6 results in competition with other T-box transcription 
factors 
In addition to the competition between Tbx6 and T in the PS and tailbud of the embryo, we have 
also demonstrated that Tbx6 can compete with other T-box transcription factors when expressed 
outside of its endogenous expression domain.  We developed a 3-component transgenic system 
that allowed us to drive ectopic expression of Tbx6 in the PSM and in all downstream derivatives 
in particular the somites, in addition to the limb buds.  Although expression was highly mosaic, 
common skeletal defects were noted in 3-component embryos treated with DOX at e8.5 and 
dissected at e13.5.  These included shortened and malformed fore- and hindlimbs, expansion of 
the vertebral pedicles, fusion and malformations of the atlas and axis, missing or underdeveloped 
digits and distal portions of the ribs, and occasionally an ectopic foramen within the scapular 
blade.  These phenotypes are strikingly similar to those observed in Tbx18 and Tbx15 null 
embryos (Bussen et al., 2004; Singh et al., 2005), suggesting that Tbx6 has the ability to compete 
with other T-box transcription factors when expressed outside of its endogenous domain.  
Although it had been previously proposed that Tbx6 and Tbx18 compete for binding at the Dll1 
enhancer (Farin et al., 2007), our work supplies the first in vivo evidence of competition between 
these factors.  Although we hypothesize that this competition occurs at the level of DNA 
binding, it is certainly possible that ectopic expression of Tbx6 competes for a common co-factor 
of Tbx15 and Tbx18. Tbx15 and Tbx18 interact with the paired box protein, Pax3 via their DNA 
binding domains (Farin et al., 2008).  It is not known whether Tbx6 has the ability to interact 
with Pax3, although it is certainly possible that Tbx6 can also interact with Pax3, thereby 
reducing the ability of Tbx15 or Tbx18 to exert their transcriptional effects in vivo. 
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In our luciferase assays, myc-Tbx18 was a much better competitor than Tbx15 at both 
tested enhancers (Dll1-msd, and ANF).  PCR-based binding site selection assays revealed that 
both Tbx15 and Tbx18 bind the same sequences, however Tbx18 exclusively preferred a 
palindromic binding sequence, while Tbx15 equally selected palindromic sequences and direct 
repeats of the core sequence (Farin et al., 2007). This indicates that like T and Tbx6, differences 
in binding preferences may exist between Tbx18 and Tbx15.  These differences may ultimately 
result in the differential ability to compete with Tbx6 at each of the tested enhancers.  
Additionally, it has been previously shown that Tbx18 is a better transcriptional repressor at a 
synthetic enhancer compared to Tbx15 (Farin et al., 2007). We observed differential expression 
of Tbx18 and Tbx15 relative to Tbx6 that may play a role in their lowered ability to repress a 
Tbx6-mediated transcriptional program. The studies by Farin et al. did not examine the 
expression levels of these proteins relative to one another. Overall, this data suggests that 
ectopically expressed Tbx6 is able to compete at the level of DNA binding with other T-box 
transcription factors resulting in phenotypes resembling Tbx15 and Tbx18 null embryos.  There 
are no known downstream targets of Tbx15, and Dll1 and ANF are the only known downstream 
targets of Tbx18.  Once additional targets of Tbx15 and Tbx18 are identified, it will be 
interesting to examine how their expression level changes when Tbx6 is misexpressed.  We 
predict that ectopic expression of Tbx6 may result in an upregulation of Tbx15 and Tbx18 target 
genes in this ectopic expression domain, as both Tbx15 and Tbx18 serve as transcriptional 
repressors.  
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5.1.4 Competition between other transcription factors with conserved DNA binding 
domains 
Proper temporal and spatial gene expression requires a high degree of transcription factor 
specificity for recognition sequences.  This represents a daunting task if one considers that a 
random 6-mer sequence will be represented within the human genome greater than 700,000 
times just by chance (Georges et al., 2010).   
Although this work focuses on the T-box family of transcription factors, there are other 
families of transcription factors that share a conserved DBD, and therefore bind similar DNA 
sequences. This implies that this work can be extrapolated to other paralogous transcription 
factors co-expressed either during development or in adult tissues. Within these paralogous 
transcription factor families limited differences in specificity for binding sites or interactions 
with different co-factors that modify behavior partially encompass mechanisms of specific 
modulation of target genes.  Two examples of other well-characterized families of transcription 
factors with similar properties to the T-box family of transcription factors are the Forkhead box 
and Homeobox transcription factors. 
5.1.4.1 Forkhead box (Fox) transcription factor family specificity 
Fox transcription factors contain a 110 amino acid DBD that is conserved from yeast to humans. 
Humans have over forty Fox proteins, grouped into subfamilies that are varied and share little 
sequence similarity or global domain architecture outside of the DBD. Similar to the T-box 
family, the conserved nature of the Forkhead DBD allows for binding to a consensus 5’-
(G/A)(T/C)(A/C)AA(C/T)A-3’ sequence (Friedman and Kaestner, 2006).  Specificity for 
particular nucleotides within this consensus sequence are subfamily dependent and can partially, 
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but not entirely, explain Fox transcription factor specificity (Georges et al., 2010).  As with T-
box transcription factors, direct sequence-specific contact between the Fox DBD and DNA is 
primarily achieved through invariantly conserved residues (Littler et al., 2010).   Additional 
levels of specificity of the Fox transcription factor family has been partially attributed to unique 
affinities for tandem copies (either palindromic repeats or direct repeats) of the consensus 
binding site, although these are rare and poorly conserved throughout the genome (Korver et al., 
1997; Littler et al., 2010), suggesting that additional levels of specificity exist for Fox 
transcription factors.  As with T-box factors, concurrent binding of other transcription factors is 
essential for activation of downstream targets.  For example, cis-binding of both Foxa1 and the 
glucocorticoid nuclear hormone receptor is required during the fasting response to regulate 
expression of downstream targets in the adult mouse, such as proglucagon (Kaestner et al., 1999; 
Zhang et al., 2005).  Additionally, Fox transcription factors also interact directly with other 
transcription factors to regulate their downstream targets.  For instance, Engrailed, a 
homeodomain transcription factor, directly interacts with Foxa2 to regulate the downstream 
target MAP1B, which encodes a neuronal associated microtubule binding protein that is 
important for the development of the nervous system (Foucher et al., 2003). This data in 
combination with what is known about the regulation of T-box targets indicates a common theme 
amongst families of paralogous transcription factors for proper regulation of downstream targets 
in vivo. 
5.1.4.2 Homeobox (Hox) transcription factor family specificity 
Hox genes encode transcription factors found in all animal species that act during development 
and contain a highly conserved sixty amino acid motif (the homeodomain) that binds DNA in a 
sequence-specific manner (Levine and Hoey, 1988).  In mammals, there are 39 Hox genes 
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organized in four clusters (A-D) on different chromosomes, and are thought to have arisen 
through cis-amplification and trans-duplication (Scott, 1992).  Similar to T-box transcription 
factors, certain Hox transcription factors are more effective at activating transcription from some 
enhancer regions than other Hox transcription factors. Thus, the overall transcriptional output is 
the result of a competition between co-expressed Hox genes (Goff and Tabin, 1997).  In support 
of this hypothesis is the observation that misexpression of Hoxd-13 in the developing chick limb 
appears to act in a dominant-negative manner to suppress Hoxd-11 mediated transcription (Goff 
and Tabin, 1997).  This highlights the importance of the relative levels of paralogous 
transcription factors.   
Crystal structures of several homeodomain proteins bound to the consensus 5’-TAAT-3’ 
motif revealed conservation of amino acids that directly contact the DNA (Kissinger et al., 1990; 
Piper et al., 1999; Qian et al., 1989).  As with T-box transcription factors, the flanking 
nucleotides 3’ of the conserved core binding sequence directly influence DNA binding affinity 
(Pellerin et al., 1994), despite the fact that the residue that makes contact with the nucleotides 3’ 
of the core sequence is completely conserved across all family members (Ekker et al., 1992).  
The perplexing issue of altered affinity for flanking sequences when all amino acids making 
direct DNA contacts are highly conserved is clearly a common theme in transcriptional 
regulation by paralogous transcription factors.   
 Hox protein specificity is also partially determined by interactions with co-factors.  Many 
identified Hox binding sites are paired with Pbx/Meis binding sites in target genes. Several Hox 
proteins directly interact with Pbx proteins to form a higher order complex where each 
component binds DNA to regulate transcription (Svingen and Tonissen, 2006).  In the case of 
Hoxb8, which specifies thoracic vertebrae, mutation of the Pbx interaction domain results in an 
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anterior homeotic transformation, similar to a Hoxb8 null phenotype (Medina-Martinez and 
Ramirez-Solis, 2003).   
 Overall, the similarities between target regulation in the Hox family and T-box family 
indicates a common theme for paralogous families of transcription factors in target regulation.   
5.1.5 Summary 
Integration of multiple strategies likely helps differentiate transcription factors with related 
DBDs to ensure specific downstream transcriptional responses.  Arrangement and spacing of 
binding sites, flanking nucleotides, synergistic activation of transcription in concert with other 
transcription factors, and direct interaction with a wide array of other protein modifiers can act in 
a complementary fashion to ensure specificity of a particular transcription factor.  Each of these 
effects alone may not entirely explain transcription factor specificity, but in combination may 
allow for exquisitely sensitive control of this process.  We hypothesize that results from studies 
within this thesis can therefore be applied not only to the T-box family of transcription factors, 
but can be extrapolated to other families such as the Fox and Hox families with conserved 
DBDs. 
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5.2 FUTURE DIRECTIONS 
5.2.1 Potential uses for 3-component fibroblasts  
We have demonstrated that approximately 50% of fibroblasts derived from 3-component 
embryos express myc-Tbx6.  These myc-Tbx6 positive fibroblasts were derived from 
mesodermal tissue cell types.  As a true ‘embryonic mesoderm’ cell line does not exist, these 
fibroblast cell lines may also be useful for studies to identify interacting proteins and protein 
modifications in a more relevant embryonic mesoderm cell type.  As these fibroblasts are not 
immortalized, they can only be passaged approximately four times before they senesce.  This 
means that access to a source of the embryos themselves must be maintained to perform multiple 
rounds of these types of experiments.  To this end, one could utilize the population of cells for 
immunoprecipitation followed by mass spectrometry to identify potential Tbx6 interacting 
proteins.  These potential interacting proteins may not be expressed in other commercially 
available cell lines commonly used for investigation of T-box transcription factors, such as 
HEK293T, HeLa, or Cos-7.  To date, there are no known interacting partners of murine Tbx6.   
5.2.2  Investigation of potential cooperativity at the Dll1-msd enhancer 
While our luciferase transcriptional assays demonstrate Tbx6 and T activate transcription from 
the Dll1-msd enhancer at different levels, these assays did not take into account the possibility of 
cooperative binding of any combination of the four binding sites.  Cooperative binding of Tbx6 
to the Dll1-msd enhancer may explain why a significant drop in RLUs is observed upon the 
addition of relatively small amounts of T in our luciferase assays.   Although T does not bind 
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significantly to BS1, in this scenario, binding of T to BS2 would block the ability of Tbx6 to 
bind not only to BS2, but also BS1, thereby greatly reducing the overall RLUs measured when a 
small amount of T is added. 
To investigate the potential role of cooperative binding, we propose to make site-directed 
mutants of each of the four BS individually, and in combination and test how these mutations 
affect T and Tbx6. Based on our EMSA data, we hypothesize that mutation of BS3 and BS4 will 
have no effect on Tbx6 or T transcriptional activity.  We expect that mutation of BS2 would 
effectively mitigate T’s transcriptional activation, as T only binds significantly to BS2.  In 
contrast, if there is no cooperativity of binding, mutation of BS2 should not completely diminish 
Tbx6 activation, as it would still be able to bind BS1.  Mutation of BS1 may only affect the 
transcriptional activity of Tbx6, as T did not significantly bind BS1.  If mutation of BS1 affects 
T’s transcriptional activity, it would suggest that BS1 is a physiologically relevant site for T.   
We can also make combinatorial mutations, such as a mutation in BS2 and BS1, which 
we predict would abrogate all transcriptional activity from the Dll1-msd enhancer for both T and 
Tbx6.  If transcriptional activity were not completely extinguished for both T and Tbx6, it would 
indicate that BS3 and BS4 could potentially play a role in activation from the enhancer at a level 
that cannot be detected in our EMSA experiments.  Cooperativity in binding can enhance 
specificity of transcription factors and generally implies dimerization between the two 
transcription factors. This dimerization leads to a sigmoidal response to transcription factor 
concentrations, allowing for a exquisitely sensitive molecular switch (Georges et al., 2010).  This 
is interesting in that sigmoidal binding behavior was observed in our quantitative EMSA 
experiments using BS1 and BS2 of the Dll1-msd and the DBD of Tbx6 and T.   
 131 
Overall, dissecting of the role of each binding site should lend insight into potential 
differences and/or similarities in T and Tbx6 transcriptional regulation from the Dll1-msd 
enhancer.  Additionally, these assays should allow us to investigate the potential role of 
cooperativity for binding each of the four binding sites.  
5.2.3 ChIP-seq to identify common and unique targets of Tbx6 and T 
In this work, we demonstrated that Tbx6 and T share the downstream target Dll1, and that they 
have inherently different transcriptional activities at the Dll1-msd enhancer in our luciferase 
assays. We hypothesize that there are additional shared targets of Tbx6 and T, in addition to 
unique targets for each.  To identify these targets, we plan to use ChIP followed by next-
generation sequencing (ChIP-seq).  To this end, we have currently collected over 1,500 tailbud 
and somitic tissue fragments for use in ChIP-seq experiments.  We estimate 700 tissue fragments 
are necessary for each antibody used.   
Briefly, the samples will be subjected to identical immunoprecipitation conditions as for 
the ChIP experiments discussed in section 2.4.3, and subsequently sent to the University of 
Pittsburgh Center for Genomics and Proteomics, who will further prepare samples to run on the 
Applied Biosystems’ SolID3 massively parallel sequencer.  Sequences generated from 
immunoprecipitated fragments will be compared to sequences generated from input DNA to 
account for biases in sequencing and shearing efficiency. Enrichment of the immunoprecipitated 
regions as compared to input DNA will delineate where each factor is bound within the genome.  
Furthermore, The Center for Genomics and Proteomics will develop algorithms to search within 
enriched sequences for the canonical 5’-AGGTGT-3’ sequences.  We expect that true targets of 
Tbx6 and T will harbor this sequence within the immunoprecipitated region.  A similar approach 
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has been used to identify common and unique downstream targets of two related transcription 
factors, FoxA1 and FoxA3, in the development and specification of the hepatic lineage 
(Motallebipour et al., 2009).  
Comparison of the selected genomic regions from Tbx6 and T will allow us to begin to 
uncover shared and unique targets of each factor.  Sequence data can be compiled to begin to 
identify differences in orientation of half-sites and flanking nucleotides preferences of Tbx6 and 
T in vivo, and compared to in vitro PCR-based binding site selection data.  Once these targets are 
uncovered, we can use our genetic toolbox to alter the expression levels of Tbx6 and T within the 
tailbud, followed by directed ChIP and quantitative PCR to determine whether occupancy at 
these targets is altered when relative expression levels of Tbx6 or T is changed. 
Lastly, we plan to search the enhancer regions of T and Tbx6 targets for potential binding 
sites of other transcription factors.  Expression of the four known downstream targets of Tbx6 is 
dependent on not only Tbx6, but also other signaling pathways (see section 1.4.4), ensuring tight 
regulation of expression of these targets.  For example, expression of Dll1 within the PSM 
depends on the presence of both Tbx6 and LEF/TCF transcription factors (Hofmann et al., 2004).  
We predict that other downstream targets of Tbx6 and T will also require input from other 
signaling pathways to properly regulate expression of these targets.  
The enhancer regions of target genes can then be further dissected using cell-based assays 
and biochemical techniques as is described in this work to characterize how T and Tbx6 act 
independently and together to regulate expression of downstream targets in vivo.  The broad 
concepts derived from this work can be applied to other tissues in development with co-
expression of more than one T-box transcription factor, as well as other families of transcription 
factors such as the Fox family and the Hox family that share a conserved DBD. 
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6.0  MATERIALS AND METHODS 
6.1 GENERAL CELL CULTURE AND TRANSFECTIONS 
Cell lines were maintained in a 37oC incubator with 5% CO2 and passaged regularly (every 2-3 
days).  HEK293T, NIH3T3, and isolated embryonic fibroblast cells were grown in DMEM + 
10% fetal calf serum, 1x Penicillin/Streptomyocin, and 1x L-glutamine with regular media 
changes.  All transfections were performed with cells in suspension using 5μL of Lipofectamine 
(Invitrogen) 2000 per 35mm dish and DNA diluted in Optimem media (Gibco).   
6.2 WESTERN BLOTTING 
Tissue dissected from embryos or tissue culture cells were treated with RIPA buffer with added 
protease inhibitor cocktail (Sigma); tissue was also dounce homogenized to facilitate lysis.  
When indicated, Bradford dye assay was performed to determine total protein concentration to 
ensure equal loading. Lysates were loaded onto a SDS-PAGE gel, and transferred to 
nitrocellulose (Immobilon).  The membrane was blocked in TBTT + 5% dry milk (blocking 
buffer), and then incubated in the appropriate primary antibody (1:500 rabbit-anti-Tbx6, 1:500 
mouse-anti-myc (Sigma), 1:500 goat-anti-T (Santa Cruz), 1:500 mouse-anti-tubulin (Sigma) 
diluted in blocking buffer, and subsequently incubated in horseradish peroxidase-conjugated 
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secondary antibody (1:2500 dilution in blocking buffer).  Some blots were subsequently stripped 
and re-probed with anti-tubulin (1:500 dilution, Sigma) in blocking buffer to ensure equal 
loading.  
6.3 IMMUNOFLUORESCENCE  
Cells were transiently transfected in 6-well plate with a sterilized coverslip.  Twenty-four hours 
later, cells were fixed in 4% paraformaldehyde in PBS, and permeablized to allow antigen 
retrieval in PBS + 0.1% Triton X-100.  5% normal goat serum (NGS) or normal donkey serum 
(NDS, for goat-anti-T primary antibody) in PBS was used as a blocking solution.  Primary 
antibodies were diluted in blocking serum:  1:250 mouse-anti-myc (Sigma), 1:250 rabbit-anti-
Tbx6, 1:250 goat-anti-T (Santa Cruz) for one hour at room temperature.  Coverslips were washed 
three times in PBS.  Appropriate secondary antibodies (Alexa fluor, Invitrogen) at 1:500 
concentration with 1:2000 TO-PRO3 were subsequently diluted in blocking serum and added for 
one hour.  Coverslips were washed three times in PBS and mounted in Vectashield mounting 
medium.  
All images were captured on a BioRad scanning laser confocal microscope, and 
assembled using ObjectImage2.10 and Photoshop.   
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6.4 PREPARATION OF NUCLEAR LYSATES 
Nuclear lysates were prepared according to a protocol adapted from Wadman et al. (Wadman et 
al., 1997).  Briefly, 5x107 cells (approximately one confluent well of a 6-well plate) were washed 
twice with ice cold PBS and lysed with 500μL of Buffer A (10mM HEPES, 1.5 mM MgCl2, 
10mM KCl, 0.5 mM DTT, with added protease inhibitors, pH 7.9) and incubated on ice for 15 
minutes. NP-40 was added to a final concentration of 0.5%, and cells were vortexed for 10 
seconds. Nuclei were pelleted by centrifugation at 6500g for 30 seconds.  Supernatant from this 
spin was considered the “cytoplasmic fraction”.  The nuclear pellet was resuspended in 150μL 
Buffer C (20mM HEPES, 1.5mM MgCl2, 420mM NaCl, 0.2mM EDTA, 25% v/v glycerol, with 
protease inhibitors, pH 7.9) and rotated at 4oC for 30 minutes.  Lysed nuclei were centrifuged at 
full-speed for 10 minutes, and the supernatant was collected as the “nuclear fraction”.  
6.5 EMSA 
Sources of proteins included nuclear lysates prepared from transfected HEK293T cells or 
purified proteins, as indicated.  In all cases, a Bradford assay was performed to determine total 
protein concentration, and equivalent amounts of total protein were used in EMSA reactions. 3μg 
of total protein from nuclear extracts were used.  Amounts of purified proteins used are as 
indicated.   
Oligonucleotides were end-labeled with γ-32P-ATP using T4 polynucleotide kinase.  
Oligonuclotides were then annealed by placing in a water bath at 95oC for 5 minutes, then 
allowing to cool to room temperature (power turned off on water bath). After annealing, 
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purification was performed using Micro Bio-Spin P-30 Tris purification columns (BioRad).  The 
percentage of double-stranded versus single-stranded probe was determined by running probes 
on an 18% non-denaturing PAGE, and quantitating the fraction of double stranded probe using 
the Fuji BAS-2500 Phosphoimager and ImageGauge software. The percentage of double 
stranded probe recovered was greater than 85% in all cases. Subsequently, the percentage of 
double-stranded probe for each experiment was standardized so equivalent amounts were used.  
All EMSA binding reactions were prepared in a final reaction volume of 10μL in BBT buffer 
(25mM HEPES pH 7.4, 75mM NaCl, 1mM DTT. 0.25mM EDTA, 0.1% NP-40, 1mM MgCl2, 
10% glycerol, 10μg/mL BSA).  0.1mg/mL Poly dI-dC was added as a non-specific competitor.
 Binding reactions were incubated at room temperature for 20 minutes before addition of 
1μg of antibody (anti-Tbx6 or anti-myc).  After addition of antibody, reactions were incubated at 
room temperature for 15 minutes before loading on 4-6% non-denaturing PAGE (37.5:1) run in 
1x TAE. Gels were dried unfixed, exposed to a phosphoimager screen and imaged on a Fuji 
BAS-2500 Phosphoimager.   
Oligonucleotides used: (bold letters indicate core binding sequence) 
Tbind: 5’-CTAGTCACACCTAGGTGTGAAATT-3’ 
Thalf: 5’-ATCGAATTCAGGTGTGAAATTGGATCCACT-3 
Tmut: 5’-CTAGTCACACCTATTTTTGAAATT-3’ 
Dll1BS1: 5’-TCACTGTAGGTGTTGCTGTCCTGT-3’ 
Dll1BS2: 5’-TCCCGAGGTGTGATTCTTGGA-3’ 
Dll1BS3: 5’-GTGGATCCAGGTGTCCTCACTGGGCTGC-3’ 
Dll1BS4: 5’-TGGATCCTAGGGTGTACCTGACGGCTGC-3’ 
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6.6 PRODUCTION OF RECOMBINANT TBX6-DBD AND T-DBD 
The region of T and Tbx6 corresponding to the T-box DNA binding domain (Tbx6: AA 94-195; 
T: AA 41-223) was PCR amplified and cloned into the pTOPO151 vector, producing a 
Histidine-tagged fusion protein.  Transformed bacterial cultures were auto-induced, lysed and 
His-tagged fusion proteins were purified over a nickel-NTA column.  Subsequently a sizing 
column was utilized to exclude large aggregates.  Limited trypsin proteolysis revealed that >90% 
of isolated, purified proteins were correctly folded.   
6.7 QUANTITATIVE EMSA 
EMSA reactions were prepared as described in section 6.6, except increasing amounts of Tbx6-
DBD (range: 2.1 x 10-8 – 2.1 x 10-5M) or T-DBD (range: 4.0 x 10-6 – 2.4 x 10-5M) were added to 
a constant, limiting amount of labeled BS1-4 oligonucleotides (10pM) and incubated one hour at 
room temperature to ensure reactions were at equilibrium. Reactions were run on a 6% non-
denaturing PAGE. Quantitation was performed as described in (Harada et al., 1994).  Briefly, the 
amount of free and bound DNA was quantitated using a Fuji BAS-2500 phosphoimager and 
analysis with ImageGauge software.  Percentage of bound DNA was determined by the 
following formula:  (Shifted DNA)/(Shifted DNA+Free DNA).  The concentration of Tbx6-DBD 
or T-DBD was plotted versus the percentage of DNA bound.   The data was fit to a 3-parameter 
Hill equation using SigmaPlot software (equation: y= axb/(cb + xb), where a= the maximum value 
of y (percent bound), b= the Hill co-efficient, and c= Kd).   
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6.8 LUCIFERASE ASSAYS 
1x105 HEK293T cells were plated per well in a tissue culture treated 96-well dish, and 
transfected in suspension. 10-25ng of the indicated luciferase reporter vector was transfected per 
well along with 1 ng of pRenilla Luciferase-CMV, which served as an internal control.  Amounts 
of protein expression construct are as indicated in experiments and empty pCS3 vector was 
transfected where needed to keep amounts of transfected DNA constant.  Twenty-four hours 
after transfection, cells were processed with Dual Glo luciferase reagent (Promega) according to 
manufacturer’s directions, and intensity measured on a Berthold XS3 LB960 luminometer.  
Luciferase readings were normalized to the Renilla luciferase, and ratios were normalized to 
levels of luciferase reporter when transfected with a protein empty vector control as follows:  
(Luciferase reading/Renilla reading) = Ratio for each condition. Ratio for each condition was 
then divided by the ratio obtained with the empty vector control to account for background 
activation of the reporter.  Mean values for results performed in triplicate, and repeated at least 
twice were graphed and standard error was calculated (Standard Error = standard 
deviation/square root of number of replicates).   
6.9 CHROMATIN IMMUNOPRECIPITATIONS (CHIP) 
Confluent 100mm dishes of cells or approximately 50 dissected tailbuds or equivalent portions 
of somitic tissue were processed using the ChIP kit from Millipore, according to the 
manufacture’s directions.  Briefly, formaldehyde at a final concentration of 1% in PBS was 
added to cells or tissue and incubated at 37oC for ten minutes. After fixation, cells were lysed 
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with SDS lysis buffer (provided in kit) with added protease inhibitor cocktail (Sigma) for ten 
minutes on ice.  200μL was added for every 1x106 cells or fifty dissected tissue pieces.  
Dissected tissue was also dounce homogenized at this time to break up large tissue pieces.  The 
released DNA with bound proteins was sonicated three times for three seconds each to shear the 
DNA to 200-1000 base-pair fragments.  Shearing efficiency was initially tested by collecting 
20μL of sheared lysate and running it on a 1.5% agarose gel.  The lysate was pre-cleared with 
protein sepharose A or G, depending on the antibody used, for thirty minutes at 4oC. 2.5% of the 
total volume was removed as “input”.  Lysates were split into two pools:  one which had primary 
antibody added (3μg goat anti-T, Santa Cruz Biotechnology or rabbit anti-Tbx6) and one pool 
which had no antibody added, overnight at 4oC. Protein sepharose A (rabbit anti-Tbx6) or protein 
sepharose G (goat anti-T) were subsequently added to collect all antibody bound fragments.  
Washing and collection of DNA fragments was performed according to  
ChIP kit manufacturer’s directions except Qiagen PCR purification columns were used to purify 
immunoprecipitated DNA rather than Phenol:Sevaq extraction. Two separate radioactive PCR 
reactions were performed using 2μL of elutate with a standard PCR protocol.   An extension time 
of 30 seconds with an annealing temperature of 55oC for Dll1 and 65oC for Wnt7a for a total of 
25 cycles was utilized.   
PCR primers are as follows:  
Dll1-Fwd: 5’ – CATGCGAAGGTTTTCCTC – 3’ 
Dll1-Rev: 5’ – CCATCTTTAGAGGGGCC – 3’ 
Wnt7a-Fwd: 5’ - CTCTTCGGTGGTAGCTCTGG – 3’ 
Wnt7a-Rev: 5’ – CCTTCCCGAAGACAGTACGC – 3’   
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PCR products were run on a 6% polyacrylamide gel (29:1) in TAE, exposed to a phosphoimager 
plate, and imaged with a Fuji-BAS-2500 phosphoimager.   
6.10 GENERATION OF DLL1-MSD CRE RECOMBINASE TRANSGENIC MICE 
The Dll1-msd enhancer element was PCR amplified from C57Bl6/J wild type genomic DNA 
using the following primers: 5’-GAAGAAGAAGAGCAGGAAGGAG-3’ and 5’-
AGGTTTTTACACATCCATCAG-3’.  The resulting 1.5 kb product was digested with NotI and 
XbaI and the Dll1-msd enhancer element was cloned into the NotI/SpeI sites of pAKH-Cre9, 
upstream of the β-globin minimal promoter, a nuclear localized Cre recombinase and β-actin 
polyadenylation signal (pAKH gift of K. Hadjantonakis, Sloan Kettering).  The transgene insert 
was gel purified and injected into the pronuclei of fertilized eggs from FVB/N mice (Transgenic 
Core Facility, University of Pittsburgh Medical Center).  Two founder lines were established, 
both with similar Cre recombinase activity domains.  One line, Dll1-msd Cre Tg33, was chosen 
for further characterization.  Mice were genotyped for the presence of the Dll1-msd Cre 
transgene by PCR using primers specific to the Cre recombinase (forward 5’-
GGACATGTTCAGGGATCGCCAGGC-3’; reverse 5’- CGACGATGAAGCATGTTTAGCTG 
3’), which generates a 219 bp product. 
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6.11 CHARACTERIZATION OF DLL1-MSD CRE TRANSGENIC MICE 
To examine the spatial and temporal activity of the Dll1-msd Cre recombinase, Dll1-msd Cre 
transgenic mice were mated to ROSA26-lacZ reporter mice (Gt(ROSA)26Sortm1Sor/J) (Soriano, 
1999).  Embryos were dissected between e7.0 and e14.5, (embryonic day 0.5 corresponding to 
the day the vaginal plug was found).  Reporter gene activity was assayed by β-galactosidase 
staining according to standard protocols (Nagy et al., 2003).  Embryos were stained for two 
hours either at room temperature (RT) or 37oC or overnight at RT.  Following β-galactosidase 
staining, some embryos were fixed in Bouin’s fixative, paraffin embedded and sectioned.  
Sections were counterstained with eosin.  e13.5 and e14.5 embryos were fixed in 4% 
paraformaldehyde and frozen in OCT for cryosectioning and subsequent β-galactosidase staining 
according to standard protocols (Nagy et al., 2003). 
 
6.12 GENERATION OF DLL1-MSD CRE, ROSA26-RTTA EMBRYONIC 
FIBROBLASTS 
Fibroblasts were derived from embryos hemizygous for the Dll1-msd Cre transgene and 
heterozygous for ROSA26-rtTA (Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J, Jackson Lab) (Belteki et al., 
2005) according to standard protocols (Abbondanzo et al., 1993).  Briefly, e13.5 embryos were 
dissected free of extraembryonic tissue and the head and liver were removed.  In a second set of 
experiments, neural tissue, heart and lungs were also removed.  Isolated tissue was macerated by 
passing it through an 18-gauge needle and then cultured in DMEM supplemented with 10% fetal 
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calf serum.  Fibroblasts were expanded and at the fourth passage plated onto coverslips for 
immunocytochemistry.  Cells on coverslips were fixed in 4% paraformaldehyde, permeablized in 
0.1% Triton X-100 in PBS, and blocked in 5% goat serum in PBS.  Coverslips were incubated 
with rabbit anti-GFP antibody (Torey Pines Biolabs, 1:1000 dilution in blocking buffer), washed 
and then incubated with goat anti-rabbit 568-secondary antibody (Molecular Probes, 1:400 
dilution in blocking buffer) and TO-PRO3 nuclear stain (Molecular Probes, 1:1000 dilution in 
blocking buffer).  Cells were mounted on slides using Vectashield mounting medium and optical 
sections were visualized on a BioRad scanning laser confocal microscope.  Photoshop was used 
to merge the different channel images.  The number of EGFP positive nuclei or Tbx6 positive 
nuclei was divided by the total number of nuclei in each frame to determine the percentage of 
EGFP positive cells.  Two images derived from two separate coverslips were counted to obtain 
the average percentage of fibroblasts that were EGFP positive. 
6.13 IN SITU HYBRIDIZATIONS 
Whole-mount in situ hybridization was performed as previously described (Wilkinson, 1992) 
using antisense riboprobes for Dll1, Fgf8, mesp2, myogenin, Ripply2, Tbx6, Tbx18, Tbx15 and 
uncx4.1.  Hybridizations and washes were performed at 63°C.  
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6.14 WHOLE-MOUNT IMMUNOCYTOCHEMISTRY 
Immunocytochemistry was performed as described in Nagy et al. (2003). The Tbx6 N-terminal 
affinity purified antibody was used at a 1:500 dilution.  Goat anti-rabbit:HRP-conjugated 
secondary antibody (Jackson ImmunoResearch) was used at a 1:500 dilution and staining was 
performed in the presence of DAB, hydrogen peroxide and nickel chloride.   
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